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ABSTRACT 
Scott William Krabbe: Strategic Applications of New Redox Transformations in Organic Synthesis 
(Under the direction of Jeffrey S. Johnson) 
 
I. Copper(II)-Catalyzed Aerobic Hydroperoxidation of Meldrum’s Acid Derivatives and 
Application in Intramolecular Oxidation: A Conceptual Blueprint For O2/H2 Dihydroxylation 
 Aerobic hydroperoxidation of Meldrum’s acid derivatives via a Cu(II)-catalyzed process is 
presented. The mild reaction conditions are tolerant to pendant unsaturation allowing the formation of 
endoperoxides via electrophilic activation. Cleavage of the OO bond provides 1,n-diols with 
differentiation of the hydroxy groups. 
 
II. Copper-Catalyzed Asymmetric Hydrogenation of Aryl and Heteroaryl Ketones 
 High-throughput screening enabled the development of a Cu-based catalyst system for the 
asymmetric hydrogenation of prochiral aryl and heteroaryl ketones that operates at H2 pressures as low 
as 5 bar. A ligand combination of (R,S)-N-Me-3,5-xylyl-BoPhoz and tris(3,5-xylyl)phosphine provided 
benzylic alcohols in good yields and enantioselectivities. The electronic and steric characteristics of the 
ancillary triarylphosphine were important in determining both reactivity and selectivity. A library of novel 
chiral trisphosphine ligands was also prepared and investigated.  
iv 
 
III.  Asymmetric Total Syntheses of Megacerotonic Acid and Shimobashiric Acid A 
 The asymmetric total syntheses of the -benzylidene--butyrolactone natural products 
megacerotonic acid and shimobashiric acid A have been accomplished in nine and eleven steps, 
respectively, from simple, commercially available starting materials. The key step for each synthesis is the 
(arene)RuCl(monosulfonamide)-catalyzed dynamic kinetic resolution-asymmetric transfer hydrogenation 
(DKR-ATH) of racemic ,-diketo--aryl esters to establish the absolute stereochemistry. Intramolecular 
diastereoselective Dieckmann cyclization forms the lactone core and ketone reduction/alcohol elimination 
installs the -arylidene. 
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CHAPTER ONE: COPPER(II)-CATALYZED AEROBIC HYDROPEROXIDATION OF MELDRUM’S 
ACID DERIVATIVES AND APPLICATION IN INTRAMOLECULAR OXIDATION: A CONCEPTUAL 
BLUEPRINT FOR O2/H2 DIHYDROXYLATION
*
 
 
 
1.1 Introduction 
 
 The preparation of -functionalized carbonyl compounds is often achieved via enolate oxidation, 
and extant methodologies with oxygen electrophiles are generally concerned with hydroxylation (OH), 
despite the potential advantages of hydroperoxidation (OOH). The retained hydroperoxide can provide 
atom economical access to endoperoxides via remote oxidation of pendant unsaturation and (1,n)-diols 
via hydrogenolysis of the resulting endoperoxidic OO bond. In this chapter we report the discovery and 
optimization of mild, aerobic hydroperoxidation conditions for Meldrum’s acid derivatives and the utility of 
the retained hydroperoxide in remote, intramolecular oxidation (Scheme 1-1). 
Scheme 1-1. Hydroperoxidation of Meldrum’s Acid Derivatives and Application in Intramolecular 
Oxidation 
 
1.2 Background 
1.2.1 Benefits of Enolate Oxidation with Higher Oxidation State Electrophiles 
 Enolate oxidation is an important tool in organic synthesis for the preparation of various -
functionalized carbonyl compounds.
1
 This reaction is often achieved through the application of oxygen-
based electrophiles such as oxaziridines, dioxiranes, and diacyl peroxides (Scheme 1-2a); these
                                                          
*
 Reproduced in part by permission of the American Chemical Society: Krabbe, S. W.; Do, D. T.; Johnson, 
J. S. Org. Lett. 2012, 14, 5932-5935. 
2 
reagents are useful for the installation of a hydroxyl group or hydroxyl surrogate but their atom economy 
is relatively poor.
2
  
Scheme 1-2. Traditional Versus Elevated Oxidation State Enolate Functionalization 
 
In the rarer cases where hydroperoxides 2 are generated during the course of enolate functionalization 
(often as ROH/RO2H mixtures), it is common practice to reduce the mixture to the hydroxylation (ROH) 
product 1 upon workup (Scheme 1-2b). This reductive workup in essence squanders one oxidation level 
conferred by the oxidant. By contrast, an enolate oxidation that preserved the elevated product oxidation 
state could in principle be used to functionalize remote sites, so long as the distal functionality was 
compatible with the oxidation conditions. Initially providing an endoperoxide 3, hydrogenolysis of the OO 
bond would provide formal dihydroxylation products 4 in a redox economical manner.
3
 Moreover, a 
catalytic enolate oxidation reaction that used O2 would carry the inherent advantages of complete atom 
economy and the use of a green oxidant. At issue in translating this construct to practice is (1) the 
development of a mild, functional group-tolerant enolate oxidation using O2, and (2) the development of 
tools for remote functionalization using the hydroperoxide products. 
1.2.2 Extant Methodologies for Enolate Hydroperoxidation 
 Despite it’s apparent simplicity, the peroxidation of enolates is a synthetic problem with few 
simple solutions in the literature. The formation of dialkyl peroxides from -dicarbonyls and tert-
butylhydroperoxide in a Cu(II)-catalyzed process has been reported,
4
 but the products are precluded from 
being used for remote oxidation as the peroxide is already fully substituted (Scheme 1-3). 
  
3 
Scheme 1-3. Copper-Catalyzed Internal Peroxide Formation 
 
 Extant methods for hydroperoxidation of -dicarbonyls are scant and often suffer from harsh 
conditions and/or form mixtures of hydroperoxide and alcohol. The use of photosensitized 
1
O2 allows the 
formal addition of O2 into an active methine of 6-acyl or 6-carboalkoxybenzylcycloalkenones (Scheme 1-
4a).
5
 The foremost methods for hydroperoxidation of active CH bonds utilize aerobic oxidation of 
dimedone derivatives (Scheme 1-4b)
6
 or employ Mn(III)/O2 to peroxidize 1,2-diphenylpyrazolidine-3,5-
diones and barbituric acid derivatives (Scheme 1-4c).
7
  
Scheme 1-4. Extant Methods for Hydroperoxidation of -Dicarbonyl Compounds 
 
 The aerobic oxidation conditions are quite specific to dimedone derivatives with no 
hydroperoxidation of Meldrum’s acid derivatives occurring under the reported conditions, and Mn(III) is 
well-known to give electrophilic radical intermediates with -dicarbonyls, providing endoperoxidic 
hemiketal products via carbon-carbon bond formation followed by radical trapping with oxygen and 
cyclization (Scheme 1-5).
8
 This reactivity clearly indicates incompatibility with pendant unsaturation due 
to competitive cyclization.
9
 A method compatible with unsaturation is highly desirable as the heightened 
oxidation state gained by hydroperoxidation can be effectively utilized in remote intramolecular oxidation. 
4 
Scheme 1-5. Cerium(III) or Manganese(III) Promoted Peroxidation/Cyclization 
 
1.2.3 Biologically Active Endoperoxides and Selected Methodologies for The Synthesis of 
Endoperoxides and (1,n)-Diols 
 Endoperoxides are prevalent in a number of natural products exhibiting antimalarial (artemisinin 
and its derivatives) and anticancer (plakinic acids) activity.
10
 With this knowledge and the findings that 
structurally simpler cyclic peroxides can still exhibit useful biological activity,
11
 the short and efficient 
synthesis of new cyclic peroxides has become a topic of increased effort.
12
  
Figure 1-1. Selected Biologically Active Natural Endoperoxides 
 
 A wide variety of methodologies have been developed for the synthesis of endoperoxides, but the 
most relevant methods to this work are the cyclization of hydroperoxides onto pendant alkenes. This 
cyclization has been accomplished by peroxy radical cyclization (Scheme 1-6a),
13
 attack onto in situ 
formed halonium or mercuronium ions (Scheme 1-6b),
14
 conjugate addition into electron deficient 
alkenes (Scheme 1-6c),
15
 or olefin activation by electrophilic transition metal catalysis (Scheme 1-6d).
16
  
  
5 
Scheme 1-6. Approaches to Endoperoxides Via Cyclization Onto Pendant Alkenes 
 
 In addition to biological relevance, endoperoxides also provide access to (1,n-diols) via OO 
bond cleavage by thiourea/MeOH
17
 or metal-catalyzed hydrogenolysis.
18
 The latter case is especially 
attractive from a green chemistry perspective
19
 since the overall sequence could in principle provide 
formal dihydroxylation with O2 as the oxidant and H2 as the reductant. 
1.2.4 Discovery of Mild Hydroperoxidation Conditions for Meldrum’s Acid Derivatives 
 Our laboratory recently reported oxidative deacylation of acetoacetates under mild conditions 
providing -ketoesters with retention of stereochemistry at the -position (Scheme 1-7a).
20
 This 
copper(II)-catalyzed process is proposed to occur via formation of copper enolate 5 followed by one 
electron oxidation to provide radical 6 (Scheme 1-7b). Reaction with oxygen provides 7 which rearranges 
to provide 1,2-dioxetane 8. Cycloreversion resulting in the expulsion of acetic acid provides the -keto 
ester product. 
  
6 
Scheme 1-7. Oxidative Deacylation of Acetoacetates and Proposed Mechanism 
 
 In considering the extension of this methodology to other -dicarbonyl substrates, Meldrum’s 
acid
21
 derivatives emerged with excellent potential due to ease of access to the enol tautomer
22
 and the 
fact that asymmetric syntheses of -stereogenic derivatives had been developed to a high level of 
sophistication, simplicity, and scalability.
23,24
 The expected reaction mechanism follows an identical 
pathway to that reported for acetoacetates, except upon [2+2] cycloreversion the expulsion of acetone 
and carbon dioxide would provide -stereogenic--ketoacids which represent interesting synthetic 
intermediates and therapeutics with varied biological activities.
25
 Upon exposing Meldrum’s acid 
derivative 10a to the conditions reported, no oxidative deacylation was observed and a mixture of 
hydroperoxide 11a and alcohol 12a products were obtained (Scheme 1-8). Increasing the temperature 
(up to 95 °C) provided no detectable conversion to 13. This truncated reactivity is likely a result of 
decreased electrophilicity of the ester carbonyl. 
Scheme 1-8. Failed Oxidative Deacylation of Meldrum’s Acid Derivative 
 
7 
 Surprisingly, the hydroperoxidation of Meldrum’s acid derivatives had not been previously 
reported, and we sought to develop this newly found reactivity into a simple, efficient, and green oxidation 
selectively providing hydroperoxides with a variety of useful, secondary transformations. 
1.3 Results and Discussion 
1.3.1 Optimization of Conditions for Hydroperoxidation of Meldrum’s Acid Derivatives 
 Our point of departure for this investigation was the application of the previously reported 
oxidative deacylation conditions utilizing a standard Fisher-Porter bottle for pressurized air
20a
 to isopropyl 
Meldrum’s acid derivative 10a resulting in a mixture of hydroperoxide and alcohol (Table 1-1, entry 1).  
Shortening reaction time resulted in a more acceptable ratio of 11a to 12a, but these products proved 
inseparable by flash chromatography and additional hydroperoxide reduction on silica gel was observed 
(entry 2). We hypothesized that lower catalyst loading might still provide efficient reaction rate while 
increasing the ratio of 11a to 12a, but no decrease in alcohol formation was observed (entry 3). Increased 
catalyst loading provided marginal reduction in alcohol formation (entry 4), and reducing the temperature 
to 0 °C eliminated the formation of alcohol while still providing good conversion to hydroperoxide (entry 
5). Operational simplicity was further achieved without detriment to yield by using a balloon of O2, 
eliminating the need for a pressure vessel (entry 6).
26
   
Table 1-1. Initial Hydroperoxidation Results and Optimization 
 
Entry Cu Loading (mol %) T (°C) Time (h) 11a:12a
a 
1 20 23 17 2:1 
2 20 23 1 10:1 
3
 
10 23 2 10:1
b
 
4
 
25 23 2 13:1 
5
 
25 0 5 >20:1 
6 25 0 6 >20:1
c 
a
 Ratio by integration characteristic peaks by 
1
H NMR spectroscopy; 
b
 SM also remaining; 
c
 Balloon of O2 
instead of 55 psig air in pressure vessel, >95% isolated yield of 11a; 
 
1.3.2 Scope and Limitations of Hydroperoxidation of Meldrum’s Acid Derivatives 
 With optimized conditions realized, a variety of Meldrum’s acid derivatives 10a-p were subjected 
to hydroperoxidation (Table 1-2). -Alkyl or aryl substituted derivatives provided the corresponding 
8 
hydroperoxides in excellent yield (entries 1-4), and alkynyl-substituted Meldrum’s acids were also well 
tolerated (entries 5-9). In general these hydroperoxide products were obtained analytically pure after a 
simple aqueous work-up. Unsubstituted alkene substrates provided modest to good yields of the desired 
hydroperoxides following purification (entries 10-12), while more substituted alkene products gave 
complex mixtures of products with no appreciable amount of hydroperoxide present (entries 13-16). This 
outcome may be attributable to epoxidation of the alkene under the reaction conditions, which was 
observed in the oxidative deacylation of acetoacetates.
20a
 Upon epoxidation, a multitude of reaction 
pathways are possible likely accounting for the complex mixture of products observed. In addition to 
providing hydroperoxy Meldrum’s acid derivatives in good yield, this methodology also provided the 
barbituric acid derivative 14 with pendant unsaturation in modest yield, a product presumably unattainable 
in Mn(III)-catalyzed hydroperoxidations (entry 17). 
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Table 1-2. Scope and Limitations of Hydroperoxidation of Meldrum’s Acid Derivatives 
 
Entry Product  t (h) Yield (%)
a 
 
1 
2 
3 
4 
 
 
 
R' = CH3 
        H 
            Ph 
        2,3-di-OMe-C6H3 
 
 
11a 
11b 
11c 
11d 
 
6 
6 
2 
3 
 
>95 
  92 
>95 
>95 
5 
6 
7 
8 
9 
 
R' = H 
       CH3 
       C5H11 
       CO2Et 
       Ph 
11e 
11f 
11g 
11h 
11i 
2 
2 
2 
3 
2 
  80 
  78 
  80 
>95 
>95 
 
10 
11 
 
 
n = 0 
      1 
 
11j 
11k 
 
4 
4.5 
 
  59
b,c 
  86
b,d 
12 
 
 11l 3   95
b,e 
13 
14 
15 
16 
 
R
1
 = Ph; R
2
, R
3
 = H 
R
1
 = Me; R
2
 = H; R
3
 = Ph 
R
1
 = 
i
Pr; R
2
 = CO2Et; R
3
 = H  
R
1
 = H; R
2
, R
3
 = Me 
- 
- 
11m 
- 
1 
4 
2 
2 
  NDP 
  NDP 
  21
b,f 
  NDP 
 
17 
 
  
14 
 
8 
 
  49
b 
a
 Isolated yield of clean hydroperoxide without need for purificaton;
 b
 Yield following purification on SiO2; 
c
 
10:1 with alcohol; 
d
 17:1 with alcohol; 
e
 20:1 with alcohol; 
f
 5:1 with alcohol; 
 
1.3.3 Attempted Solutions to Alkene Reactivity Issues 
To circumvent issues with substituted alkene substrates, we sought to prefunctionalize the alkene 
as an epoxide in hopes that successful hydroperoxidation followed by electrophilic trapping would provide 
endoperoxides 16 with pendant alcohols (Scheme 1-9). Unfortunately, initial attempts at epoxidation 
under standard conditions (m-CPBA, DMDO) were unsuccessful. 
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Scheme 1-9. Proposed Hydroperoxidation of Epoxide Substituted Meldrum’s Acids 
 
 We believed the acidic site on Meldrum’s acid was potentially causing issues, so we investigated 
“protecting” this site prior to epoxidation. Installation of a halogen at the acidic methine of -dicarbonyl 
compounds containing alkenes is easily achieved via deprotonation and quenching with a suitable 
halonium ion source.
27
 Chlorination of isoprenyl Meldrum’s acid 10p and subsequent epoxidation 
proceeded smoothly providing chloro-epoxy Meldrum’s acid 18 in good overall yield. 
Scheme 1-10. Acidic Methine Protection Strategy 
 
 Removal of the chloride protecting group proved facile, but the desired epoxy Meldrum’s acid 19 
was not obtained (Scheme 1-11). Instead, nucleophilic opening of the epoxide by a Meldrum’s acid 
carbonyl occurred yielding dihydrofuran 20. Milder and less conventional conditions utilizing visible light 
photoredox catalysis [Ru(bpy)2Cl2] still provided dihydrofuran 20 as the major product.
28 
 
Scheme 1-11. Formation of Dihydrofuran 20 Upon Attempted Chloride Removal 
 
 As a last effort to utilize the chlorination protection strategy, chloro-epoxy Meldrum’s acid 18 was 
submitted to the hydroperoxidation conditions in hopes that in situ deprotection followed by 
hydroperoxidation and nucleophilic opening of the epoxide would lead to endoperoxide 21 (Scheme 1-
12). At 0 C, no reaction was observed, but upon warming to room temperature smooth conversion to one 
major product occurred. Unfortunately, the product obtained was orthoester 22 resulting from epoxide 
11 
opening by a Meldrum’s acid carbonyl oxygen followed by attack of the resulting alkoxide on the 
oxocarbenium ion formed.  Due to the propensity for epoxide opening by a Meldrum’s acid carbonyl, 
protection strategies via epoxidation of alkene substrates were abandoned. 
Scheme 1-12: Attempted Hydroperoxidation of Chloro-Epoxy Meldrum’s Acid 5. 
 
1.3.4 Access to Endoperoxides Via Intramolecular Oxidation of Alkenyl Hydroperoxides 
Although our attempts to access endoperoxide products in a one-pot manner were unsuccessful, 
alkenyl hydroperoxy Meldrum’s acid derivatives 11j-l provided the opportunity to investigate remote 
oxidation strategies. The formation of endoperoxide products from the retained hydroperoxide and 
pendant unsaturation was envisioned by electrophilic activation of the alkene followed by nucleophilic 
addition of the hydroperoxide. A number of conditions reported for Pd(II)-catalyzed cycloetherification 
were initially investigated with 11j,
29
 but only starting material decomposition was observed. Switching to 
electrophilic activation via iodonium ion formation, success was realized with N-iodosuccinimide providing 
the iodoendoperoxide 23a with excellent regio- and diastereoselectivity, albeit in modest yield (Scheme 
1-13).
14 
Scheme 1-13. Iodoendoperoxidation of Hydroperoxy Meldrum’s Acid 
 
 Attempts to optimize this cyclization were met with limited success. Addition of base (Et3N, 
KO
t
Bu, K2CO3, or Cs2CO3) in hopes of increasing the nucleophilicity of the hydroperoxide either provided 
complete consumption of starting material without product formation or rendered the hydroperoxide 
completely unreactive. After screening a number of solvents (acetone, toluene, EtOAc, THF, Et2O, 2-
MeTHF, IPA) CH2Cl2 proved to be optimal. Evaluation of I
+
 sources [I(collidine)2PF6,
30
 N-iodopyrrolidine.
31
 
12 
1,3-diiodo-5,5-dimethylhydantoin
32
] was also conducted, and the only source giving a better result than 
NIS was a modest increase in yield with 1,3-diiodo-5,5-dimethylhydantoin (Scheme 1-14). The isopropyl 
substituent proved important as decreasing its size (11j11k11l) led to decreased yields of 
endoperoxide clearly indicating a Thrope-Ingold effect at play in the cyclization.
33
 Applying these 
conditions to N,N-dimethylbarbituric acid derivative 14 resulted in analogous reactivity, providing 
endoperoxide 24.  
Scheme 1-14. Iodoendoperoxidation with 1,3-Diiodo-5,5-Dimethylhydantoin 
 
1.3.5 Secondary Transformations of Endoperoxides 
With successful access to endoperoxides realized, we turned our attention to their conversion to 
1,3-diols and cleavage of the Meldrum’s acid. Metal catalyzed hydrogenolysis
18
 or thiourea/MeOH
17
 
provided smooth O–O bond cleavage of 23a (Scheme 1-15). Concomitant cyclization/ring opening 
occurred on the Meldrum’s acid with complete diastereotopic group discrimination to provide the 
differentiated 1,3-diol functionality in the form of lactone 25. Difficulty encountered in purification by flash 
chromatography of this alkyl iodide product prompted its isolation as the dicyclohexylamine salt in good 
yield as a single diastereomer. The relative configuration of 25 was determined by single crystal x-ray 
diffraction. 
  
13 
Scheme 1-15. Endoperoxide Cleavage in 1,2-Dioxolane System 
 
Cleavage of the Meldrum’s acid of 23a while retaining the endoperoxide proved more difficult 
than endoperoxide O–O bond cleavage. Sensitive, fully substituted Meldrum’s acids have only been 
cleaved using a method reported by Spino.
34
 In our hands, these conditions resulted in a messy reaction 
in which only two products were isolated in poor yield, and the desired endoperoxide product was not 
observed (Scheme 1-16). Reducing the reaction temperature provided a modest yield of lactone 27, but 
no desired product was observed under these conditions.  
Scheme 1-16. Attempts at Selective Meldrum’s Acid Cleavage. 
 
Formation of 26 and 27 is proposed to occur by Lewis acid catalyzed methanolysis of Meldrum’s 
acid providing alkoxide 29 following expulsion of acetone and carbon dioxide (Scheme 1-17). 
Lactonization followed by enolization provides 27 while epoxide formation and subsequent elimination 
provides 26. Additional attempts at cleaving the Meldrum’s acid selectively were not attempted due to the 
relative instability of the endoperoxide. 
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Scheme 1-17. Proposed Mechanism for the Formation of 26 and 27 
 
1.3.6 Au(I)-Catalyzed Endoperoxidation of Alkynyl Substituted Hydroperoxides and Secondary 
Transformations of the Resulting Mixed Ketal Products
†
 
We next assayed the utility of alkynyl hydroperoxide products in intramolecular oxidation via 
endoperoxide formation. Au(I)-catalyzed cycloetherifications have been reported with a variety of gold 
catalysts,
35
 but to the best of our knowledge the corresponding endoperoxidation was unknown. Alkyl 
substituted alkynyl hydroperoxides 11f-g undergo 6-endo cyclization catalyzed by 
triphenylphosphinegold(I) triflimide
36
 in MeOH to give mixed ketal endoperoxides in good yield (Scheme 
1-18).
37
 Subsequent reductive cleavage of the OO bond of 30a followed by hemiketal formation with the 
transient ketone provides hemiketal 31 in excellent yield with 3:1 dr. Ionic hydrogenation of 31 affords 
tetrahydrofuran 32
38
 in a highly diastereoconvergent process.
39 
By reversing the order of operations, 
entirely different products can be accessed from the same mixed ketal endoperoxide. Ionic hydrogenation 
of 30a provides endoperoxide 33 in modest yield with good diastereoselectivity. Reductive cleavage of 
the OO bond with concomitant Meldrum’s acid opening and decarboxylation gives the desired 1,4-diol 
functionality as lactone 34 in good yield as a single diastereomer, implying that the 
decarboxylation/protonation is completely stereoselective. 
                                                          
†
This topic is purposefully truncated. For a full discussion see: Do, D. T. Ph. D. Dissertation, University of 
North Carolina at Chapel Hill. Chapel Hill, NC 2014.  
15 
Scheme 1-18. Gold(I)-Catalyzed Endoperoxidation of Alkynyl Hydroperoxides and Secondary 
Transformation of Endoperoxides 
 
1.4 Conclusion 
In summary, we developed a simple, mild and efficient catalytic method for the aerobic 
hydroperoxidation of Meldrum’s acid derivatives, including those with unsaturation. The hydroperoxide 
products can be used for intramolecular oxidation via electrophilic activation of the pendant πC≡C and πC=C 
functionality. Au(I)-catalyzed endoperoxidations of hydroperoxyalkynes were reported for the first time. 
Reductive cleavage of the O–O bond yields 1,n-diol functionality with convenient differentiation of the 
alcohols via lactonization, thereby providing the conceptual blueprint for the development of atom-efficient 
O2/H2 dihydroxylations. 
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1.5 Experimental Details 
Methods. Infrared (IR) spectra were obtained using a Jasco 260 Plus Fourier transform infrared 
spectrometer. Proton and carbon nuclear magnetic resonance spectra (
1
H NMR and 
13
C NMR) were 
recorded on a Bruker DRX 400 or 600 (
1
H NMR at 400 MHz or 600 MHz and 
13
C NMR at 100 or 150 
MHz) spectrometer with solvent resonance as the internal standard (
1
H NMR: CDCl3 at 7.26 ppm. 
13
C 
NMR: CDCl3 at 77.0 ppm). 
1
H NMR data are reported as follows: chemical shift, multiplicity (s = singlet, 
bs = broad singlet, d = doublet, dd = doublet of doublet, ddd = doublet of doublet of doublets, t = triplet, q 
= quartet, m = multiplet), coupling constants (Hz), and integration. Melting point data was collected on a 
Thomas Hoover Capillary Melting Point Apparatus and are uncorrected. Thermogravimetric data was 
collected on a PerkinElmer Pyris 1 Thermogravimetric Analyzer (25 C initial temperature, 20 C/min 
ramp rate, Purge gas: N2 at 20 mL/min).  Analytical thin layer chromatography (TLC) was performed on 
Sorbent Technologies Silica G 0.20 mm silica gel plates. Visualization was accomplished with UV light, 
aqueous basic potassium permanganate solution, or aqueous ceric ammonium molybdate solution 
followed by heating. Flash chromatography was performed using Silia-P flash silica gel (40-63 μm) 
purchased from Silicycle. Yield refers to isolated yield of analytically pure material unless otherwise 
noted. Yields and diastereomeric ratios (dr) are reported for a specific experiment and as a result may 
differ slightly from those found in the tables, which are averages of at least two experiments. 
Materials. Copper(II) nitrate trihydrate, acetonitrile, and thiourea were purchased from Fisher and used 
as received. Methylmagnesium bromide, vinylmagnesium bromide, ethylmagesium bromide and 
ethynylmagnesium chloride were purchased from Sigma Aldrich and used as received. Dichloromethane, 
diethyl ether and tetrahydrofuran were passed through a column of neutral alumina under nitrogen prior to 
use. The following reagents were prepared by literature procedures: 1,3-diiodo-5,5-dimethylhydantoin,
32
 
Meldrum’s acid,
21b
 isopropylidene Meldrum’s acid 34,
40
 3-methylbutylidine Meldrum’s acid 35,
41
 N,Nꞌ-
dimethylbarbituric acid 36,
42
 isopropyl Meldrum’s acid 10a,
43
 ethyl Meldrum’s acid 10b,
43
 1-phenethyl 
Meldrum’s acid 10c,
44
 2,2-dimethyl-5-(2-methylhex-4-yn-3-yl)-1,3-dioxane-4,6-dione 10f,
23c
 Ethyl 4-(2,2-
dimethyl-4,6-dioxo-1,3-dioxan-5-yl)-5-methylhex-2-ynoate 10h,
45
 2,2-dimethyl-5-(1-phenylallyl)-1,3-
dioxane-4,6-dione 10m,
46
 methylidene Meldrum’s acid 37,
47
 5-(2,3-dimethoxybenzylidene)-2,2-dimethyl-
1,3-dioxane-4,6-dione 38,
48
 (E)-2,2-dimethyl-5-(3-phenylallylidene)-1,3-dioxane-4,6-dione 39.
49
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Preparation of 2,2-dimethyl-5-(4-methylpent-1-yn-3-yl)-1,3-dioxane-4,6-dione (10e) 
 
To a flame-dried 150-mL round bottomed flask was added a 0.6 M solution of ethynylmagnesium chloride 
in THF/toluene (6.0 mmol, 2.0 equiv) under N2. A solution of alkylidene Meldrum’s acid 34 (594 mg, 3.0 
mmol) in dry THF (12 mL) was added over 10 min. The reaction was stirred at rt overnight then was 
quenched with 1 M citric acid (20 mL) and extracted with Et2O (2 x 50 mL). The combined organic 
extracts were washed with brine (15 mL), dried (MgSO4) and concentrated. Flash chromatography with 
gradient elution (20-30% EtOAc/hexanes) afforded 10e (403 mg, 1.8 mmol, 60% yield) as a white solid. 
Analytical data for 10e: mp 92-93 C; IR (thin film, cm
-1
) 3276, 2970, 2369, 1744, 1473, 1387, 1336, 
1307, 1209, 1079, 996; 
1
H NMR (400 MHz, CDCl3)  3.67 (d, J = 2.6 Hz, 1H), 3.09-3.06 (ddd, J = 2.4, 2.6, 
10.5 Hz, 1H), 2.48-2.41 (doublet of septets, J = 6.6, 10.5 Hz, 1H), 2.18 (d, J = 2.4 Hz, 1H), 1.79 (s, 3 H), 
1.77 (s, 3H), 1.17 (d, J = 6.6 Hz, 3H), 0.98 (d, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3)  165.1, 163.5, 
105.3, 82.4, 72.1, 47.5, 39.4, 29.9, 28.5, 27.8, 21.8, 20.2; TLC (30% EtOAc/hexanes) Rf = 0.35. HRMS 
(ESI) Calculated for C12H17O4: 225.1127, Found: 225.1121. 
Preparation of 2,2-dimethyl-5-(2-methyldec-4-yn-3-yl)-1,3-dioxane-4,6-dione (10g) 
 
To a flame-dried 150-mL round bottomed flask containing 1-heptyne (6.0 mmol, 3.0 equiv)  in  THF (12 
mL) was added a 3.0 M solution of methylmagnesium bromide in THF (4.4 mmol, 2.2 equiv) under N2. 
The reaction was then stirred at rt for 2 h.  A solution of alkylidene Meldrum’s acid 34 (396 mg, 2.0 mmol) 
in dry THF (20 mL) was then added over 10 min and the reaction was stirred at rt overnight. The reaction 
was quenched with 1 M citric acid (20 mL) and extracted with Et2O (2 x 50 mL). The combined organic 
extracts were washed with brine (15 mL), dried (MgSO4) and concentrated. Flash chromatography with 
gradient elution (20-30% EtOAc/hexanes) afforded 10g (529 mg, 1.8 mmol, 90% yield) as a white solid. 
Analytical data for 10g: mp 52-53 C; IR (thin film, cm
-1
) 2961, 2871,  2235, 1785, 1750, 1394, 1335, 
18 
1294, 1207, 1075; 
1
H NMR (400 MHz, CDCl3)  3.61 (d, J = 2.9 Hz, 1H), 3.02-2.98 (ddd, J = 2.3, 2.9, 10.6 
Hz, 1H), 2.41-2.37 (doublet of septets, J = 6.7, 10.6 Hz, 1H), 2.14-2.09 (ddd, J = 2.3, 6.7, 6.7 Hz, 2H), 
1.79 (s, 3H), 1.75 (s, 3H),  1.47-1.41 (m, 2 H), 1.34-1.26 (m, 4H), 1.13 (d, J = 6.7 Hz, 3H), 0.99 (d, J = 6.7 
Hz, 3H), 0.88 (t, J = 7.0 Hz, 3H); 
13
C NMR (150 MHz, CDCl3)  166.1, 164.0, 105.1, 84.6, 78.1, 47.7, 40.6, 
30.9, 30.4, 28.5, 28.4, 28.1, 22.1, 21.8, 20.3, 18.6, 14.0; TLC (20% EtOAc/hexanes) Rf = 0.30. HRMS 
(ESI) Calculated for C17H27O4: 295.1909, Found: 295.1908. 
Preparation of 2,2-dimethyl-5-(4-methyl-1-phenylpent-1-yn-3-yl)-1,3-dioxane-4,6-dione (10i) 
 
To a flame-dried 250-mL round bottomed flask containing phenylacetylene (2.37 g, 23.2 mmol, 2.00 
equiv) and dry THF (25 mL) under N2
 
was added a 1.0 M solution of ethylmagnesium bromide in THF 
(23.2 mL, 23.2 mmol, 2.0 equiv) over 5 min. A solution of alkylidene Meldrum’s acid 34 (2.30 g, 11.6 
mmol) in dry THF (20 mL) was added via syringe pump over 3 h. After the addition was completed, the 
reaction was allowed to warm to RT and was stirred for 3 h. The reaction was quenched with 1 M HCl (10 
mL) and the resulting mixture was extracted with Et2O (2 x 50 mL). The combined organic extracts were 
washed with brine (15 mL), dried (MgSO4) and concentrated. Flash chromatography (10% 
EtOAc/hexanes) afforded 10i (3.02 g, 10.1 mmol, 87 % yield) as an off-white solid. Analytical data 
matched that previously reported.
23g
 
Preparation of 2,2-dimethyl-5-(1-(2,3-dimethoxyphenyl)ethyl)-1,3-dioxane-4,6-dione (10d) 
 
To a flame-dried 20 mL scintilliation vial were added CuBr (14.3 mg, 0.10 mmol, 0.10 equiv) and Et2O (2 
mL). After cooling to 0 °C, methylmagnesium bromide (0.67 mL, 3 M in Et2O, 2.0 mmol, 2 equiv) was 
added. After 30 min, a solution of 38 (0.292 mg, 1.0 mmol, 1 equiv) in Et2O (10 mL) was added dropwise 
over 30 min. Following the addition the reaction was allowed to warm to rt. After 10 additional min the 
19 
reaction was quenched by slow addition of 1 M HCl and extracted with Et2O (2 x 30 mL). The combined 
organic extracts were washed with brine, dried (Na2SO4), and concentrated in vacuo. Flash 
chromatography (5-20% EtOAc/hexanes) provided 10d (191 mg, 0.62 mmol, 62%) as a very pale yellow 
oil. Analytical data matched that previously reported.
50
  
Preparation of 2,2-dimethyl-5-(4-methylpent-1-en-3-yl)-1,3-dioxane-4,6-dione (10j)
51
 
 
To a flame-dried 250-mL round bottomed flask was added dry THF (50 mL) and 0.7 M vinylmagnesium 
bromide in THF (33.7 mmol, 1.5 equiv) under N2. The resulting solution was cooled to 0 C and a solution 
of alkylidene Meldrum’s acid 34 (4.45 g, 22.5 mmol) in dry THF (20 mL) was added via syringe pump (10 
mL/h). After the addition was completed, the reaction was allowed to warm to rt and was stirred for 1.5 h. 
The reaction was quenched with 1 M HCl (100 mL) and the resulting mixture was extracted with Et2O (3 x 
150 mL). The combined organic extracts were washed with brine (50 mL), dried (MgSO4), and 
concentrated. Flash chromatography (15% EtOAc/hexanes) afforded 10j (4.59 g, 20.3 mmol, 90 % yield) 
as an off-white solid. Analytical data for 10j: mp 55-57 C; IR (thin film, cm
-1
) 3081, 2963, 2873, 1782, 
1748, 1385, 1292, 1207, 1006, 840; 
1
H NMR (400 MHz, CDCl3)  5.80-5.70 (m, 1H), 5.18-5.11 (m, 2H), 
3.64 (d, J = 2.5 Hz, 1H), 2.74 (ddd, J = 2.5, 10.0, 10.0 Hz, 1H), 2.27-2.17 (doublet of septets, J = 6.7, 10.0 
Hz, 1H), 1.72 (s, 3 H), 1.71 (s, 3 H), 0.97 (d, J = 6.7 Hz, 3H) 0.91 (d, J = 6.7 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3)  165.8, 164.6, 136.9, 119.4, 104.9, 51.7, 48.1, 28.5, 28.3, 27.8, 21.4, 20.6; TLC (25% 
EtOAc/hexanes) Rf = 0.58. HRMS (ESI) Calculated for C12H18O4Na: 249.1103, Found: 249.1098. 
Preparation of 2,2-dimethyl-5-(5-methylhex-1-en-3-yl)-1,3-dioxane-4,6-dione (10k) 
 
To a flame-dried 100-mL round bottomed flask was added a 1.0 M solution of vinylmagnesium bromide in 
THF (9.43 mmol, 2.0 equiv) under N2. The flask was cooled to 0 C and a solution of alkylidene 
Meldrum’s acid 35 (1.00 g, 4.71 mmol) in dry THF (8 mL) was added over 5 min. After the addition was 
20 
completed, the reaction was allowed to warm to rt and was stirred for 40 min. The reaction was quenched 
with 1M HCl (20 mL) and extracted with Et2O (2 x 50 mL). The combined organic extracts were washed 
with brine (15 mL), dried (MgSO4) and concentrated. Flash chromatography (5% EtOAc/hexanes) 
afforded 10k (0.840 g, 3.50 mmol, 74% yield) as a white solid. Analytical data for 10k: mp 62-64 C; IR 
(thin film, cm
-1
) 2957, 2871, 1783, 1748, 1385, 1295, 1205, 1007, 884; 
1
H NMR (400 MHz, CDCl3)  5.95-
5.86 (ddd, J = 10.2, 10.2, 16.5 Hz, 1H), 5.21-5.16 (ddd, J = 0.7, 1.6, 16.5 Hz, 1H), 5.13-5.10 (dd, J = 1.6, 
10.2 Hz, 1H), 3.49 (d J = 2.7 Hz, 1H), 3.26-3.19 (m, 1H), 1.83-1.77 (ddd, J = 4.8, 10.5, 13.4 Hz, 1H), 1.73 
(s, 3H), 1.72 (s, 3H), 1.62-1.53 (s, 3H), 1.26-1.19 (ddd, J = 4.4, 9.1, 13.4 Hz, 1H), 0.90 (d, J = 6.5 Hz, 3H), 
0.88 (d, J = 6.3 Hz, 3H); 
13
C NMR (100 MHz, CDCl3)  164.9, 164.5, 137.8, 118.3, 104.8, 51.1, 41.5, 40.5, 
28.3, 27.4, 25.6, 23.4, 21.2; TLC (25% EtOAc/hexanes) Rf = 0.39. HRMS (ESI) Calculated for 
C13H20O4Na: 263.1260, Found: 263.1254. 
Preparation of 5-(but-3-en-2-yl)-2,2-dimethyl-1,3-dioxane-4,6-dione (10l) 
 
To a flame-dried 100-mL round bottomed flask was added a 1.0 M solution of vinylmagnesium bromide in 
THF (17.5 mmol, 2.0 equiv) under N2. The flask was cooled to 0 C and a solution of alkylidene 
Meldrum’s acid 37 (1.49 g, 8.76 mmol) in dry THF (17 mL) was added over 5 min. After the addition was 
completed, the reaction was allowed to warm to rt and was stirred for 7.5 h. The reaction was quenched 
with 1M HCl (20 mL) and extracted with Et2O (2 x 50 mL). The combined organic extracts were washed 
with brine (15 mL), dried (MgSO4) and concentrated. Flash chromatography (15% EtOAc/hexanes) 
afforded 10l (1.17 g, 5.90 mmol, 67% yield) as a white solid. Analytical data for 10l: 
1
H NMR (400 MHz, 
CDCl3)  5.97 (ddd, J = 17.2, 10.2, 7.9 Hz, 1H), 5.12 (dt, J = 17.2, 1.4 Hz, 1H), 5.04 (dt, J = 10.3, 1.2 Hz, 
1H), 3.53 (d, J = 3.0 Hz, 1H), 3.27 (dddd, J = 8.2, 7.0, 5.7, 3.5 Hz, 1H), 1.72 (s, 3H), 1.69 (s, 3H), 1.23 (d, 
J = 7.0 Hz, 3H). 
13
C NMR (100 MHz, CDCl3)  164.5, 164.3, 139.0, 116.3, 104.7, 51.2, 37.3, 28.2, 27.1, 
16.9.; TLC (15% EtOAc/hexanes) Rf = 0.34. 
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Preparation of 1,3-dimethyl-5-(2-methylpropylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (40) 
 
To a stirred mixture of N,N'-dimethylbarbituric acid 36 (0.50 g, 3.2 mmol) and H2O (30 mL) was added 
isobutyraldehyde (0.44 mL, 4.8 mmol, 1.5 equiv) at rt in a 100-mL round bottomed flask. After stirring for 
18 h, the reaction was extracted with EtOAc (2 x 30 mL). The combined organic extracts were dried 
(MgSO4) and concentrated. Flash chromatography (5% EtOAc/hexanes) afforded 40 (393 mg, 1.87 mmol, 
58%) as a white solid. Analytical data for 40: mp 50-52 C; IR (thin film, cm
-1
) 2965, 2871, 1737, 1672, 
1620, 1378, 1094, 795; 
1
H NMR (400 MHz, CDCl3)  7.71 (d, J = 10.3 Hz, 1H), 3.98-3.89 (doublet of 
septets, J = 6.6, 10.3 Hz, 1H), 3.31 (s, 3H), 3.30 (s, 3H), 1.11 (d, J = 6.6 Hz, 6H); 
13
C NMR (100 MHz, 
CDCl3)  173.8, 161.7, 160.8, 151.3, 118.3, 29.1, 28.7, 28.0, 21.3; TLC (25% EtOAc/hexanes) Rf = 0.58. 
HRMS (ESI) Calculated for C10H15N2O3: 211.1082, Found: 211.1074. 
Preparation of 1,3-dimethyl-5-(4-methylpent-1-en-3-yl)pyrimidine-2,4,6(1H,3H,5H)-trione (41) 
 
To a flame-dried 50-mL round bottomed flask was added a 1.0 M solution of vinylmagnesium bromide in 
THF (3.26 mmol, 2.0 equiv) under N2. The flask was cooled to 0 C and a solution of alkylidene barbituric 
acid 40 (343 mg, 1.63 mmol) in dry THF (7 mL) was added over 5 min. After the addition was completed, 
the reaction was stirred for 30 min. The reaction was allowed to warm rt and was stirred for an additional 
2 h. The reaction was quenched with 1M HCl (10 mL) and extracted with Et2O (2 x 30 mL). The combined 
organic extracts were washed with brine (15 mL), dried (MgSO4) and concentrated. Flash 
chromatography with gradient elution (5-10% EtOAc/hexanes) afforded 41 (303 mg, 1.09 mmol, 67% 
yield) as a white solid. Analytical data for 41: mp 44-46 C; IR (thin film, cm
-1
) 2963, 2360, 1681, 1455, 
1377, 1288, 1000, 929; 
1
H NMR (400 MHz, CDCl3)  5.43-5.34 (m, 1H), 5.05-4.96 (m, 2H), 3.67 (d, J = 
3.4 Hz, 1H), 3.22 (s, 3H), 3.20 (s, 3H), 2.44 (ddd, J = 3.4, 10.1, 10.1 Hz), 2.00-1.87 (doublet of septets, J 
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= 6.6, 10.1 Hz, 1H), 1.08 (d, J = 6.6 Hz, 3 H), 0.83 (d, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3)  
169.2, 167.2, 151.7, 135.5, 119.2, 56.8, 51.2, 28.6, 28.2, 28.0, 20.9, 20.7; TLC (25% EtOAc/hexanes) Rf 
= 0.42. HRMS (ESI) Calculated for C12H19N2O3: 239.1395, Found: 239.1393. 
Preparation of (E)-2,2-dimethyl-5-(4-phenylbut-3-en-2-yl)-1,3-dioxane-4,6-dione (10n)  
 
To a solution of 39 (0.500 g, 1.94 mmol, 1.0 equiv) in dry THF (12 mL) at 0 °C was added methyl 
magnesium bromide (0.90 mL, 3 M in THF, 2.71 mmol, 1.4 equiv) over 1 min. After 25 min, the reaction 
was slowly quenched with 1 M HCl (15 mL) and extracted with Et2O (2 x 10 mL). The combined organic 
extracts were washed with brine, dried (Na2SO4) and concentrated in vacuo. Precipitaion from EtOH with 
H2O provided 10n (0.374 g, 1.36 mmol, 70%) as a white solid. Analytical data for 10n: 
1
H NMR (400 MHz, 
CDCl3)  7.40 – 7.35 (m, 2H), 7.30 (ddd, J = 7.7, 6.7, 1.3 Hz, 2H), 7.25 – 7.18 (m, 1H), 6.55 (d, J = 15.9 
Hz, 1H), 6.44 (dd, J = 15.9, 8.5 Hz, 1H), 3.58 (d, J = 2.8 Hz, 1H), 3.56 – 3.42 (m, 1H), 1.76 (s, 3H), 1.73 
(s, 3H), 1.38 (d, J = 7.0 Hz, 3H). 
Preparation of ethyl (E)-4-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)-5-methylhex-2-enoate (10o) and 
ethyl (Z)-4-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)-5-methylhex-2-enoate (42) 
 
To a solid mixture of 10h (50 mg, 0.169 mmol, 1.0 equiv) and Pd/CaCO3 (3.5% Pb, 5% Pd, 8.5 mg, 50 
mg/mmol) under nitrogen was added EtOAc. The vial was purged with H2 (balloon) and stirred under H2 
(balloon). After 3 h, the reaction was filtered over a plug of Celite rinsing with EtOAc. The filtration was 
concentrated to give a 10:1 mixture of 10o to 42 (51 mg, 0.17 mmol, 100%) as a white solid. This material 
was used without further purification in the hydroperoxidation. Analytical data for 10o (cis): 
1
H NMR (400 
MHz, CDCl3)  6.42 (dd, J = 11.6, 9.6 Hz, 1H), 5.90 (dd, J = 11.5, 1.2 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 
4.11 – 4.04 (m, 1H), 3.89 (d, J = 2.8 Hz, 1H), 2.13 (dp, J = 9.7, 6.8 Hz, 1H), 1.74 (s, 3H), 1.73 (s, 3H), 
1.28 (t, J = 7.2 Hz, 3H), 0.93 (d, J = 6.7 Hz, 3H), 0.87 (d, J = 6.8 Hz, 3H). Analytical data for 42 (trans): 
23 
1
H NMR (400 MHz, CDCl3)   6.92 (ddd, J = 15.7, 10.1, 1.0 Hz, 1H), 5.93 (dd, J = 15.7 1H), 4.15 (m, 2H), 
3.69 (d, J = 2.5 Hz, 1H), 2.92 (td, J = 10.3, 2.6 Hz, 1H), 2.40 – 2.25 (m, 1H), 1.76 (s, 3H), 1.73 (s, 3H), 
1.27 (m, 3H), 0.99 (d, J = 6.7 Hz, 3H), 0.92 (d, J = 6.7, 3H). 
Preparation of 2,2-dimethyl-5-(3-methylbut-2-en-1-yl)-1,3-dioxane-4,6-dione (10q) 
 
To a stirred suspension of Meldrum’s acid (4.85 g, 33.7 mmol, 1.5 equiv) and ethylenediammonium 
diacetate (1.01 g, 5.61 mmol, 0.25 equiv) in EtOH (20 mL) was added as solution of prenal (2.86 g, 66% 
pure, 22.4 mmol, 1.0 equiv) in EtOH (10 mL). The resulting clear solution slowly turned orange in color. 
After 1 h, borane dimethylamine complex (1.32 g, 22.4 mmol, 1.0 equiv) was added in small portions. The 
reaction warmed slightly and turned yellow. After 17 h, the reaction was diluted with H2O (100 mL) and 1 
M HCl (12 mL), and extracted with CH2Cl2 (3 x 50 mL). The combined organic extracts dried (Na2SO4) 
and concentrated in vacuo. Flash chromatography (5-20% EtOAc/hexanes) provided a mixture of 10p 
and unidentified impurity. Recrystallization from hot EtOH provided 10p (1.85 g, 8.7 mmol, 39%) as a 
white solid. Analytical data for 10p: 
1
H NMR (400 MHz, CDCl3)  5.13 (ddt, J = 7.3, 5.8, 1.5 Hz, 1H), 3.53 
(t, J = 4.9 Hz, 1H), 2.88 – 2.80 (m, 2H), 1.77 (s, 3H), 1.75 (s, 3H), 1.69 (s, 6H).  
Preparation of 5-chloro-2,2-dimethyl-5-(3-methylbut-2-en-1-yl)-1,3-dioxane-4,6-dione (17) 
 
To a suspension of NaH (175.6 mg, 60% in mineral, 4.39 mmol, 2.0 equiv) in dry THF (3 mL) at 0 °C was 
added a solution of 10p (466 mg, 2.20 mmol, 1.0 equiv) in dry THF (7 mL). After 1 h, N-chlorosuccinimide 
(439 mg, 3.29 mmol, 1.5 equiv) was added to the stirred suspension at 0 °C. After 30 min, the reaction 
was allowed to warm to rt. After 2 h 20 min, the reaction was slowly quenched with aqueous saturated 
sodium thiosulfate, diluted with H2O (25 mL), and extracted with CH2Cl2 (3 x 50 mL). The combined 
organic extracts were dried (Na2SO4) and concentrated in vacuo. Flash chromatography (5% 
EtOAc/hexanes) provided 17 (406 mg, 1.65 mmol, 75%) as a white solid. Analytical data for 17: 
1
H NMR 
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(400 MHz, CDCl3)  4.85 (tdt, J = 7.7, 2.9, 1.5 Hz, 1H), 3.16 (d, J = 7.7, 2H), 1.88 (s, 3H), 1.73 (s, 3H), 
1.67 (s, 3H), 1.65 (s, 3H).
13
C NMR (100 MHz, CDCl3)  163.9, 141.3, 114.0, 106.5, 56.5, 38.9, 28.5, 28.4, 
26.0, 18.2; TLC (25% EtOAc/hexanes) Rf = 0.60. 
Preparation of 5-chloro-5-((3,3-dimethyloxiran-2-yl)methyl)-2,2-dimethyl-1,3-dioxane-4,6-dione (18) 
 
To a solution of 17 (271 mg, 1.10 mmol, 1 equiv) in CH2Cl2 (10 mL) at 0 °C was added m-CPBA (505 mg, 
75% pure, 2.20 mmol, 2.0 equiv). After 6.5 h, the reaction was quenched with aqueous saturated sodium 
thiosulfate (5 mL) and extracted with CH2Cl2 (3 x 25 mL). The combined organic extracts were washed 
with aqueous saturated NaHCO3 (20 mL), dried (Na2SO4) and concentrated in vacuo to give 18 (289 mg, 
1.10 mmol, 100%) as a white solid. Analytical data for 18: 
1
H NMR (400 MHz, CDCl3)  2.88 – 2.68 (m, 
3H), 1.92 (s, 3H), 1.82 (s, 3H), 1.30 (s, 3H), 1.27 (s, 3H); 
13
C NMR (100 MHz, CDCl3)  163.4, 163.4, 
107.1, 60.1, 58.6, 55.0, 37.6, 28.4, 28.3, 24.3, 18.2; TLC (25% EtOAc/hexanes) Rf = 0.55. 
Preparation of 6-(2-hydroxypropan-2-yl)-2,2-dimethyl-5,6-dihydro-4H-furo[2,3-d][1,3]dioxin-4-one 
(20) 
 
To a solution of 18 (7.0 mg, 0.027 mmol, 1.0 equiv) in AcOH:H2O (10 mL, 9:1) at 0 °C was added Zn 
powder (40 mg). The resulting suspension was stirred for 15 min then warmed to rt. The reaction was 
concentrated and residue taken up in CH2Cl2, washed with aqueous saturated NaHCO3, brine, dried 
(Na2SO4) and concentrated to give 20 (5.7 mg, 0.025 mmol, 94%) as a clear oil. Analytical data for 20: 
1
H 
NMR (400 MHz, CDCl3)  3.79 (t, J = 5.2 Hz, 1H), 2.62 (dd, J = 16.0, 4.8 Hz, 1H), 2.37 (dd, 16.0, 5.4 Hz, 
1H), 1.70 (s, 3H), 1.69 (s, 3H), 1.40 (s, 3H), 1.36 (s, 3H). 
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Preparation of 4a-chloro-2,2,7,7-tetramethyltetrahydro-4H-6,8a-epoxypyrano[2,3-d][1,3]dioxin-4-
one (22) 
 
To a solid mixture of Meldrum’s acid derivative 18 (131 mg, 0.50 mmol, 1 equiv) and Cu(NO3)23H2O (30 
mg, 0.125 mmol, 0.25 equiv) at 0 C in a round bottomed flask was added CH3CN (1.3 mL) at rt. The flask 
was capped with a Teflon septum and the headspace was purged with O2 (balloon) for 3-5 min. After 6 h, 
the reaction was partitioned between H2O and EtOAc. The aqueous layer was separated and extracted a 
second time with EtOAc. The combined organic extracts were dried (MgSO4) and concentrated to afford 
22 (100 mg, 0.383 mmol, 77%) as a white solid. Analytical data for 22: 4.27 (d, J = 5.6 Hz, 1H), 2.98 (dd, 
J = 14.6, 5.6 Hz, 1H), 2.56 (d, J = 14.6 Hz, 1H), 1.76 (s, 3H), 1.74 (s, 3H), 1.48 (s, 3H), 1.41 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3)  166.2, 118.4, 108.3, 83.3, 79.8, 58.5, 38.1, 28.9, 28.6, 27.3, 22.8; TLC (25% 
EtOAc/hexanes) Rf = 0.43. The structure of 22 was confirmed by x-ray crystallography.  
General Procedure A for Hydroperoxidation of Meldrum’s Acid Derivatives 
 
To a solid mixture of Meldrum’s acid derivative 10a-p and Cu(NO3)23H2O at 0 C in a round bottomed 
flask was added cold CH3CN (0 C). The flask was capped with a Teflon septum and charged with O2 in 
one of two ways. For small volume reactions (<0.5 mL) the headspace was purged with O2 (balloon) for 3-
5 min. For larger volume reactions, O2 (balloon) was bubbled through the solvent for 5 min. When the 
starting material was consumed (TLC analysis) the reaction was partitioned between H2O and EtOAc. 
The aqueous layer was separated and extracted a second time with EtOAc. The combined organic 
extracts were dried (MgSO4) and concentrated to afford hydroperoxy Meldrum’s acid derivatives 11a-m 
as white solids unless otherwise noted. [Note: The hydroperoxide products failed to provide the molecular 
ion during analysis by mass spectrometry.  In addition to several derivatizations that verify the presence 
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of the ROOH functionality, several hydroperoxides were reduced with PPh3 to provide the corresponding 
alcohols (vide infra).  The ROOH functionality was inferred from these successful reductions.] 
Analytical data for 5-hydroperoxy-5-isopropyl-2,2-dimethyl-1,3-dioxane-4,6-dione 
(11a): mp 73-75 C; IR (thin film, cm
-1
) 3612, 3358, 2979, 2945, 2882, 1790, 1755, 1283, 
912, 620; 
1
H NMR (400 MHz, CDCl3)  9.40 (s, 1H), 2.46-2.39 (septet, J = 6.9 Hz, 1H), 1.81 (s, 3 H), 1.77 
(s, 3H), 1.07 (d, J = 6.9 Hz, 6H); 
13
C NMR (100 MHz, CDCl3)  166.3, 107.0, 89.3, 36.8, 30.2, 27.7, 16.9; 
TLC (25% EtOAc/hexanes) Rf = 0.50. 
Analytical data for 5-ethyl-5-hydroperoxy-2,2-dimethyl-1,3-dioxane-4,6-dione (11b): 
mp 91-93 C; IR (thin film, cm
-1
) 3354, 3006, 2989, 2950, 1791, 1757, 1395, 1079, 914, 
693; 
1
H NMR (400 MHz, CDCl3)  10.09 (s, 1H), 2.06 (q, J = 7.6 Hz, 2H), 1.82 (s, 3H), 
1.77 (s, 3H), 1.00 (t, J = 7.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3)  166.6, 107.1, 86.3, 30.5, 30.0, 28.0, 
7.7; TLC (25% EtOAc/hexanes) Rf = 0.45. 
Analytical data for 5-hydroperoxy-2,2-dimethyl-5-(1-phenylethyl)-1,3-dioxane-4,6-
dione (11c): mp 71-73 C; IR (thin film, cm
-1
) 3362, 1746, 1383, 1294, 1201, 1135, 913, 
701; 
1
H NMR (400 MHz, CDCl3)  9.52 (bs, 1H), 7.35-7.30 (m, 3H), 7.20-7.18 (m, 2H), 3.61 (q, J = 7.2 Hz, 
1H), 1.64 (s, 3H), 1.53 (d, J = 7.2 Hz, 3H), 0.98 (s, 3H); 
13
C NMR (100 MHz, CDCl3)  167.0, 164.7, 
136.2, 128.8, 128.7, 128.4, 107.1, 88.6, 47.3, 30.2, 26.8, 14.1; TLC (25% 
EtOAc/hexanes) Rf = 0.53. 
Analytical data for 5-hydroperoxy-2,2-dimethyl-5-(1-(2,3-
dimethoxyphenyl)ethyl)-1,3-dioxane-4,6-dione (11d): 
1
H NMR (400 MHz, CDCl3)  9.10 (s, 1H), 7.03 
(t, J = 8.1 Hz, 1H), 6.85 (ddd, J = 7.9, 4.6, 1.5 Hz, 2H), 4.15 (q, J = 7.3 Hz, 1H), 3.84 (s, 3H), 3.84 (s, 4H), 
1.68 (s, 3H), 1.56 (s, 3H), 1.46 (d, J = 7.3 Hz, 3H), 1.34 (s, 3H). 
Analytical data for 5-hydroperoxy-2,2-dimethyl-5-(4-methylpent-1-yn-3-yl)-1,3-
dioxane-4,6-dione (11e): mp 96-97 C; IR (thin film, cm
-1
) 3419, 2970, 2360, 1748, 
1647, 1383, 1338, 1286, 1299, 1120, 915; 
1
H NMR (400 MHz, CDCl3)  9.11 (s, 1H), 
3.09 (dd, J = 2.8, 3.5 Hz, 1H), 2.41 (d, J = 2.8, 1H), 2.19-2.11 (doublet of septets, J = 3.5, 6.6 Hz 1H), 
1.81 (s, 3H), 1.80 (s, 3H), 1.06 (d, J = 6.6 Hz, 3H), 1.02 (d, J = 6.6 Hz, 3H); 
13
C NMR (150 MHz, CDCl3)  
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165.3, 164.6, 107.5, 87.0, 76.4, 76.3, 46.1, 30.4, 27.8, 27.5, 23.3, 18.8; TLC (30% EtOAc/hexanes) Rf = 
0.32. 
Analytical data for 5-hydroperoxy-2,2-dimethyl-5-(2-methylhex-4-yn-3-l)-1,3-
dioxane-4,6-dione (11f): mp 88-89 C; IR (thin film, cm
-1
) 3377, 2970, 2875, 1786, 
1744, 1394, 1339, 1286, 1265, 1124, 1022, 917; 
1
H NMR (400 MHz, CDCl3)  9.38 (s, 
1H), 3.03-3.01 (m, 1H), 2.16-2.11 (m, 1H), 1.85 (d, J = 2.5 Hz, 1H), 1.81 (s, 3H), 1.80 (s, 3H),  1.02 (d, J = 
6.7 Hz, 3H), 0.97 (d, J = 6.6 Hz, 3H); 
13
C NMR (150 MHz, CDCl3)  166.1, 164.9, 107.4, 87.5, 84.2, 71.4, 
46.7, 30.3, 27.8, 27.7, 23.4, 19.3, 3.7; TLC (30% EtOAc/hexanes) Rf = 0.34. 
Analytical data for 5-hydroperoxy-2,2-dimethyl-5-(2-methyldec-4-yn-3-yl)-1,3-
dioxane-4,6-dione (11g): mp 70-71 C; IR (thin film, cm
-1
) 3366, 2960, 2933, 2872, 
2360, 1791, 1749, 1394, 1264, 1200, 1123, 916; 
1
H NMR (600 MHz, CDCl3)  9.44 (s, 
1H), 3.05 (m, 1H), 2.21-2.10 (m, 2H), 2.14 (m, 1H), 1.80 (s, 3H), 1.79 (s, 3H), 1.52-1.49 (m, 2 H), 1.35-
1.26 (m, 4H), 1.03 (d, J = 6.6 Hz, 3H), 0.97 (d, J = 6.0 Hz, 3H), 0.88 (t, J = 6.6 Hz, 3H); 
13
C NMR (150 
MHz, CDCl3)  165.7, 164.7, 107.1, 88.9, 87.7, 72.2, 46.7, 31.0, 30.4, 28.2, 27.8, 27.7, 23.4, 22.1, 19.2, 
18.8, 13.9; TLC (30% EtOAc/hexanes) Rf = 0.43. 
Analytical data for ethyl 4-(5-hydroperoxy-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)-
5-methylhex-2-ynoate (11h): Clear, colorless oil; IR (thin film, cm
-1
) 3346, 2972, 2877, 
2240, 1792, 1759, 1714, 1467, 1395, 1253, 917; 
1
H NMR (400 MHz, CDCl3)  9.87 (bs, 1 
H), 4.23 (q, J = 7.1 Hz, 2H), 3.20 (d, J = 4.0 Hz, 1H), 2.23-2.18 (doublet of septets, J = 4.0, 6.7 Hz, 1H), 
1.85 (s, 3H), 1.82 (s, 3H), 1.30 (t, J = 7.1 Hz, 3H), 1.08 (d, J = 6.7 Hz, 3H), 1.03 (d, J = 6.7 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3)  165.1, 164.4, 152.9, 107.9, 85.8, 80.1, 79.6, 62.3, 45.9, 30.2, 27.7, 27.6, 23.3, 
19.2, 13.9; TLC (25% EtOAc/hexanes) Rf = 0.45. 
Analytical data for 5-hydroperoxy-2,2-dimethyl-5-(4-methyl-1-phenylpent-1-yn-3-yl)-
1,3-dioxane-4,6-dione (11i): mp 75-77 C; IR (thin film, cm
-1
) 3357, 2967, 1791, 1749, 
1349, 1270, 1200, 1120, 916; 
1
H NMR (400 MHz, CDCl3)  9.69 (bs, 1H), 7.45-7.42 (m, 2 
H), 7.33-7.28 (m, 3H), 3.29 (d, J = 4.0 Hz, 1H), 2.31-2.23 (doublet of septets, J = 4.0, 6.7 Hz, 1H), 1.79 (s, 
3H), 1.70 (s, 3H), 1.10 (d, J = 6.7 Hz, 3H), 1.07 (d, J = 6.7 Hz, 3H); 
13
C NMR (100 MHz, CDCl3)  165.7, 
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164.7, 131.8, 128.7, 128.3, 122.2, 107.5, 88.3, 87.4, 81.8, 47.1, 30.4, 27.9, 27.7, 23.5, 19.4; TLC (25% 
EtOAc/hexanes) Rf = 0.53. 
Analytical data for 5-hydroperoxy-2,2-dimethyl-5-(4-methylpent-1-en-3-yl)-1,3-
dioxane-4,6-dione (11j): mp 74-75 C; IR (thin film, cm
-1
) 3408, 2966, 1784, 1740, 
1385, 1296, 1150, 916; 
1
H NMR (400 MHz, CDCl3)  9.57 (bs, 1H), 5.72-5.62 (ddd, J = 
10.2, 10.2, 16.9 Hz, 1H), 5.29 (dd, J = 1.2, 10.2 Hz, 1H), 5.13 (dd, J = 1.2, 16.9 Hz, 1H), 2.56 (dd, J = 3.5, 
10.4 Hz, 1H), 2.10-2.03 (doublet of septets, J = 3.5, 6.8 Hz, 1H), 1.78 (s, 3H), 1.77 (s, 3H), 0.93 (d, J = 
6.8 Hz, 3H), 0.84 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3)  165.7, 165.6, 129.9, 122.0, 107.1, 
89.0, 57.7, 30.3, 27.8, 27.3, 23.0, 18.4; TLC (25% EtOAc/hexanes) Rf = 0.32. The hydroperoxide was 
purified by flash chromatography on SiO2 (10% EtOAc/hexanes) to afford a 10:1 mixture of hydroperoxide 
and alcohol. 
Analytical data for 5-hydroperoxy-2,2-dimethyl-5-(5-methylhex-1-en-3-yl)-1,3-
dioxane-4,6-dione (11k): mp 62-65 C; IR (thin film, cm
-1
) 3357, 2958, 2871, 1791, 
1749, 1287, 1096, 913; 
1
H NMR (400 MHz, CDCl3)  9.49 (bs, 1H), 5.50-5.40 (m, 1H), 
5.28-5.18 (m, 2H), 2.84 (ddd, J = 4.0, 10.0, 10.0 Hz, 1H), 1.79 (s, 3H), 1.74 (s, 3H), 1.53-1.45 (m, 1H), 
1.41-1.29 (m, 2H), 0.89 (d, J = 6.6 Hz, 3H), 0.79 (d,  J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3)  166.0, 
165.3, 132.8, 121.4, 107.1, 88.3. 49.9, 36.6, 30.4, 27.8, 24.8, 23.8, 20.4; TLC (25% EtOAc/hexanes) Rf = 
0.47. The hydroperoxide was purified by flash chromatography on SiO2 (10% EtOAc/hexanes) to afford a 
17:1 mixture of hydroperoxide and alcohol. 
 Analytical data for 5-hydroperoxy-2,2-dimethyl-5-(but-3-en-2-yl)-1,3-dioxane-4,6-
dione (11l) mp 63-64 C; 
1
H NMR (400 MHz, CDCl3)  10.23 (s, 1H), 5.62 (ddd, J = 
16.9, 10.3, 8.5 Hz, 1H), 5.29 – 5.01 (m, 2H), 3.05 – 2.76 (m, 1H), 1.79 (s, 3H), 1.73 (s, 3H), 1.14 (d, J = 
7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3)  166.2, 165.5, 133.9, 119.5, 107.2, 88.2, 45.8, 30.3, 27.7, 14.2; 
The hydroperoxide was purified by flash chromatography on SiO2 (10% EtOAc/hexanes) to afford a >20:1 
mixture of hydroperoxide and alcohol. 
Analytical data for 5-hydroperoxy-2,2-dimethyl-5-(but-3-en-2-yl)-1,3-dioxane-4,6-
dione (11m): 10:1 cis:trans starting material was utilized; 
1
H NMR (400 MHz, CDCl3)  
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9.74 (s, 1H), 6.78 (dd, J = 15.5, 11.0 Hz, 1H), 5.87 (d, J = 15.5 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 2.73 (dd, 
J = 11.0, 4.0 Hz, 1H), 2.09 (pd, J = 6.9, 4.1 Hz, 1H), 1.79 (s, 3H), 1.77 (s, 3H), 1.29 (t, J = 7.2 Hz, 3H), 
0.96 (d, J = 6.8 Hz, 3H), 0.86 (d, J = 6.8 Hz, 3H); The hydroperoxide was purified by flash 
chromatography on SiO2 (10% EtOAc/hexanes) to afford a 5:1 mixture of hydroperoxide and alcohol. 
Analytical data for 5-hydroperoxy-1,3-dimethyl-5-(4-methylpent-1-en-3-
yl)pyrimidine-2,4,6(1H,3H,5H)-trione (14): mp 104-105 C; IR (thin film, cm
-1
) 3404, 
2963, 1684, 1447, 1377, 1051; 
1
H NMR (400 MHz, CDCl3)  10.21 (bs, 1H), 5.51 (ddd, J 
= 10.4, 16.8, 16.8 Hz 1H), 5.19 (dd, J = 1.2, 10.4 Hz, 1H), 5.05 (dd, J = 0.9, 16.8 Hz, 1H), 3.33 (s, 3H) 
3.26 (s, 3H), 2.46 (dd, J = 3.9, 10.4 Hz, 1H), 2.03-1.96 (doublet of septet, J = 3.9, 6.7 Hz, 1H), 0.89 (d, J = 
6.7 Hz, 3H), 0.72 (d, J = 6.7 Hz, 3H); 
13
C NMR (100 MHz, CDCl3)  168.1, 167.5, 150.6, 130.1, 121.7, 
89.4, 58.1, 29.0, 28.7, 26.9, 22.9, 18.9; TLC (25% EtOAc/hexanes) Rf = 0.23. The hydroperoxide was 
purified by flash chromatography on SiO2 (5-15% EtOAc/hexanes). 
General Procedure B for reduction of Meldrum’s acid hydroperoxides to alcohols 
 
To a solution of hydroperoxide in dry Et2O (0.1M) at 0 C under N2 atmosphere was added 
triphenylphosphine (1.0 equiv). After 3 h the reaction was concentrated and flash chromatography on 
SiO2 (5-15% EtOAc/hexanes) provided the alcohol product as a white solid. 
Analytical data for 5-hydroxy-2,2-dimethyl-5-(1-phenylethyl)-1,3-dioxane-4,6-dione 
(43a): 61% yield; mp 97-99 C; IR (thin film, cm
-1
) 3455, 3000, 1784, 1748, 1384, 1292, 
1201, 1139, 908; 
1
H NMR (400 MHz, CDCl3)  7.34-7.32 (m, 3H), 7.22-7.20 (m, 2H), 3.46 (q, J = 7.2 Hz, 
1H), 3.26 (s, 1H), 1.67 (s, 3H), 1.52 (d, J = 7.2 Hz, 3H), 1.42 (s, 3H); 
13
C NMR (100 MHz, CDCl3)  167.9, 
166.8, 137.0, 128.7, 128.6, 128.2, 106.9, 78.3, 50.1, 30.6, 26.7, 14.2; TLC (25% EtOAc/hexanes) Rf = 
0.35. HRMS (ESI) Calculated for C14H16O5Na: 287.0896, Found: 287.0894. 
Analytical data for 5-hydroxy-5-isopropyl-2,2-dimethyl-1,3-dioxane-4,6-dione (43c): 
89% yield; mp 75-76 C; IR (thin film, cm
-1
) 3453, 2981, 2945, 1785, 1747, 1466, 1309, 
1161, 1089, 1053, 913; 
1
H NMR (400 MHz, CDCl3)  3.36 (bs, 1H), 2.26 (septet, J = 6.8 Hz, 1H), 1.75 (s, 
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3 H), 1.71, (s, 3H), 1.01 (d, J = 6.8 Hz, 6H); 
13
C NMR (100 MHz, CDCl3)  167.9, 106.8, 78.3, 38.8, 30.6, 
27.2, 16.4; TLC (25% EtOAc/hexanes) Rf = 0.24. 
General Procedure C for gold(I)-catalyzed endoperoxidation of Meldrum’s acid hydroperoxides 
11f-g 
 
A mixture of the hydroperoxide 11f-g, Ph3PAuNTf2 (2 mol %), and PPTS (10 mol %) in methanol (~0.3-
1.0 M) was stirred under nitrogen atmosphere at room temperature. After completion of the reaction (TLC 
analysis), the mixture was filtered through a short pad of Celite (CH2Cl2), and the solvents were 
evaporated under reduced pressure to give the crude mixed acetal endoperoxides 30a-b. Flash 
chromatography (30% EtOAc/hexanes) afforded 30a-b as a mixture of diastereomers. 
 
Analytical data for 5-isopropyl-3-methoxy-3,9,9-trimethyl-1,2,8,10-
tetraoxaspiro[5.5]undecane-7,11-dione (30a): mp 94-95 C; IR (thin film, cm
-1
) 2964, 
2878, 1787, 1753, 1295, 1240, 1202, 1102, 1085, 928; 
1
H NMR of major diastereomer 
(400 MHz, CDCl3)  3.33 (s, 3H), 2.89-2.83 (ddd, J = 5.8, 9.1, 12.1 Hz, 1H), 2.21-2.14 (dd, J = 12.1, 13.4 
Hz, 1H), 2.10-2.05 (dd, J = 5.8, 13.4 Hz, 1H), 1.95 (s, 3H), 1.76 (s, 3H), 1.64-1.58 (doublet of septets, J = 
6.6, 9.1 Hz, 1H),  1.33 (s, 3H), 0.99 (d, J = 6.6 Hz, 3H), 0.80 (d, J = 6.6 Hz, 3H); 
13
C NMR (150 MHz, 
CDCl3)  162.5, 161.6, 161.1, 106.9, 106.7, 102.8, 79.4, 49.8, 49.2, 43.4, 38.5, 34.2, 33.3, 29.6, 29.4, 
28.7, 28.6, 28.2, 21.5, 21.1, 20.9, 20.5, 20.4; TLC (10% EtOAc/hexanes) Rf1(major) = 0.26, Rf2 (minor) = 
0.30. 
Analytical data for 5-isopropyl-3-methoxy-9,9-dimethyl-3-pentyl-1,2,8,10-
tetraoxaspiro[5.5]undecane-7,11-dione (30b): mp 63-64C; IR (thin film, cm
-1
) 
2957, 2873, 1788, 1756, 1464, 1394, 1290, 1203, 1085, 925; 
1
H NMR of major 
diastereomer (600 MHz, CDCl3)  3.26 (s, 1H), 2.82-2.80 (m, 1H), 2.09-2.05 (t, J = 13.2 Hz, 1H), 2.04-
2.00 (dd, J = 6.0, 13.2 Hz, 1H), 1.95 (s, 3H), 1.76 (s, 3H), 1.66-1.59 (m, 1H), 1.41-1.29 (m, 8H), 0.96 (d, J 
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= 6.6 Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H), 0.80-0.79 (d, J = 6.6 Hz, 3H); 
1
H NMR of minor diastereomer 
(600MHz, CDCl3)  3.31 (s, 1H), 2.50-2.60 (m, 1H), 2.30-2.10 (m, 2H), 1.88 (s, 3H), 1.75 (s, 3H), 1.66-
1.59 (m, 1H), 1.41-1.29 (m, 8H), 1.0 (d, J = 6.0 Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H), 0.80-0.79 (d, J = 6.6 Hz, 
3H); 
13
C NMR (150 MHz, CDCl3)  162.5, 161.1, 106.8, 106.6, 104.3, 79.7, 49.5, 48.7, 43.4, 38.3, 32.3, 
31.9, 31.9, 31.8, 30.0, 29.5, 28.7, 28.6, 28.2, 22.5, 22.4, 22.3, 22.1, 21.5, 21.1, 20.8, 20.5, 14.0, 13.9; 
TLC (10% EtOAc/hexanes) Rf1 = 0.32, Rf2 = 0.34. HRMS (ESI) Calculated for C18H20O7Na: 381.1889, 
Found: 381.1890. 
Preparation of 2-hydroxy-4-isopropyl-2,8,8-trimethyl-1,7,9-trioxaspiro[4.5]decane-6,10-dione (31) 
by palladium-catalyzed hydrogenolysis 
 
To a solution of mixed acetal endoperoxide 30a (131 mg, 0.43 mmol) in dichloromethane (2 mL) was 
added 10% Pd/C (44 mg, 100mg/mmol). The reaction was then stirred under H2 (balloon) atmosphere at 
room temperature for 30 minutes. The mixture was filtered through a short pad of Celite (CH2Cl2), and the 
solvents were evaporated under reduced pressure. Flash chromatography (30% EtOAc/hexane) afforded 
31 (104 mg, 0.38 mmol, 88 %) as a 3:1 mixture of diastereomers. Analytical data for 31: mp 108-109 C; 
IR (thin film, cm
-1
) 3525, 2965, 2876, 1784, 1751, 1394, 1309, 1289, 1201, 1073, 916; 
1
H NMR (400 MHz, 
CDCl3, major diastereomer)  3.16-3.10 (m, 2H), 2.33-2.22 (m, 3H), 1.82 (s, 3H), 1.76 (s, 3H), 0.95 (d, J = 
6.8 Hz, 3H), 0.88 (d, J = 6.4 Hz, 3H); characteristic peaks of minor diastereomer:  3.70-3.56 (m, 1H), 
2.96-2.88 (m, 1H), 2.57-2.51 (dd, J = 8.0, 13.2 Hz, 1H), 1.86 (s, 3H), 1.77 (s, 3H); 
13
C NMR (150 MHz, 
CDCl3)  170.5, 168.1, 166.8, 110.7, 109.4, 106.3, 106.1, 81.8, 81.3, 58.8, 58.5, 45.4, 44.0, 30.2, 28.9, 
28.6, 27.4, 27.2, 27.2, 26.3, 22.3, 22.2, 21.7, 21.3; TLC (30% EtOAc/hexanes) Rf = 0.35. HRMS (ESI) 
Calculated for C13H20O6Na: 295.1158, Found: 295.1164. 
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Preparation of 4-isopropyl-2,8,8-trimethyl-1,7,9-trioxaspiro[4.5]decane-6,10-dione (32) by ionic 
hydrogenation 
 
To a solution hemiacetal 31 (68 mg, 0.25 mmol) and triethylsilane (43.5 mg, 0.375 mmol, 1.5 equiv) in 
dichloromethane (2 mL) at -43 °C was slowly added triflic acid (~10 equiv). The reaction was maintained 
at -43 °C and monitored (TLC analysis) until the starting material was consumed. The reaction was 
quenched with water and extracted with dichloromethane (2 x 15 mL). The combined organic extracts 
were dried (Na2SO4) and concentrated. Flash chromatography (10% EtOAc/hexanes) afforded 32 (58 mg, 
0.23 mmol, 90%). Analytical data for 32: mp 108-109 C; IR (thin film, cm
-1
) 2973, 2911, 1785, 1750, 
1396, 1302, 1207, 1110, 1069, 1001, 918; 
1
H NMR (400 MHz, CDCl3)  4.53-4.48 (m, 1H), 2.98-2.90 
(ddd, J = 6.4, 10.9, 12.7 Hz, 1H), 2.32-2.25 (m, 1H), 2.04-1.91 (m, 1H), 1.87-1.75 (m, 1H), 1.85 (s, 3H), 
1.74 (s, 3H), 1.32 (d, J = 6.1 Hz, 3H), 0.96 (d, J = 6.6 Hz, 3H), 0.83 (d, J = 6.6 Hz); 
13
C NMR (150 MHz, 
CDCl3)  169.9, 167.6, 105.7, 80.9, 80.4, 60.0, 39.6, 29.9, 28.5, 27.5, 22.4, 21.7, 20.4; TLC (10% 
EtOAc/hexanes) Rf = 0.32. HRMS (ESI) Calculated for C13H20O5Na: 279.1209, Found: 279.1205. 
Preparation of 5-isopropyl-3,9,9-trimethyl-1,2,8,10-tetraoxaspiro[5.5]undecane-7,11-dione (33) by 
ionic hydrogenation 
 
To a solution of mixed acetal endoperoxide 30a (35 mg, 0.116 mmol) and triethylsilane (20 mg, 0.174 
mmol, 1.5 equiv) in dichloromethane (1.5 mL) at -43 °C was slowly added triflic acid (~10 equiv). The 
reaction was maintained at -43 °C and monitored by TLC until the starting material was consumed. The 
reaction was quenched with water and extracted with dichloromethane (2 x 10 mL). The combined 
organic extracts were dried (Na2SO4) and concentrated. Flash chromatography (10% EtOAc/hexane) 
afforded 33 (20 mg, 61 %). Analytical data for 33: mp 114-115C; IR (thin film, cm
-1
) 2953, 1779, 1749, 
33 
1396, 1289, 1203, 1020, 947, 925; 
1
H NMR (600 MHz, CDCl3)  4.46-4.42 (m, 1H), 2.63-2.58 (m, 1H), 
2.01-1.94 (m, 2H), 1.93 (s, 3H), 1.76 (s, 3H) 1.73-1.66 (m, 1H), 1.21 (d, J = 6.4 Hz, 3H), 0.99 (d, J = 6.6 
Hz, 3H), 0.80 (d, J = 6.6 Hz, 3H); 
13
C NMR (150 MHz, CDCl3)  162.8, 160.9, 107.0, 80.3, 78.2, 42.4, 
32.5, 29.7, 28.7, 28.6, 21.0, 20.7, 18.6; TLC (10% EtOAc/hexanes) Rf = 0.31. HRMS (ESI) Calculated for 
C13H20O6Na: 295.1158, Found: 295.1164. 
Preparation of 3-hydroxy-4-isopropyl-6-methyltetrahydro-2H-pyran-2-one (34) by palladium-
catalyzed hydrogenolysis 
 
To a solution of endoperoxide 33 (60 mg, 0.22 mmol) in CH2Cl2 (2 mL) was added 10% Pd/C catalyst (88 
mg, 400mg/mmol). The reaction was stirred under H2 (balloon) atmosphere at room temperature 
overnight. The mixture was filtered through a short pad of Celite (CH2Cl2), and the solvents were 
evaporated under reduced pressure. Flash chromatography (30% EtOAc/hexane) afforded 34 (20 mg, 
0.12 mmol, 53% yield). Analytical data for 34: mp 95-96C; IR (thin film, cm
-1
) 3419, 2956, 2872, 1729, 
1540, 1472, 1226, 1210, 1130, 1091, 967; 
1
H NMR (600 MHz, CDCl3)  4.51-4.45 (m, 1H), 4.45-4.41 (dd, 
J = 2.6, 9.2 Hz, 1H), 3.08 (d, 2.6 Hz, 1H), 2.49-2.43 (m, 1H), 2.26-2.21 (m, 1H), 1.94-1.89 (ddd, J = 2.7, 
6.4, 14.6 Hz, 1H), 1.56- 1.50 (ddd, J = 8.5, 11.9, 14.6 Hz, 1H), 1.41 (d, J = 6.1 Hz, 3H), 0.88 (d, J = 7.0 
Hz), 0.75 (d, J = 6.8 Hz); 
13
C NMR (100 MHz, CDCl3)  176.4, 73.2, 67.1, 39.4, 29.5, 26.0, 21.2, 20.5, 
16.1; TLC (30% EtOAc/hexanes) Rf = 0.20. HRMS (ESI) Calculated for C9H16O3Na: 195.0997, Found: 
195.0990. 
General Procedure D for iodoendoperoxidation of alkenyl Meldrum’s acid and barbituric acid 
hydroperoxides (11j-l) and (14) 
To a stirred solution of hydroperoxy Meldrum’s acid or barbituric acid derivative 11j-l or 14 in dry CH2Cl2 
in a vial wrapped in aluminum foil was added 1,3-diiodo-5,5-dimethyl hydantoin (1.2 equiv). The vial was 
capped and stirred for 16 h. The reaction was quenched with aqueous saturated sodium thiosulfate (until 
pink color dissipates) and the resulting mixture was extracted with CH2Cl2 (3x). The combined organic 
34 
extracts were dried (Na2SO4) and concentrated. Flash chromatography on SiO2 (5% EtOAc/hexanes) 
provided the iodoendoperoxide as a white, solid mixture of regioisomers as indicated. 
Analytical data for 3-(iodomethyl)-4-isopropyl-8,8-dimethyl-1,2,7,9-
tetraoxaspiro[4.5]decane-6,10-dione (23a): mp 114-116 C (decomp); IR (thin film, 
cm
-1
) 2962, 1779, 1754, 1396, 1296, 1200, 1023, 923; 
1
H NMR (600 MHz, CDCl3)  
4.59-4.56 (ddd, J = 2.6, 5.8, 8.4 Hz, 1H), 3.50 (dd, J = 8.4, 11.2 Hz, 1H), 3.41 (dd, J = 
2.6, 11.2 Hz, 1H), 3.38 (dd, J = 5.8, 11.0 Hz, 1H), 2.39-2.32 (m, 1H), 1.86 (s, 3H), 1.78 
(s, 3H), 1.04 (d, J = 6.7 Hz, 3H), 0.83 (d, J = 6.7 Hz, 3H); 
13
C NMR (150 MHz, CDCl3)  162.6, 161.5, 
106.9, 86.3, 83.5, 71.4, 29.3, 27.8, 27.5, 22.2, 21.8, 5.9; TLC (15% EtOAc/hexanes) Rf = 0.39. HRMS 
(ESI) Calculated for C12H17IO6Na: 406.9968, Found: 406.9974. 14:1 mixture with regioisomer 44 (at left). 
Analytical data for 3-(iodomethyl)-4-isobutyl-8,8-dimethyl-1,2,7,9-
tetraoxaspiro[4.5]decane-6,10-dione (23b): 
1
H NMR (400 MHz, CDCl3)  4.40 (q, J = 
5.9 Hz, 1H), 3.67 (td, J = 7.5, 6.4 Hz, 1H), 3.53 (dd, J = 10.9, 5.7 Hz, 1H), 3.38 (dd, J = 
10.9, 5.7 Hz, 1H), 1.80 (s, 3H), 1.77 (s, 3H), 1.56 (td, J = 7.1, 3.0 Hz, 2H), 1.42 (dp, J = 13.3, 6.6 Hz, 1H), 
0.93 (d, J = 6.5 Hz, 6H); 
13
C NMR (100 MHz, CDCl3)  164.2, 162.9, 106.5, 85.6, 83.2, 63.2, 37.3, 29.8, 
27.8, 27.1, 22.8, 22.3, 2.0; >20:1 regioselectivity. 
Analytical data for 3-(iodomethyl)-4,8,8-trimethyl-1,2,7,9-tetraoxaspiro[4.5]decane-
6,10-dione (23c): mp 115-116 C;  
1
H NMR (400 MHz, CDCl3)  4.40 (dt, J = 7.2, 5.8 
Hz, 1H), 3.54 (p, J = 7.1 Hz, 1H), 3.46 (dd, J = 10.9, 5.9 Hz, 1H), 3.34 (dd, J = 10.9, 5.6 
Hz, 1H), 1.79 (s, 3H), 1.77 (s, 3H), 1.30 (d, J = 7.0 Hz, 3H). 
13
C NMR (100 MHz, CDCl3)  164.1, 162.9, 
106.6, 85.9, 84.0, 60.0, 29.9, 27.8, 12.5, 0.4; TLC (20% EtOAc/hexanes) Rf = 0.30. >20:1 regioselectivity. 
Analytical data for 3-(iodomethyl)-4-isopropyl-7,9-dimethyl-1,2-dioxa-7,9-
diazaspiro[4.5]decane-6,8,10-trione (24): mp 100-103 C (decomp); IR (thin film, cm
-
1
) 2964, 2874, 1688, 14442, 1422, 1379, 1110, 1041, 752; 
1
H NMR (400 MHz, CDCl3)  
4.58-4.54 (ddd, J = 3.9, 5.6, 7.5 Hz, 1H), 3.52-3.47 (dd, J = 7.5, 11.1 Hz, 1H), 3.46-3.43 (dd, J = 3.9, 11.1 
Hz, 1H), 3.33 (s, 3H), 3.32 (s, 3H), 3.26 (dd, J = 5.6, 10.6 Hz, 1H), 2.30-2.21 (m, 1H), 1.01 (d, J = 6.6 Hz, 
3H), 0.72 (d, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3)  164.4, 164.2, 149.9, 85.9, 83.8, 70.7, 29.8, 
35 
28.9, 27.1, 22.1, 22.0, 5.6; TLC (15% EtOAc/hexanes) Rf = 0.24. HRMS (ESI) Calculated for 
C12H17IN2O5Na: 419.0080, Found: 419.0086. 
O-O bond cleavage of iodoendoperoxide (23a) by thiourea 
 
To a stirred solution of iodoendoperoxide (50 mg, 0.130 mmol, 10:1 mixture of 23a to 44) in dry MeOH 
(3.0 mL) in an aluminum foil wrapped vial was added thiourea (10 mg, 0.130 mmol, 1.0 equiv). After 4 h, 
the reaction was concentrated to dryness, the residue was taken up in CH2Cl2 (10 mL) and washed with 
H2O (5 mL). The aqueous layer was separated and extracted with CH2Cl2 (10 mL). The combined organic 
extracts were dried (Na2SO4), filtered, and a solution of freshly distilled dicyclohexylamine (21.2 mg, 0.90 
equiv) in CH2Cl2 was added and stirred for 5 min. The solution was concentrated to dryness, and the 
residue triturated with hexanes. The precipitate was isolated by suction filtration to give 43 mg (72%) of 
the dicyclohexylamine salt as cream colored solid (dr >20:1). Analytical data for dicyclohexylamine (±)-3-
hydroxy-5-(iodomethyl)-4-isopropyl-2-oxotetrahydrofuran-3-carboxylate 25: 
1
H NMR (400 MHz, CDCl3)  
8.95 (bs, 2H), 4.91 (bs, 1H), 4.33 (m, 1H), 3.82 (dd, J = 4.8, 10.6 Hz, 1H), 3.56 (dd, J = 6.3 Hz, 10.6 Hz, 
1H), 3.02-2.96 (m, 2H), 2.47 (app. t, J = 6.8 Hz, 1H), 2.21-2.12 (m, 1H), 2.02-1.99 (m, 4H), 1.83-1.81 (m, 
4H), 1.66 (m, 2H), 1.48-1.39 (m, 4H), 1.30-1.21 (m, 6H), 0.97 (d, J = 6.8 Hz, 3H) 0.96 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3)  175.8, 173.8, 79.9, 78.6, 53.4, 52.9, 28.9, 26.2, 24.9, 24.7, 21.2, 19.2, 8.2. 
Hydrogenolysis of iodoendoperoxide (23a) by Pt/C 
 
A degassed soln of iodoendoperoxide 23a (20 mg, 0.052 mmol, 10:1 mixture of 23a to 44) in EtOAc/EtOH 
(1:10, 2.2 mL) was added to a suspension of 5% Pt/C (10.4 mg, 200 mg/mmol) in EtOH (1 mL) under N2. 
The vial was purged with H2 (balloon) and stirred vigorously. After 5 h the reaction was filtered through a 
plug of Celite (EtOAc) and a soln of dicyclohexylamine (8.5 mg, 0.047 mmol, 0.90 equiv) in dry CH2Cl2 
was added. After 15 min, the reaction was concentrated to dryness and triturated with hexanes (4 mL). 
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The precipitate was isolated by suction filtration to give 18.3 mg (77%) of the dicyclohexylamine salt as 
cream colored solid (dr >20:1). 
Attempted Meldrum’s Acid Cleavage of 23a 
 
To a solution of 23a (21.7 mg, 0.056 mmol, 1.0 equiv) in MeOH (2.0 mL) was added Ni(acac)2 (6.5 mg, 
0.025 mmol, 0.3 equiv) and the resulting solution was heated to reflux. After 4.5 h the reaction was diluted 
with H2O and extracted with CH2Cl2 (3x). The combined organic extracts were washed with brine, dried 
(Na2SO4) and concentrated in vacuo. Flash chromatography (5-20% EtOAc/hexanes) provided 26 (1.4 
mg, 0.008 mmol, 13%) and 27 (3.9 mg, 0.014 mmol, 25%). Analytical data for 26: 
1
H NMR (600 MHz, 
CDCl3)  5.83 (d, J = 7.0 Hz, 1H), 3.56 (p, J = 6.9 Hz, 1H), 3.20 – 3.13 (m, 1H), 2.95 (ddd, J = 18.1, 6.9, 
0.9 Hz, 1H), 2.61 (ddd, J = 18.2, 2.2, 0.8 Hz, 1H), 1.10 (d, J = 6.9 Hz, 3H), 1.05 (d, J = 6.9 Hz, 3H). LRMS 
(ESI) Calculated for C9H14NaO4: 209.08, Found: 209.09. Analytical data for 27: 
1
H NMR (600 MHz, 
CDCl3)  4.69 (ddd, J = 4.4, 3.2, 0.6 Hz, 1H), 3.71 (dd, J = 11.5, 3.2 Hz, 1H), 3.41 – 3.30 (m, 1H), 2.59 – 
2.44 (m, 1H), 1.35 (d, J = 7.0 Hz, 3H), 1.22 (d, J = 7.0 Hz, 3H). 
Crystal Structure Determination of (25) 
Single crystals of 25 (C21H36INO5) were prepared via recrystallization from CH2Cl2/hexanes. A suitable 
crystal was selected and placed on a MiteGen mylar tip with paratone oil on a Bruker-AXS SMART 
APEX-II diffractometer. The crystal was kept at 100 K during data collection. Using Olex2,
52
 the structure 
was solved with the olex2.solve
53
 structure solution program using Charge Flipping and refined with the 
XL
54
 refinement package using Least Squares minimization. 
Crystal Data. C21H36INO5, M = 509.41, monoclinic, a = 13.3142(2) Å, b = 16.8691(3) Å, c = 10.6959(2) Å, 
 = 104.1800(10), V = 2329.09(7) Å
3
, T = 100, space group P21/c (no. 14), Z = 4, (CuK) = 11.044, 
11077 reflections measured, 4334 unique (Rint = 0.0526) which were used in all calculations. The final 
wR2 was 0.1110 (all data) and R1 was 0.0433 (>2sigma(I)). 
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CHAPTER TWO: COPPER-CATALYZED ASYMMETRIC HYDROGENATION OF ARYL AND 
HETEROARYL KETONES
*
 
 
2.1 Introduction 
 Asymmetric hydrogenation of simple, unactivated prochiral ketones is an important process that 
provides access to synthetically useful chiral secondary alcohol building blocks from inexpensive starting 
materials. Transition metal catalysts are generally utilized for these reductions because they provide 
highly active and selective catalysts. However, the high cost, limited supply, and sometimes significant 
toxicity of transition metals has sparked interest in the use of more environmentally friendly base metals 
such as iron and copper. In this chapter, we report a new copper-based catalyst system for the 
enantioselective hydrogenation of prochiral ketones that utilizes a chiral bidentate phosphine ligand 
(BoPhoz) in conjunction with an achiral triarylphosphine [P(3,5-xylyl)3)] to provide benzylic alcohols in 
good yields and enantioselectivities (Scheme 2-1). Development of this methodology was enabled by 
high-throughput screening in collaboration with GlaxoSmithKline. Realizing the potential of a three 
phosphine system, a number of novel, enantiopure trisphosphine ligands were prepared and evaluated 
for activity and selectivity in the asymmetric reduction of prochiral ketones. 
Scheme 2-1. Copper-Catalyzed Asymmetric Hydrogenation of Prochiral Ketones 
                                                          
*
Reproduced in part by permission of the American Chemical Society: Krabbe, S. W.; Hatcher, M. A.; 
Bowman, R. K.; Mitchell, M. B.; McClure, M. S.; Johnson, J. S. Org. Lett. 2013, 15, 4560-4563.  
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2.2 Background 
2.2.1 Importance of Chiral Secondary Alcohols 
Chiral secondary alcohols are important building blocks in organic synthesis which are generally 
prepared via asymmetric hydrogenation of prochiral ketones using transition metal catalysts (Ru, Rh, Pd, 
Ir).
1
 The limited supply and resulting high cost of transition metals have ignited investigations of more 
environmentally friendly base metals such as iron
2
 and copper for these reductions. Although major 
progress has been realized in this area, few of the reported hydrogenation methodologies rival the activity 
and selectivity obtained with transition metal catalysts. 
2.2.2 Copper Hydride Complexes in Racemic Reductions  
Racemic reductions using copper hydride complexes have been known for several decades with 
pioneering work by Stryker and co-workers providing the hexameric copper hydride species, 
[{CuH(PPh3)}6], which was particularly useful in the reduction of α,β-unsaturated carbonyl compounds 
(Scheme 2-2).
3
 
Scheme 2-2. Stryker’s Reagent in 1,4-Reductions 
 
Stryker and co-workers found that changing the phosphine ligand to 1,1,1-
tris(diphenylphosphinomethyl)ethane (tripod) allowed 1,2-reduction in unconjugated systems, but this 
complex still provided 1,4-reduction in conjugated systems, limiting its utility (Scheme 2-3).
4
 Although the 
catalyst exists in the solid state as a dimer with one of the tripod phosphines unligated, the monomeric 
species is proposed to be the active catalyst species.   
Scheme 2-3. [(
2
-tripod)CuH]2 in 1,2-Reductions 
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Mechanistic studies revealed the necessity for addition of multiple equivalents of exogenous tripod to 
slow catalyst degradation, and at pressures less than 50 psi, slow catalyst degradation occurred, while at 
pressures above 70 psi severe catalyst inhibition was observed. 
 A 1,2-selective reduction catalyst was obtained by switching the phosphine ligand to 
dimethylphenylphosphine, but no rationale for the selectivity switch was provided (Scheme 2-4).
4
 The in 
situ preparation of this complex was preferred which bears particular relevance to the preparation of 
copper complexes used in our work. Formation of [CuO
t
Bu]4 from various Cu(I) sources occurs in the 
presence of NaO
t
Bu, and its hydrogenolysis provides 
t
BuOH and the reactive CuH species.
5
 Electron 
rich ligands are generally required for stabilization of CuH, and exogenous hindered alcohols are usually 
required to turn over the catalyst following substrate reduction.
4
 
Scheme 2-4. 1,2-Selective CuH Reduction and In Situ Formation of CuH 
 
2.2.3 Copper-Catalyzed Asymmetric Hydrosilylation of Prochiral Ketones 
With respect to asymmetric reduction, the use of copper hydride complexes and silanes as the 
stoichiometric reductant has been reported with a variety of chiral ligands providing exceptional reactivity 
and selectivity.
6
 Lipshutz and co-workers provided remarkable advancement in this field with their 
discovery of the activity and selectivity provided by the combination of copper and Roche’s MeO-BIPHEP 
or Takasago’s SEGPHOS ligand classes (Scheme 2-5), even commercializing a shelf stable “CuH in a 
bottle.”
6d 
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Scheme 2-5. Asymmetric Hydrosilylation of Prochiral Ketones 
 
Each of these bidentate phosphine ligands contain an electron rich, oxygenated biaryl backbone which is 
proposed to stabilize the CuH via -bonding providing an 18 electron complex.
6d
 Despite the excellent 
enantioselectivities observed in many cases, these methodologies suffer from a number of drawbacks 
including the use of cryogenic temperatures for optimal selectivity and generation of superstoichiometric 
silane by-products that detract from overall mass efficiency. A greener and more scalable alternative 
would utilize hydrogen, but significantly less work has been reported in this area.   
2.2.4 Extant Methodologies for Copper-Catalyzed Asymmetric Hydrogenation of Prochiral Ketones 
Shimizu and co-workers reported the first asymmetric copper-catalyzed ketone hydrogenation 
utilizing the chiral ligand BDPP, but only ortho-substituted aryl and heteroaryl ketones provided good 
enantioselectivities (Scheme 2-6).
7
 In their studies, Cu(NO3)(P(3,5-xylyl)3)2 provided a modest increase in 
enantioselectivity over commercially available Cu(NO3)(PPh3)2, and exogenous addition of the 
corresponding triarylphosphine was required to maintain high catalytic efficiency. 
Scheme 2-6. Copper-Catalyzed Asymmetric Hydrogenation with BDPP 
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Beller and co-workers reported a more general catalyst system using copper acetate and monodentate 
binaphthophosphepine ligands, but enantioselectivities generally did not exceed 75% (Scheme 2-7).
8
 In 
addition to the moderate enantioselectivities, both methodologies required hydrogen pressures (50 bar) 
generally outside the desired range for process applications. 
Scheme 2-7. Copper-Catalyzed Asymmetric Hydrogenation with Binaphthophosphepine Ligands 
 
2.2.5 High-Throughput Experimentation (HTE) Collaboration with GlaxoSmithKline 
 High-Throughput Experimentation (HTE) has emerged as an important tool in the discovery and 
optimization of new synthetic methodology.
9
 In collaboration with GlaxoSmithKline (GSK), we believed the 
use of HTE would provide an excellent opportunity to improve upon the copper-catalyzed hydrogenation 
of prochiral ketones previously reported. The Screening and Catalysis Group at GSK operates a library of 
~75 commercially available chiral bis(phosphine) ligands in addition to a multitude of metal catalysts, 
bases, and triarylphosphines. These reagents are stored in source vials that can be dispensed by a 
FLEXIWEIGH solid dispensing robot allowing the automated setup of to 48 reactions (~50 mg substrate) 
at once. Cat96 parallel hydrogenation equipment allows the reactions to be carried out simultaneously 
and conversions/selectivities can be determined by HPLC in an automated fashion. Following the 
successful discovery of improved conditions, scale-up experiments (~500 mg scale) can be performed 
using an HEL Chemscan apparatus which allows temperature modulation and monitoring of hydrogen 
uptake to determine reaction times. 
2.3 Results and Discussion 
2.3.1 Initial Ligand Screening for Copper-Catalyzed Asymmetric Ketone Reduction 
 Our point of departure for this study was the translation of conditions reported by Shimizu
7
 and 
Beller
8
 to the high-throughput manifold (vide supra). This operation required using lower pressures than 
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previously reported due to instrument limitations. Gratifyingly, several active and selective complexes 
were identified from the ~60 ligands screened under similar conditions to those reported (for additional 
screening data, please see the experimental section), even at lower hydrogen pressures (20 bar vs 50 
bar). Given the precedent for asymmetric ketone reduction with BIPHEP- and SEGPHOS-ligated copper 
hydride species, their activity, and that of closely related ligands, under the current conditions is not 
surprising (Figure 2-1).
6d
 Unfortunately, commercially available variants of these ligands provided little 
increase in selectivity, so we turned our attention to optimization of other reaction parameters.  
Figure 2-1. Ligands Identified by Parallel Screening 
 
2.3.2 Optimization of Reaction Conditions for Active Ligands 
 A number of reaction parameters might nominally be expected to influence reactivity and 
selectivity including the identity of base, solvent and copper source. Initial experiments varying the base 
with chiral ligand BDPP showed tert-butoxides (KO
t
Bu  NaO
t
Bu) gave better reactivity and selectivity in 
comparison to other bases investigated (KOSiMe3  LiO
t
Bu  Cs2CO3  K3PO4  LiOH). These results 
were not overly surprising, as formation of the active CuH species likely arises from hydrogenolysis of in 
situ formed [CuO
t
Bu]4.
5
 Based on these results, we chose to use KO
t
Bu for the remainder of the 
investigations. By the same manner, 
i
PrOH was chosen as the solvent for further investigations as it 
proved optimal for a number of bis(phosphines) under otherwise standard conditions.  
Under our standard screening conditions (with 3), a comparison of several copper sources (CuCl, 
(PPh3)2CuNO3) with three of the active chiral bis(phosphine) ligands gave essentially identical reactivity 
and enantioselectivity to that observed with Cu(OAc)2, except in the case of (PPh3)2CuNO3 (Table 2-1). In 
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the presence of exogenous P(3,5-xylyl)3, (PPh3)2CuNO3 gave lower enantioselectivity and a further drop 
in selectivity was observed in the absence of P(3,5-xylyl)3. Furthermore, in the absence of P(3,5-xylyl)3, 
CuCl showed remarkably decreased reactivity in comparison to (PPh3)2CuNO3. Cu(OAc)2 was chosen for 
all further investigations based on stability, ease of robotic dispensing, and the negligible difference in 
results observed versus Cu(I) salts. Collectively, these results provided an early indication to the 
important role of the ancillary triarylphosphine for both reactivity and enantioselectivity, and led to the 
screening of active bis(phosphine) ligands with a variety of non-chiral ancillary triarylphosphines. 
Table 2-1. Results of Varying Copper Source on Reactivity and Selectivity
 
 
  With 3a Without 3a 
Cu Source Ligand Conv. (%) er (R:S) Conv. (%) er (R:S) 
Cu(OAc)2 (S,R)-N-Me-BoPhoz (4) 99 24:76 39 49:51 
CuCl  100 24:76 25 50:50 
(PPh3)2CuNO3  100 40:60 100 44:56 
Cu(OAc)2 (R)-p-tol-MeO-BIPHEP (5) 78 14:86 4 ND 
CuCl  75 15:85 0 ND 
(PPh3)2CuNO3  85 25:75 56 46:54 
Cu(OAc)2 (R)-SEGPHOS (6) 94 12:88 27 50:50 
CuCl  46 13:87 0 ND 
(PPh3)2CuNO3  77 23:77 38 43:57 
Conversions determined by comparison of relative integration by HPLC of alcohol to ketone. 
Enantioselectivity was determined by HPLC analysis.  
 
2.3.3 Screening of Active Ligands with Various Non-Chiral Ancillary Phosphines 
 The most promising bis(phosphine) ligands identified in initial screening were matrixed against a 
library of achiral ancillary phosphines to investigate the influence of the ancillary phosphine on both 
reactivity and selectivity (Table 2-2). A subset of those phosphines investigated will be discussed here to 
show overall trends, while the comprehensive list of ancillary phosphines investigated can be found in the 
experimental section. In the absence of ancillary phosphine, poor reactivity and no enantioselectivity is 
observed (Row 1). Trialkylphosphines also provided poor reactivity and enantioselectivity (Row 2). 
Reactive, but non-selective catalysts are formed with PPh3, while more hindered P(o-tol)3 provided 
essentially no reactivity (Rows 3-4). Similar reactivity and increasing enantioselectivity trends were 
observed for para-, meta-, 3,5-di-methyl-substituion, respectively (Rows 5-7). In addition to steric 
considerations, electron density of the phosphine also played a key role in reactivity. Relatively electron 
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rich ancillary phosphines gave more reactive catalysts than similarly substituted electron deficient ones 
(Rows 7-8). Considering the importance of 3,5-di-substitution, more sterically demanding ancillary 
phosphines were evaluated, but these provided only decreased reactivity and selectivity (Rows 9-10). 
The variance in reactivity and enantioselectivity with different ancillary phosphines clearly points to its 
playing a pivotal role beyond simply reduction of Cu(II) to Cu(I). 
Table 2-2. Reactivity and Selectivity Trends Observed by Varying Ancillary Triarylphosphine
 
 
   Chiral Bis(phosphine) Ligand 
   (R)-SEGPHOS (R)-p-tol-MeO-BIPHEP (S, R)-N-Me-BoPhoz 
Row Ancillary Phosphine Conv. (%)  er (R:S) Conv. (%)  er (R:S) Conv. (%)  er (R:S) 
1 None - 27 50:50 4 ND 39 50:50 
2 PCy3 3b 10 ND 19 49:51 40 46:54 
3 PPh3 3c 91 41:59 95 45:55 96 44:56 
4 P(o-tol)3 3d 3 ND 7 ND 12 48:52 
5 P(p-tol)3 3e 83 44:56 97 48:52 96 43:57 
6 P(m-tol)3 3f 98 20:80 98 22:78 95 37:63 
7 P(3,5-xylyl)3 3a 94 12:88 100 14:86 97 24:76 
8 P(3,5-diCF3-C6H3)3 3g 22 57:44 25 48:52 12 75:25 
9 P(3,5-di
t
Bu-C6H3)3 3h 15 45:55 11 50:50 16 49:51 
10 P(3,5-diEt-C6H3)3 3i 61 25:75 66 28:72 92 27:73 
Conversions determined by comparison of relative integration by HPLC of alcohol to ketone. 
Enantioselectivity was determined by HPLC analysis.  
 
2.3.4 Screening of Active Ligands with Various Chiral Ancillary Phosphines 
 Having determined the importance of the ancillary triarylphosphine for both reactivity and 
selectivity, we postulated that the use of a chiral mono(phosphine) in conjunction with the chiral 
bis(phosphine) ligand could further increase the selectivity observed. Cognizant of the possibility for 
matched/mismatched chiral ligand interactions, both enantiomers of the chiral bis(phosphine) were 
investigated with each chiral mono(phosphine). A small subset of the chiral mono(phosphine) ligands 
investigated will be discussed here, while the full list can be found in the experimental section. We began 
our investigation with (R)- and (S)-monophos in conjunction with each enantiomer of p-tol-MeO-BIPHEP 
(Table 2-3). Although no increase in reactivity or selectivity was observed, important information was 
garnered from this reaction set. Clearly, both the mono(phosphine) and bis(phosphine) play active roles in 
determining selectivity as evidenced by the change in absolute configuration when switching from P(3,5-
xylyl)3 to either enantiomer of MonoPhos. Furthermore, it seems the bis(phosphine) controls the relative 
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stereochemistry as it is unaffected by changing from (R)- to (S)-monophos. Inactivity in the absence of 
bis(phosphine) clearly indicates the importance of both mono- and bis(phosphine) being present. 
Interestingly, no matched/mismatched interactions were observed as conversions and selectivities 
remained essentially constant throughout the screen. A different outcome was observed in reactions 
utilizing (S)-PipPhos which clearly showed matched/mismatched interactions as conversions were 
remarkably different for each enantiomer of p-tol-MeO-BIPHEP. In general, the mono(phosphine) did not 
provide an active catalyst in the absence of bis(phosphine), but this was not the case for (R)-SITCP which 
bears resemblance to the chiral mono(phosphines) utilized by Beller and coworkers. This 
mono(phosphine) overrode the selectivity expected when used in conjunction with (S)-p-tol-MeO-BIPHEP 
and even provided an active catalyst in the absence of bis(phosphine). 
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Table 2-3. Chiral Mono(phosphines) as Ancillary Ligands
 
 
 Bis(phosphine) 
 (R)-p-tol-MeO-BIPHEP (S)-p-tol-MeO-BIPHEP None 
Mono(phosphine) Conv. (%) er (R:S) Conv. (%) er (R:S) Conv. (%) er (R:S) 
P(3,5-xylyl)3 (3a) 100 9:81 97 81:9 0 - 
 
75 67:33 72 33:67 <5 - 
 
68 67:33 73 36:64 <5 - 
 
23 70:30 75 45 (S) <5 - 
 
47 71:29 78 61:39 31 65:35 
Conversions determined by comparison of relative integration by HPLC of alcohol to ketone. 
Enantioselectivity was determined by HPLC analysis.  
 
2.3.5 Precomplexation Studies with Active Ligands 
 The inability to increase enantioselectivity by varying the ancillary phosphine prompted us to 
investigate a number of different scenarios that could account for the decreased selectivity. The setup for 
these reactions remained constant throughout our investigations with all reagents being mixed together 
and submitted directly to the hydrogenation conditions without a catalyst precomplexation period. To rule 
out the possibility of unligated and therefore non-selective CuH species as a cause for lower 
enantioselectivity, a number of the most promising bis(phosphines) were submitted to four different sets 
of conditions: precomplexation period in the presence of substrate under N2, precomplexation in the 
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absence of substrate under N2, precomplexation in the absence of substrate under H2, and standard 
conditions without a precomplexation period. In all cases, the enantioselectivity remained essentially 
unchanged thereby ruling out the possibility of a non-selective CuH species as a source for the 
decreased selectivity. 
Table 2-4. Catalyst Precomplexation Studies
 
 
 Ligand 
 (R)-SEGPHOS (R)-p-tol-OMe-BIPHEP (S,R)-N-Me-BoPhoz 
 Precomplexation Conditions er (R:S) er (R:S) er (R:S) 
w/Substrate (under N2) ND 13:87 22:78 
w/out Substrate (under N2) 11:89 14:86 21:79 
w/out Substrate (under H2) 11:89 14:86 21:79 
None 11:89 14:86 21:79 
 >95% conversion for all reactions 
2.3.6 Pressure Effects in Hydrogenation with Active Ligands 
To ensure operation at the ideal pressure and rule out any pressure effects in our system, several 
catalyst systems were submitted to three different reaction pressures: 5 bar, 20 bar, and 29 bar (limit of 
equipment). Under these conditions, selectivity remained essentially the same throughout, while reactivity 
diminished significantly at 5 bar H2.  
Table 2-5. Absence of Pressure Effects in Hydrogenation 
 
 Ligand 
 (R)-SEGPHOS (R)-p-tol-OMe-BIPHEP (S,R)-N-Me-BoPhoz 
 H2 Pressure Conv. (%) er (R:S) Conv. (%) er (R:S) Conv. (%) er (R:S) 
5 bar 82 12:88 58 14:86 54 21:79 
20 bar 100 11:89 100 14:86 100 21:79 
29 bar 86 11:89 94 14:86 94 21:79 
 
2.3.7 Transfer Hydrogenation Studies 
 The presence of both a Lewis acid and isopropanol, prompted us to investigate the possibility of 
Meerwein-Ponndorf-Verley reduction as this pathway would result in stereoerosion.
10
 We submitted 
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several bis(phosphines) to reaction conditions in the absence of H2 to test for such a reaction pathway, a 
few of which will be discussed here. For SEGPHOS, low conversion to racemic product under the normal 
reaction conditions was observed, while much greater conversion was observed when the reaction was 
heated to 70 °C. Similar results were observed for p-tol-MeO-BIPHEP over an extended reaction period, 
while no reduction was observed when N-Me-BoPhoz was used. These results directed us towards the 
use of BoPhoz ligands, even though selectivities for the parent ligand were less than satisfactory. 
Table 2-6. Transfer Hydrogenation Studies 
 
Ligand Conv. (%) er (R:S) 
(R)-SEGPHOS
a
 13 50:50 
(R)-SEGPHOS
b 
65 49:51 
(R)-p-tol-OMe-BIPHEP
c 
7 ND 
(S,R)-N-Me-BoPhoz
c 
0 - 
 a
 16 h at 30 °C; 
b
 12 h at 70 °C; 
c 
60 h at 30 °C 
2.3.8 Synthesis of BoPhoz Analogs 
 A number of factors influenced our decision to pursue the synthesis of BoPhoz analogs, the most 
important being increased reactivity observed versus other bis(phosphine) ligands. In general, less base 
(30 vs. 50 mol %) and decreased ancillary triarylphosphine equivalents (1 vs. 3 or more) were required for 
BoPhoz systems to maintain equal reactivity. Furthermore, the modular synthesis of BoPhoz ligands 
allows rapid access to ligand diversity for reaction optimization.
11
  
Scheme 2-8. Modular Synthesis of Bophoz Derivatives 
 
 Nineteen different BoPhoz derivatives and four BoPhoz precursors were prepared and evaluated 
under our standard reaction conditions (Table 2-7). Evaluation of BoPhoz precursors clearly indicated 
that presence of the aminophosphine was paramount for reactivity and selectivity. Variation of the alkyl-
amino group from methyl to ethyl resulted in diminished reactivity and selectivity, and both further 
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decreased when the free amino group was used. Systematic variation of the aryl substituents on the non-
ferrocenyl phosphorus was easily achieved from a single precursor and a variety of diaryl phosphorus 
chlorides. Decreased electron density on this phosphorus resulted in less reactive systems (entries 4-6). 
Electron releasing para-substituents showed little to no increase in selectivity (entries 7-9). Gratifyingly, 
3,5-dimethyl-substitution resulted in an increase in selectivity while maintaining reactivity (entry 10). 
Increasing steric demand at the 3- and 5-positions from Me to 
t
Bu resulted in a similarly selective catalyst 
albeit with diminished reactivity (entry 14). Considering chiral substitution of the amino group led us to 
investigate BINOL phosphoramidites but these resulted in complete loss of reactivity, irrespective of the 
BINOL enantiomer used (entries 19-20). Stereogenic ferrocenyl phosphorus derivatives were also 
evaluated but provided only decreased reactivity and selectivity (entries 21-22). Additional variation of the 
ferrocenyl phosphorus showed no change in selectivity; as a result further modulation at this center was 
not investigated (entry 23). 
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Table 2-7. Investigation of BoPhoz Derivatives in Acetophenone Reduction 
 
entry R
1 
R
2 
 conv. (%) er (R:S) 
1 Me Me 12 7 - 
2 Me H 11a 22 51:49 
3 Et H 11b 11 - 
4 
c
Hex H 11c 5 - 
5 Me PPh2 4a 100 79:21 
6 Et PPh2 4b 98 72:28 
7 H PPh2 4c 16 67:33 
8 Me P(4-CF3C6H4)2 4d 52 75:25 
9 Me P(4-F-C6H4)2 4e 76 67:33 
10 Me P(3,5-diCF3-C6H3)2 4f 0 - 
11 Me P(4-CH3-C6H4)2 4g 100 79:21 
12 Et P(4-CH3C6H4)2 4h 100 74:26 
13 Me P(4-OMe-C6H4)2 4i 100 68:32 
14 Me P(3,5-diMe-C6H3)2 4j 100 91:9 
15 H P(3,5-diMe-C6H3)2 4k 53 57:43 
16 Et P(3,5-diMe-C6H3)2 4l 76 80:20 
17 Me P(3,5-diMe-4-OMe-C6H2)2 4m 100 67:33 
18 Me P(3,5-tBu-4-OMe-C6H2)2 4n 43 89:11 
19 Me R-BINOL Phosphoramidite 4o 0 - 
20 Me S-BINOL Phosphoramidite 4p 0 - 
21 
 
4q 10 57:43 
22 
 
4r 54 85:15 
23 
 
4s 100 91:9 
Conversions determined by comparison of relative integration by HPLC of alcohol to ketone. 
Enantioselectivity was determined by HPLC analysis.  
 
2.3.9 Screening of Various Ancillary Ligands with BoPhoz Analogs 
 Having identified BoPhoz ligand 4j as the most selective of those examined, we revisited the 
impact of the ancillary triarylphosphine (Table 2-8). As previously observed with commercial (S,R)-N-Me-
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BoPhoz, the electronic and steric characteristics of the aryl substituents played a key role in determining 
reactivity and selectivity. In the absence of added triarylphosphine, poor reactivity and selectivity were 
observed (entry 6). Relatively electron deficient phosphines favored the formation of the (S)-alcohol 
(entries 1-5), while electron rich phosphines favored formation of the (R)-alcohol (Entries 7-15). 
Remarkably, complete reversal of enantioselectivity could be achieved by switching from phosphine 3f to 
3a (entries 2 and 13).
12 
 This reversal in enantioselectivity was observed with almost all of the BoPhoz 
derivatives examined when switching between these ancillary phosphines, although this effect was not 
always as pronounced. Unfortunately, ancillary phosphine 3f was only effective when 
t
BuOH was used as 
the solvent (entry 1 vs. 2). Lower isolated yields of the chiral alcohols were obtained with 
t
BuOH resulting 
from unproductive side reactions of the starting material; therefore, 
i
PrOH was selected for further study. 
Table 2-8. Investigation of Various Ancillary Phosphines with (R,S)-N-Me-3,5-xylyl-BoPhoz 
 
entry R  conv (%)
a 
er (R:S)
b 
1 3,5-CF3-C6H3 3f 10 31:69 
2
c 
3,5-CF3-C6H3 3f 78 8:92 
3 3,5-F-C6H3 3o 37 42:58 
4 4-F-C6H4 3p >99 41:59 
5 3-F-C6H4 3q >99 47:53 
6 No Ancillary - 17 53:47 
7 Ph 3c >99 51:49 
8 c-hexyl 3b 24 52:48 
9 4-Me-C6H4 3e >99 52:48 
10 2-Me-C6H4 3d 17 53:47 
11 3-Me-C6H4 3f >99 75:25 
12 3-Et-C6H4 3r >99 66:34 
13 3,5-Me-C6H3 3a >99 91:9 
14 3,5-Et-C6H3 3i 90 87:13 
15 3,5-Me-4-OMe-C6H2 3h >99 89:11 
a
Determined by comparison of relative HPLC integration of alcohol to ketone. 
b
Determined by HPLC 
analysis. 
c
 
t
BuOH instead of 
i
PrOH. 
 
2.3.10 Optimization of Reaction Conditions for (R,S)-N-Me-3,5-xylyl-BoPhoz 
We then turned our attention to the effects of both temperature and pressure on selectivity (Table 
2-9). Lowering the temperature provided a modest increase in selectivity without greatly increasing 
reaction time (entries 1-5). Gratifyingly, in contrast to the Cu-catalyzed hydrogenations previously 
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reported, the current system still operates efficiently at pressures as low as 5 bar, giving the same 
selectivity with only a slight increase in reaction time (entry 6). 
Table 2-9. Pressure and Temperature Optimization for Hydrogenation 
 
entry
a
 temp (°C) pressure (bar) t (h) er (R:S)
b
 
1 30 20 16 89.5:10.5 
2 25 20 24 90.5:9.5 
3 20 20 24 90.7:9.3 
4 15 20 24 92.1:7.9 
5 10 20 24 92.3:7.7 
6 25 5 28 90.6:9.4 
All reactions proceeded to >97% conversion in the specified time period. 
b
Determined by HPLC analysis. 
2.3.11 Scope and Limitations of Copper-Catalyzed Asymmetric Ketone Reduction 
With optimal conditions realized, we examined the substrate scope of this hydrogenation (Table 
2-10). A variety of 4- and 3-substituted acetophenones, both electron-rich and –deficient, were effectively 
reduced under the standard conditions with good enantioselectivities (entries 3-9). 2-Substituted 
acetophenones were also reduced, albeit in slightly decreased enantioselectivities (entries 10-11). 
Increasing steric demand by variation of the ketone α-substitution was well tolerated (entries 13-14). 
Although the selectivity remains modest, 4-phenyl-2-butanone was reduced with increased 
enantioselectivity than previously reported with Cu-catalyzed hydrogenation (entry 15). Several heteroaryl 
substituted ketones were also viable substrates (entries 16-20), some of which gave the best 
enantioselectivities observed with this methodology. The reduction of acetylferrocene, the first step in the 
synthesis of BoPhoz ligands, can also be performed with this catalyst system providing 2s in excellent 
yield and good enantioselectivity (entry 21). 
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Table 2-10. Substrate Scope for Cu-Catalyzed Hydrogenation 
 
entry product t (h)
a 
yield (%)
b 
er (R:S)
c 
 
 
 
   
1
d 
H 2a 16 68 93:7 
  2
d,e 
H ent-2a 16 68 12:88 
3 H 2a 24 93 92:8 
4
f 
4-OMe 2b 24 >95 93:7 
5 4-F 2c 24 92 92:8 
6 4-CF3 2d 12 79 93:7 
7 3-Me 2e 38 92 95:5 
8 3-Br 2f 24 86 92:8 
9 3-CF3 2g 10 77 90:10 
10
f 
2-Me 2h 30 >95 88:12 
11 2-Br 2i 30 75 86:14 
12 
 
2j 33 >95 93:7 
13
g 
 
2k 24 >95 95:5 
14 
 
2l 18 93 97:3 
15 
 
2m 16 >95 75:25 
16
f 
 
2n 24 >95 84:16 
17 
 
2o 14 70 83:17 
18 
 
2p 24 90 85:15 
19
f 
 
2q 24 96 98:2 
20
f 
 
2r 27 91 97:3 
21
f 
 
2s 45 >95 92:8 
a
Time when hydrogen uptake ceased. 
b
Isolated yield. 
c
Determined by HPLC analysis. 
d t
BuOH instead of 
i
PrOH. 
e
3f instead of 3a, 30 °C. 
f
3.0 mol % Cu(OAc)2, 3.0 mol % 4j, 3.0 mol % 3a, 45 mol % KO
t
Bu. 
g
25 
°C. 
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2.3.12 Chiral Trisphosphine Ligands 
 
 The obvious need for a three phosphine system for efficient reduction prompted us to investigate 
the possibility of tethering all three phosphines in a single chiral ligand. We hoped this approach would 
limit conformational flexibility about CuH thereby increasing enantioselectivity and potentially providing a 
more robust catalyst system. Literature pertaining to the synthesis and utility of chiral trisphosphine 
ligands is remarkably scarce in comparison to chiral bis(phosphines).
13
 Most reports are limited to their 
synthesis and metal binding studies, with little application in asymmetric catalysis (Figure 2-2).   
Figure 2-2. Selected Chiral Trisphosphines 
 
By far the most utilized chiral trisphosphine is Pigiphos 15 reported by Togni and coworkers for Ni-
catalyzed 1,3-dipolar cycloadditions
13i
 and hydroaminations,
13e
 and Ru-catalyzed transfer hydrogenation 
of acetophenone derivatives.
13c
 Unfortunately, although 15 provided an active hydrogenation catalyst, no 
enantioselectivity was observed. In the presence of added P(3,5-xylyl)3, remarkable catalyst inhibition 
was observed (Scheme 2-9). 
Scheme 2-9. Evaluation of Pigiphos in Cu-Catalyzed 2-Naphthone Hydrogenation 
 
Based on our success with BoPhoz ligands, we garnered inspiration from a BoPhoz-like P-stereogenic 
bis(phosphine) ChenPhos (17).
14
 We postulated that installation of a third phosphine would follow an 
exact route to that utilized for BoPhoz derivatives allowing rapid access to analogs from a single 
precursor. Furthermore, variation of the other two phosphine substituents would open a multitude of sites 
for optimization of reactivity and selectivity. Access to ChenPhos occurred as reported, and several 
derivatives with variation of the non-stereogenic ferrocenyl phosphine were also prepared to elucidate its 
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influence on reactivity and selectivity. Installation of the aminophosphine followed the same three-step 
route utilized for BoPhoz derivatives and allowed the rapid generation of several analogs for investigation 
(Scheme 2-10). Variation of the P-stereogenic center was much less facile, as the 
dichloroarylphosphines required are not commercially available and attempts with 
dichloroalkylphosphines resulted in highly oxidizable products. 
Scheme 2-10. Synthesis of New Chiral Trisphosphine Ligands from ChenPhos Derivatives 
 
 Having successfully prepared a library of new chiral trisphosphine ligands, we initiated 
investigation of their utility in Cu-catalyzed asymmetric hydrogenation of 2-naphthone. Control 
experiments in the absence of ferrocenyl diaryl phosphine or aminophosphine revealed that catalytic 
activity suffered in either’s absence (entries 1 and 2) clearly pointing to the necessity of a three phosphine 
system. Gratifyingly, an active and moderately selective catalyst was formed with 19a. Variation of the 
aminophosphine from diphenyl resulted in only decreased selectivity (entries 4-9), and utilizing a catalyst 
precomplexation period provided no increase selectivity (entry 9-10). The necessity for at least one diaryl 
phosphine on either the ferrocene or amino group was highlighted by the inactivity of 19j, and switching 
the ferrocenyl phosphine to dialkyl resulted in an interesting switch in enantioselectivity in comparison to 
its regioisomer 19h versus 19d. Substitution of the diphenylphosphino group for other phosphinoaryl 
groups provided no increase in selectivity (entries 14-16). 
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Table 2-11. Investigation of Chiral Trisphosphine Ligands in Asymmetric Ketone Reduction 
 
Entry R
1 
R
2 
 Time (h) Conv (%) er (S:R) 
1 H P(3,5-xylyl)2 20 21 38 60:40 
2 PPh2 Me 17a 16.5 23 51:49 
3 PPh2 PPh2 19a 20.5 >99 75:25 
4 PPh2 P(p-tol)2 19b 16 >99 74:26 
5 PPh2 P(3,5-xylyl)2 19c 21 >99 65:35 
6 PPh2 PCy2 19d 16 56 73:27 
7 PPh2 P(2-furyl)2 19e 16 >99 58:42 
8 PPh2 P(3,5-diCF3-C6H3)2 19f 16 29 45:55 
9 PPh2 P(
i
Pr)2 19g 16 94 68:32 
10 PPh2 P(
i
Pr)2 19g 16 95 69:31
a 
11 PCy2 PPh2 19h 16 76 30:70 
12 PCy2 P(p-tol)2 19i 16 38 34:66 
13 PCy2 P(
i
Pr)2 19j 16 <5% - 
14 P(3,5-xylyl)2/H (1:1) PPh2 19k 16 >99 66:34 
15 P(3,5-xylyl)2/H (4:1) PPh2 19k 16 >99 67:33 
16 P(4-F-C6H4)2 PPh2 19l 16 >99 66:34 
 a
 Precomplexed w/ Cu(CH3CN)4BF4 
2.3.13. 
31
P NMR Experiment Showing Ligation of Three Phosphines 
 Although all evidence to date suggested the requirement of a three phosphine system, attempts 
to visualize by 
31
P NMR the simultaneous ligation of Cu(I) to BoPhoz ligands and P(3,5-xylyl)3 were met 
with failure. Based on our initial hypothesis of a more robust catalyst system, we investigated the ligation 
of 19g with Cu(CH3CN)4BF4 and were delighted to find clear indication of ligation of all three phosphines. 
Certainly this information does not implicate a trisphosphine copper hydride complex as the active 
catalyst, but merely provides evidence that all three phosphines can ligand copper(I) simultaneously. 
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Figure 2-3. 
31
P NMR Comparison of Free and Bound 19g. 
 
Although this investigation provided a library of new chiral trisphosphine ligands, their 
unsatisfactory results in Cu-catalyzed hydrogenation in comparison to the BoPhoz/(3,5-xylyl)3 system 
resulted in our ending this research endeavor. 
2.4 Conclusion 
In summary, high-throughput screening enabled the identification of commercially available (S)-N-
Me-BoPhoz as a lead ligand in the Cu-catalyzed asymmetric reduction of prochiral ketones. Systematic 
structural variation of both the chiral BoPhoz ligand and the ancillary triarylphosphine provided a catalyst 
system which operates at moderate H2 pressures and provides good enantioselectivities for a variety of 
aryl and heteroaryl ketones. The necessity of a three phosphine system led to the synthesis of a library of 
new chiral trisphosphine ligands that provided active Cu-catalysts for hydrogenation but provided low 
enantioselectivity.  
  
19g 
Cu(CH3CN)4BF4 + 19g 
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2.5 Experimental Details 
Methods: Proton and carbon nuclear magnetic resonance spectra (
1
H NMR and 
1
C NMR) were recorded 
on a Bruker 500 (
1
H NMR at 500 MHz and 
13
C NMR at 125 MHz) spectrometer with solvent resonance as 
the internal standard (
1
H NMR: CDCl3 at 7.27 ppm. 
13
C NMR: CDCl3 at 77.0 ppm). 
1
H NMR data are 
reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet), coupling constants (Hz), and integration. Analytical thin layer chromatography (TLC) was 
performed on EMD Chemicals Inc. Silica Gel 60 F254 glass backed silica gel plates. Visualization was 
accomplished with UV light and aqueous basic potassium permanganate solution followed by heating. 
Flash chromatography was performed using 230-400 mesh silica gel purchased from Sigma Aldrich. Yield 
refers to isolated yield of analytically pure material unless otherwise noted. Yields and enantiomeric ratios 
(er) are reported for a specific experiment and as a result may differ slightly from those found in the 
tables, which are averages of at least two experiments. 
Materials: Solvents and bases were purchased from commercial sources and used without purification or 
drying. It is important to note that reaction times increased as the potassium tert-butoxide aged, 
presumably from increased water content, but the enantioselectivity was unaffected. All ketones were 
purchased from commercial sources and used without further purification. Achiral phosphines were 
purchased from commercial sources and used as received except P(3,5-tert-butylphenyl)3,
15
 P(3,5-
dimethylphenyl)3,
16
 P(3,5-difluorophenyl)3,
17
 P(3,5-diethylphenyl)3,
18
 P(3-ethylphenyl)3,
18
 and P(3-
isopropylphenyl)3
18
 which were prepared according to modified literature methods. All chiral phosphine 
ligands were purchased from commercial sources (vide infra) and used as received except BoPhoz 
derivatives which were prepared by modification of established literature procedures.
11 
All chiral alcohols 
have been previously reported and configuration assignments were made based on comparison of optical 
rotation to that previously reported.
20 
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Synthesis of Triarylphosphines and BoPhoz Derivatives 
Preparation of Tris(3-ethylphenyl)phosphine (3r): 
 
To a dry, 4-neck 50 mL RBF fitted with a reflux condenser under N2 was added magnesium turnings 
(0.221 g, 9.10 mmol, 5.0 equiv) and THF (8 mL). To this suspension was added a portion of 1-bromo-3-
ethylbenzene (0.50 mL, 3.61 mmol) under N2. The reaction was heated to reflux with a heat gun and 
Grignard formation initiated, turning the clear solution. The remainder of the 1-bromo-3-isopropylbenzene 
(0.85 mL, 4.58 mmol, 4.5 equiv total) was added dropwise over 5 min. After complete addition the mixture 
was stirred for 2 h at which point the Mg was almost completely consumed. The reaction was cooled to 0 
ºC and neat PCl3 (0.16 mL, 1.8 mmol, 1.0 equiv) was added dropwise. Following addition, the reaction 
was heated to reflux. After 2 h, the reaction was cooled in an ice bath and slowly quenched with aq. sat. 
NH4Cl (15 mL). The resulting mixture was diluted with water (10 mL) and extracted with toluene (2 x 25 
mL). The combined organic extracts were washed with brine, dried (Na2SO4) and concentrated. The 
crude product was purified by flash chromatography on silica gel with gradient elution of ethyl 
acetate/heptanes (0.5:99.5 to 2:98) to yield 397 mg (1.15 mmol, 63 % yield) of a pale yellow oil. 
1
H NMR 
(500 MHz, CDCl3) δ 7.26-7.17 (m, 9H), 7.09 (t, J = 7.5 Hz, 3H), 2.62 (q, J = 7.5 Hz, 6H), 1.20 (t, J = 8.0 
Hz, 9H). 
13
C NMR (125.8 MHz, CDCl3) δ 144.16 (d, J = 7.5 Hz), 137.3 (d, J = 11.3 Hz), 133.3 (d, J = 22.6 
Hz), 130.9 (d, J = 10.1 Hz), 128.3 (d, J = 6.3 Hz), 128.2, 28.7, 15.5. 
Preparation of Tris(3,5-diethyl-phenyl)phosphine (3i): 
 
To a dry, 4-neck 50 mL RBF fitted with a reflux condenser under N2 was added magnesium turnings 
(0.221 g, 9.10 mmol, 5.0 equiv) and THF (8 mL). To this suspension was added a portion of 1-bromo-3,5-
diethylbenzene (0.50 mL, 3.20 mmol) under N2. The reaction was heated to reflux with a heat gun and 
Grignard formation initiated, turning the clear solution dark brown. The remainder of the 1-bromo-3,5-
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diethylbenzene (0.78 mL, 4.99 mmol, 4.5 equiv total) was added dropwise over 5 min. After complete 
addition the mixture was stirred for 1.5 h at which point the Mg was almost completely consumed. The 
reaction was cooled to 0 ºC and a solution of PCl3 (0.16 mL, 1.8 mmol, 1.0 equiv) in THF (2 mL) was 
added in a single portion. Following addition, the reaction was heated to reflux. After 3 h, the reaction was 
cooled in an ice bath and slowly quenched with aq. sat. NH4Cl (15 mL). The resulting mixture was diluted 
with water (10 mL) and extracted with toluene (2 x 25 mL). The combined organic extracts were washed 
with brine, dried (Na2SO4) and concentrated. The resulting solid was taken up in ethanol (5 mL) with 
heating and stirred as it slowly cooled to rt. Slow crystal formation was observed which increased rapidly. 
The white, fluffy solid was isolated by suction filtration to yield 120 mg. An additional 60 mg was isolated 
from the mother liquor following concentration and recrystallization for a total yield of 180 mg (0.42 mmol, 
23 %). 
1
H NMR (500 MHz, CDCl3) δ 7.03 (s, 3H), 7.01 (s, 3H), 7.00 (s, 3H), 2.58 (q, J = 7.5 Hz, 12H), 
1.18 (t, J = 7.5 Hz, 18H). 
13
C NMR (125.8 MHz, CDCl3) δ 144.1 (d, J = 7.5 Hz), 137.3 (d, J =8.8 Hz), 
130.6 (d, J = 18.9 Hz), 127.9, 28.8, 15.6. 
Preparation of Tris(3-isopropylphenyl)phosphine (21): 
 
To a dry, 4-neck 50 mL RBF fitted with a reflux condenser under N2 was added magnesium turnings 
(0.221 g, 9.10 mmol, 5.0 equiv) and THF (8 mL). To this suspension was added a portion of 1-bromo-3-
isopropylbenzene (0.75 mL, 4.82 mmol) under N2. The reaction was heated to reflux with a heat gun and 
Grignard formation initiated, turning the clear solution. The remainder of the 1-bromo-3-isopropylbenzene 
(0.52 mL, 3.36 mmol, 4.5 equiv total) was added dropwise over 5 min. After complete addition the mixture 
was stirred for 2 h at which point the Mg was almost completely consumed. The reaction was cooled to 0 
ºC and neat PCl3 (0.16 mL, 1.8 mmol, 1.0 equiv) was added dropwise. Following addition, the reaction 
was heated to reflux. After 1 h, the reaction was cooled in an ice bath and slowly quenched with aq. sat. 
NH4Cl (15 mL). The resulting mixture was diluted with water (10 mL) and extracted with toluene (2 x 25 
mL). The combined organic extracts were washed with brine, dried (Na2SO4) and concentrated. The 
crude product was purified by flash chromatography on silica gel with heptanes followed by a single 
recrystallization from hot ethanol (5 mL) to yield 426 mg (1.10 mmol, 60 % yield) of a crystalline white 
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solid. 
1
H NMR (500 MHz, CDCl3) δ 7.26-7.20 (m, 9H), 7.08 (t, J = 7.5 Hz, 3H), 2.86 (septet, J = 7.0 Hz, 
3H), 1.20 (d, J = 7.0 Hz, 18H). 
13
C NMR  (125.8 MHz, CDCl3) δ 148.8 (d, J = 7.5 Hz), 137.2 (d, J = 10.1 
Hz), 132.0 (d, J = 10.1 Hz), 131.0 (d, J = 8.8 Hz), 128.3 (d, J = 6.3 Hz), 126.7, 34.0, 23.9.  
Preparation of (R,S)-N-Et-p-tolyl-Bophoz (4h):  
 
A solution of N-Ethyl R-1-(S-2-diphenylphosphino)ferrocenylethylamine
5
(200 mg, 0.453 mmol, 1.0 equiv) 
in toluene (2.0 mL) was degassed by evacuation under house vacuum and back-filling with N2 (3 cycles). 
To the solution at 0 °C was added triethylamine (0.19 mL, 1.36 mmol, 3.0 equiv) followed by 
chlorobis(3,5-xylyl)phosphine (138 µL, 0.68 mmol, 1.5 equiv). The resulting solution was allowed to warm 
to rt. After stirring for 18 h, the reaction solution was loaded onto a dry plug of neutral alumina and 
elueted with ethyl acetate/heptanes (1:9, 100 mL). The filtrate was concentrated to give an orange foam 
(213 mg, 0.33 mmol, 72 %). 
1
H NMR (500 MHz, CDCl3) δ 7.67-7.64 (m, 2H), 7.38 (m, 3 H), 7.21-7.09 (m, 
7 H), 6.99-6.88 (m, 6 H), 4.78 (s, 1H), 4.71-4.62 (m, 1H), 4.41 (s, 1H), 4.14 (s, 1H), 3.83 (s, 5H), 2.65-
2.60 (m, 2H), 2.31 (s, 3H), 2.30 (s, 3H), 1.77 (d, J = 7.0 Hz, 3H), 0.72 (t, J = 7.5 Hz, 3H). 
Preparation of (R,S)-N-H-(3,5-xylyl)-BoPhoz (4k): 
 
To a degassed (3x house vacuum/N2 cycles) solution of R-1-(S-2-
diphenylphosphino)ferrocenylethylamine
5
 (170 mg, 0.411 mmol, 1.0 equiv) in toluene (3.0 mL) was added 
triethylamine (0.17 mL, 1.23 mmol, 3.0 equiv) followed by chlorobis(3,5-xylyl)phosphine (125 mg, 0.45 
mmol, 1.1 equiv). After stirring for 18 h, the reaction solution was loaded onto a dry plug of neutral 
alumina and eluted with ethyl acetate/heptanes (1:9, 100 mL). The filtrate was concentrated to give an 
orange foam (133 mg, 0.20 mmol, 50 %). 
1
H NMR (500 MHz, CDCl3) δ 7.55-7.52 (m, 2H), 7.24 (m, 3H), 
7.16-7.09 (m, 5H), 6.96-6.94 (m, 2H), 6.88-6.86 (m, 4H), 4.46 (s, 1H), 4.42 (q, J = 6.0 Hz, 1H), 4.28 (s, 
1H), 3.93 (s, 5 H), 3.79 (s, 1H), 2.26 (s, 6H), 2.23 (s, 6H), 1.49 (d, J = 6.7 Hz, 3H).    
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Preparation of (R,S)-N-Et-(3,5-xylyl)-BoPHoz (4l): 
 
To a degassed (3x house vacuum/N2 cycles) solution of N-ethyl R-1-(S-2-
diphenylphosphino)ferrocenylethylamine
5
 (112 mg, 0.254 mmol, 1.0 equiv) in toluene (1.1 mL) at 0 °C 
was added triethylamine (0.11 mL, 0.76 mmol, 3.0 equiv) followed by chlorobis(3,5-xylyl)phosphine (105 
mg, 0.38 mmol, 1.5 equiv). The resulting solution was allowed to warm to rt. After stirring for 18 h, the 
reaction solution was loaded onto a dry plug of neutral alumina and eluted with ethyl acetate/heptanes 
(1:9, 100 mL). The filtrate was concentrated to give an orange foam (125 mg, 0.18 mmol, 72 %). 
1
H NMR 
(500 MHz, CDCl3) δ 7.67-7.64 (m, 2H), 7.39-7.38 (m, 3H), 7.06-6.98 (m, 7H), 6.90 (s, 1H), 6.85 (s, 1H), 
6.67 (d, J = 7.0 Hz, 2H), 4.83 (s, 1H), 4.59-4.52 (m, 1H), 4.43 (s, 1H), 4.11 (s, 1H), 3.82 (s, 5H), 2.68-2.56 
(m, 2H), 2.23 (s, 6H), 2.17 (s, 6H), 1.80 (d, J = 6.5 Hz, 3H), 0.84 (t, J = 6.5 Hz, 3H).  
Preparation of (R,S)-N-Me-(4-methoxy-3,5-dimethylphenyl)-BoPhoz (4m): 
 
To a degassed (3x house vacuum/N2 cycles) solution of N-methyl R-1-(S-2-
diphenylphosphino)ferrocenylethylamine
5
 (86 mg, 0.201 mmol, 1.0 equiv) in toluene (1.0 mL) was added 
triethylamine (0.11 mL, 0.81 mmol, 4.0 equiv) followed by a solution of chlorobis(4-methoxy-3,5-dimethyl-
phenyl)phosphine (102 mg, 0.30 mmol, 1.5 equiv) in toluene (0.5 mL). After stirring for 18 h, the reaction 
solution was loaded onto a dry plug of neutral alumina and elueted with ethyl acetate/heptanes (1:9, 100 
mL). The filtrate was concentrated to give a viscous orange oil (53 mg, 0.07 mmol, 36 %). 
1
H NMR (500 
MHz, CDCl3) δ 7.69-7.66 (m, 2H), 7.39 (s, 3H), 7.07-7.04 (m, 1H), 7.02-6.95 (m, 4H), 6.91 (d, J = 6.5 Hz, 
2H), 6.78 (d, J = 7.5 Hz, 2H), 4.78-4.75 (m, 1H), 4.60 (s, 1H), 4.40 (s, 1H), 4.12 (s, 1H), 3.77 (s, 5H), 3.73 
(s, 3H), 3.67 (s, 3H), 2.27 (d, J = 4.0 Hz, 3H), 2.18 (s, 6H), 2.03 (s, 6H), 1.59 (d, J = 7.0 Hz, 3H). 
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Preparation of (R,S)-N-Me-(4-methoxy-3,5-tert-butylphenyl)-BoPhoz (4n):  
 
To a degassed (3x house vacuum/N2 cycles) solution of N-methyl R-1-(S-2-
diphenylphosphino)ferrocenylethylamine
5
 (85 mg, 0.199 mmol, 1.0 equiv) in toluene (1.0 mL) was added 
triethylamine (0.11 mL, 0.80 mmol, 4.0 equiv) followed by a solution of chlorobis(4-methoxy-3,5-
tertbutylphenyl)phosphine (111 mg, 0.22 mmol, 1.1 equiv) in toluene (0.5 mL). After stirring for 18 h, the 
reaction solution was loaded onto a dry plug of neutral alumina and elueted with ethyl acetate/heptanes 
(1:9, 100 mL). The filtrate was concentrated to give yellow/orange solid. Trituration with heptanes 
provided 96 mg (0.11 mmol, 54 %) of 3n as an orange solid. 
1
H NMR (500 MHz, CDCl3) δ 7.63-7.61 (m, 
2H), 7.39-7.38 (m, 3H), 7.11 (d, J = 7.0 Hz, 2H), 7.05 (d, J = 7.5 Hz, 2H), 6.95 (t, J = 7.5 Hz, 1H), 6.86 (t, 
J = 7.0 Hz, 2H), 6.79 (t, J = 7.0 Hz, 2H), 4.79 (s, 1H), 4.52-4.48 (m, 1H), 4.41 (s, 1H), 3.95 (s, 1H), 3.87 
(s, 5H), 3.67 (s, 3H), 3.66 (s, 3H), 2.25 (d, J = 3.0 Hz, 3H), 1.87 (d, J = 7.0 Hz, 3H), 1.35 (s, 18H), 1.32 (s, 
18H). 
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Figure 3-3. Structures of Chiral Ligands 
 
68 
 
69 
 
70 
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E. Parallel Hydrogenation Screening Procedure 
All solid reagents (copper source, chiral ligand, ancillary phosphine ligand, and base) were placed into 
source vials equipped with corkscrew dispensing caps and measured into 2 mL crimp-cap HPLC vials via 
a Mettler-Toledo FLEXIWEIGH solid dispensing robot. Liquid reagents and solvents were dispensed 
manually via electronic pipettor. The vials were sealed with a crimp-cap and the cap’s Teflon seal 
punctured twice with a needle. The vials were placed in a HEL Cat96 parallel hydrogenation apparatus 
and following three nitrogen purges (5 bar) and three hydrogen purges (5 bar), pressurized to 20 bar 
hydrogen at 30 °C for 16 h. Conversions and selectivities following this reaction period were determined 
by direct sampling of the reaction mixture on reverse phase HPLC by an Agilient 1200 series HPLC using 
an Agilent SB-C18 column (1.8 µm, 3.0 x 5.0 mm, 1.0 mL/min, 60 °C, ramp 0 to 100% acetonitrile in 
water over 4 min) and Chiracel OJ-RH column (80:20 water:acetonitrile, 0.5 mL/min flow rate, 25 °C, 
detector: 210 nm; (S) 19.5 min and (R) 21.9 min, respectively. 
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Table 2-12 Commercially Available Chiral Ligand Screening 
 
Entry Ligand Ref Chiral Ligand conv (%) er (R:S) 
1 6 (R)-(+)-SEGPHOS 53 14:86 
2 22 (R)-(+)-DM-SEGPHOS 28 42:58 
3 23 (S)-
i
Pr-MeOBIPHEP 9 ND 
4 23 (R)-MeO-BIPHEP 17 22:78 
5 25 (R)-Cl-MeO-BIPHEP <5 ND 
6 26 (R)-(+)-DTBM-SEGPHOS 6 ND 
7 27 (R)-2-Cyclobutyl-MeOBIPHEP 13 ND 
8 29 (S)-2-Furyl-MeOBIPHEP 6 ND 
9 ent-5 (S)-p-Tol-MeOBIPHEP 28 81:19 
10 5 (R)-p-Tol-MeOBIPHEP 30 ND 
11 29 (R)-3,4,5-MeO-MeOBIPHEP 9 ND 
12 30 (R)-3,5-iPr-4-NMe2-MeOBIPHEP <5 ND 
13 31 CTH-(S)-P-PHOS 21 ND 
14 32 CTH-(R)-Xylyl-P-Phos 23 ND 
15 33 (R)-3,5-t-Bu-MeOBIPHEP <5 ND 
16 34 (R)-SYNPHOS 23 22:78 
17 9 (R)-C3-TUNEPHOS 47 17:83 
18 7 (R)-Ph-Garphos 27 18:82 
19 37 (S)-BINOP-bis[(1R)-1-phenylethyl]amine 12 ND 
20 38 MeBINAP-UREAPhos <5 ND 
21 39 MeBINAP-UREA-PhenPhos 13 ND 
22 40 BINAP-cyHex-UREAPhos 6 27:73 
23 41 H8-BINAP-UREAPhos <5 ND 
24 42 H8-BINAP-UREA-PhenPhos 9 ND 
25 43 (R,R)-Bis(diphenylphospholano)ethane 30 37:63 
26 44 (R,R)-Et-BPE 6 43:57 
27 4 (S)-Me BoPhoz 61 ND 
28 45 (R,R)-DIOP 99 ND 
29 46 (R,R)-NORPHOS 5 ND 
30 47 catASium® MNXylF(R)] <5 28:72 
31 48 catASium® M(R)] 17 62:38 
32 49 (S)-PHANEPHOS <5 ND 
33 50 (S,S)-iPr-DUPHOS <5 ND 
34 51 (R,R)-(-)-DIPAMP 12 ND 
35 52 Josiphos (SL-J0015-2) 9 ND 
36 53 Josiphos (SL-J002-1) 16 43:57 
37 54 Josiphos (SL-J009-1) <5 ND 
38 55 Walphos (SL-W002-1) <5 ND 
39 56 Josiphos (SL-J011-1) 23 49:51 
40 57 Josiphos (SL-J008-1) 6 ND 
41 58 Walphos (SL-W005-1) <5 ND 
42 59 (R,S)-Ph-Bn-SIPHOX <5 ND 
43 60 (R)-Xyl-SDP <5 ND 
44 74 (S,S)-Reetz X-Diphosphonite <5 ND 
45 75 (S,S)-Reetz D-Diphosphonite 11 ND 
46 76 (S)-BINAPINE <5 ND 
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Table 2-13. Commercially Available Chiral Ligand Screening at Higher Catalyst Loading 
 
Entry Ligand Ref Chiral Ligand conv (%) er (R:S) 
1
a 
6 (R)-(+)-SEGPHOS 84 12:88 
2 S5 (R)-MeO-BIPHEP 44 17:83 
3 ent-5 (S)-p-Tol-MeOBIPHEP 99 86:14 
4
a 
29 (R)-3,4,5-MeO-MeOBIPHEP 45 83:17 
5 34 (R)-SYNPHOS 25 23:77 
6
a 
35 DifluorPhos 50 30:70 
7 9 (R)-C3-TUNEPHOS 100 14:86 
8
a 
36 (R)-3,5-xylyl-MeOBIPHEP 67 40:60 
9
a 
7 (R)-Ph-Garphos 79 15:85 
10
a 
8 (R)-p-tol-Garphos 100 14:86 
11
b 
39 MeBINAP-UREA-PhenPhos <5 ND 
12
b 
42 H8-BINAP-UREA-PhenPhos <5 ND 
13 43 (R,R)-Bis(diphenylphospholano)ethane 67 25:75 
14
c 
4 (S)-Me BoPhoz 39 50:50 
15 4 (S)-Me BoPhoz 99 24:76 
16 61 (S)-Phenyl-PHOX 26 49:51 
17 62 (S)-iPr-PHOX 95 44:56 
18
a 
3m (R)-SITCP 39 61:39 
19
b 
3m (R)-SITCP 21 60:40 
20
d 
3m (R)-SITCP 31 65:35 
21
a 
63 (R)-MOP 10 ND 
22
a 
64 (R)-SIPHOS-PE 8 ND 
23
a 
65 (S,S,S,S)-ROPHOS-bis(Otf) 8 ND 
24
a 
63 catASium T2 12 ND 
25
a 
67 catASium T3 11 ND 
26
a 
68 catASiumT1 9 ND 
27
b 
3j (R)-MONOPHOS 6 ND 
28
b 
3l (S)-PipPHOS <5 ND 
29
b 
69 (S)-H8-BINOP-dimethylamine 13 47:52 
29
b 
70 (S)-BINOP-dimethylamine <5 ND 
30
b 
71 UREA-PhenPhos <5 ND 
31
b 
72 TMS-BINAP-UREAPhos <5 ND 
32
c 
73 Taniaphos 71 43:57 
33 73 Taniaphos 76 43:57 
a
6 mol% P(3,5-xylyl)3. 
b
4.0 mol% Chiral Ligand, 6 mol% P(3,5-xylyl)3. 
c
No P(3,5-xylyl)3. 
d
4.0 mol% Chiral 
Ligand, No P(3,5-xylyl)3.  
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Table 2-14. Ancillary Phosphine Screening for Active Ligands 
 
  Chiral Bis(phosphine) Ligand 
  (R)-p-tol-MeO-BIPHEP (R)-SEGPHOS (S,R)-N-Me-BoPhoz 
Row Ancillary Phosphine conv (%) er (R:S) conv (%) er (R:S) conv (%) er (R:S) 
1 P(3,5-xylyl)3 100 14:86 94 12:88 97 24:76 
2 P(o-tol)3 7 ND 3 ND 12 48:52 
3 PCy3 19 49:51 10 ND 40 46:54 
4 PPh3 95 45:55 91 41:59 96 44:56 
5 S-Phos 7 ND 8 ND 11 48:52 
6 X-Phos - - 2 ND 15 47:53 
7 P(2-furyl)3 32 55:44 7 ND 24 58:42 
8 P(p-Me-C6H4)3 75 48:52 83 44:56 96 43:57 
9 P(p-F-C6H4)3 97 41:59 42 38:62 96 47:53 
10 P(p-MeO-C6H4)3 5 ND 78 43:57 100 46:54 
11 P(3,5-diCF3-C6H3)3 25 48:52 22 57:43 12 75:25 
12 P(o-MeO-C6H4)3 7 50:50 6 ND 14 47:53 
13 4-DMA-TPP 93 48:52 46 44:56 100 45:55 
14 cataCXium
®
 POMetB 8 50:50 4 ND 16 36:64 
15 Tris(2,4-di-tert-butylphenyl) phosphite 73 71:29 66 73:27 40 54:46 
16 BrettPhos 18 49:51 3 ND 14 48:52 
17 P(m-MeO-C6H4)3 34 40:60 15 ND 73 45:55 
18 P(m-Me-C6H4)3 98 22:76 98 20:80 95 37:63 
19 Q-Phos - - - - 26 48:52 
20 P(3,5-di-tert-butylphenyl)3 11 50:50 15 45:55 16 49:51 
21 P(3,5-di-ethylphenyl)3 61 25:75 88 68:32 92 27:73 
22 tert-butyldiphenylphosphine - - 11 56:44 32 42:58 
23 tris(3,5-dimethyl-4-F-phenyl)phosphine - - 36 14:86 100 33:67 
24 methyldiphenylphosphine - - 53 50:50 87 50:50 
25 di-tertbutylphenylphosphine - - 0 - 18 48:52 
26 di-ethylphenylphosphine - - 100 50:50 100 44:56 
27 P(3,5-difluorophenyl)3 - - - - 43 49:51 
28 P(3-isopropylphenyl)3 - - 97 33:66 95 40:60 
29 P(3-ethylphenyl)3 - - 100 29:71 98 40:60 
30 P(3-F-phenyl)3 - - 18 41:59 93 46:54 
31 P(4-methoxy-3,5-dimethylphenyl)3 - - 75 12:88 97 25:75 
32 isopropyldiphenylphosphine - - 34 51:49 94 45:55 
33 ethyldiphenylphosphine - - 100 50:50 100 45:55 
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Table 2-15. Chiral Ancillary Phosphine Screening with p-Tol-MeO-BIPHEP 
 
Entry Ligand Ref Chiral Mono(phosphine) Ligand conv (%) 
er 
(R:S) 
1
 
77 (S)-BINOP-benzyl(methyl)amine 9.2 ND 
2 78 (S)-BINOP-[(1R)-1-phenylethyl]amine 52.7 62:38 
3 79 (S)-BINOP-bis[(1S)-1-phenylethyl]amine <5 ND 
4
 
37 (S)-BINOP-bis[(1R)-1-phenylethyl]amine <5 ND 
5 80 (S)-Me-BINOP-dimethyl]amine <5 ND 
6
 
3j (R)-MONOPHOS 34.7 66:34 
7 81 
(3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-
[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-
yl)dimethylamine 
<5 ND 
8
 
3l (S)-PipPHOS 23.3 70:30 
9
 
3m (R)-SITCP 46.6 71:29 
10 63 (R)-MOP <5 ND 
11
 
64 (R)-SIPHOS-PE <5 ND 
12 82 (S)-H8-BINOP-dimethylamine 42.5 66:34 
13 3i (S)-BINOP-dimethylamine 36.7 65:35 
14 83 (S)-iPr-PHOX-ferrocene <5 ND 
15
 
84 DPP-ferrocene-aminoethane <5 ND 
16
 
85 (Ra,S)-Ph-Bn-SIPHOX <5 ND 
17
 
86 Me2-ethylamine-DPP-ferrocene <5 ND 
18
 
39 MeBINAP-UREA-PhenPhos 16.0 67:33 
19
 
87 (S)-UREAPhos <5 ND 
20
 
88 o-Tol-UREA-PhenPhos <5 ND 
21
 
38 MeBINAP-UREAPhos <5 ND 
22
 
ent-87 (R)-UREAPhos <5 ND 
23
 
71 UREA-PhenPhos 19.4 67:33 
24
 
41 H8-BINAP-UREAPhos <5 ND 
25
 
72 TMS-BINAP-UREAPhos 20.3 67:33 
26
 
88 o-Tol-UREAPhos <5 ND 
27
 
40 BINAP-cyHex-UREAPhos 11.1 ND 
28
 
61 (S)-Phenyl-PHOX <5 ND 
29
 
62 (S)-iPr-PHOX <5 ND 
30 42 H8-BINAP-UREA-PhenPhos 21.5 68:32 
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Table 2-16. Copper Source, Base and Solvent Screening 
 
Entry Copper Source Base Solvent conv (%) er (R:S) 
1
a 
Copper (I) acetate KO
t
Bu 
i
PrOH 97 24:76 
2
a,b 
Copper (I) acetate KO
t
Bu 
i
PrOH 43 49:51 
3
a 
Copper (I) Chloride KO
t
Bu 
i
PrOH 100 24:76 
4
a,b 
Copper (I) Chloride KO
t
Bu 
i
PrOH 25 50:50 
5
a 
(PPh3)2CuNO3 KO
t
Bu 
i
PrOH 100 40:60 
6
a,b 
(PPh3)2CuNO3 KO
t
Bu 
i
PrOH 100 44:56 
7 Copper (II) Acetate NaO
t
Bu 
t
BuOH 100 23:77 
8 Copper (II) Acetate K3PO4 
t
BuOH 0 ND 
9 Copper (II) Acetate Cs2CO3 
t
BuOH 0 ND 
10 Copper (II) Acetate KOSiMe3 
t
BuOH 0 ND 
11 Copper (II) Acetate LiO
t
Bu 
t
BuOH 0 ND 
12 Copper (II) Acetate KO
t
Bu t-AmylOH 0 ND 
13 Copper (II) Acetate KO
t
Bu EtOH 17 32:68 
14 Copper (II) Acetate KO
t
Bu 2-Me-THF 0 ND 
15 Copper (II) Acetate KO
t
Bu EtOAc 0 ND 
16 Copper (II) Acetate KO
t
Bu Toluene 0 ND 
17 Copper (II) Acetate KO
t
Bu NMP 0 ND 
18 Copper (II) Acetate KO
t
Bu Mesitylene 0 ND 
19 Copper (II) Acetate KO
t
Bu trifluorotoluene 0 ND 
20 Copper (II) Acetate KO
t
Bu CH2Cl2 0 ND 
21 Copper (II) Acetate KO
t
Bu H2O 11 31:69 
22 Copper (II) Acetate KO
t
Bu CF3CH2OH 0 ND 
23 Copper (II) Acetate KO
t
Bu hexaF-IPA 0 ND 
a
 50 mol% base. 
b
No P(3,5-xylyl)3. 
Table 2-17. Ancillary Phosphine and Base Loading 
 
Entry KO
t
Bu (mol%) P(3,5-xylyl)3 (mol%) conv (%) er (R:S) 
1 0.0 2.0 0 ND 
2 50.0 0.0 39 50:50 
3 20.0 0.6 25 23:77 
4 20.0 0.9 30 23:77 
5 20.0 1.3 45 22:78 
7 20.0 2.4 87 21:79 
9 30.0 2.0 100 21:79 
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Table 2-18. BoPhoz Ligand Screening 
 
Entry R Ar  conv (%)
a 
e.r (R:S)
b
 
1 Me Ph 4a 100 79:21 
2 Et Ph 4b 98 72:28 
3 H Ph 4c 16 67:33 
4 Me 4-CF3C6H4 4d 52 75:25 
5 Me 4-F-C6H4 4e 76 67:33 
6 Me 3,5-diCF3-C6H3 4f 0 - 
7 Me 4-CH3C6H4 4g 100 79:21 
8 Et 4-CH3C6H4 4h 100 74:26 
9 Me 4-OMe-C6H4 4i 100 68:32 
10 Me 3,5-diMe-C6H3 4j 100 91:9 
11 H 3,5-diMe-C6H3 4k 53 57:43 
12 Et 3,5-diMe-C6H3 4l 76 80:20 
13 Me 3,5-diMe-4-OMe-C6H2 4m 100 67:33 
14 Me 3,5-tBu-4-OMe-C6H2 4n 43 89:11 
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Table 2-19. Screening of Ancillary Phosphines with (R,S)-N-Me-3,5-xylyl-BoPhoz 
 
 
 
In 
i
PrOH In 
t
BuOH 
Entry Ancillary Phosphine Ligand conv (%) er (R:S) conv (%) er (R:S) 
1 None 17 52:47 15 50:50 
2 P(3,5-xylyl)3 99 91:9 100 92:8 
3 P(3,5-CF3-C6H3)3 10 31:69 78 8:92 
4 P(4-methoxy-3,5-dimethylphenyl)3 99 89:11 100 90:9 
5 tris(3,5-dimethyl-4-F-phenyl)phosphine 99 84:16 100 85:15 
6 P(3-isopropylphenyl)3 99 60:40 100 61:39 
7 P(p-tolyl)3 99 52:48 100 53:47 
8 P(2-furyl)3 17 47:53 60 28:72 
9 P(3,5-difluorophenyl)3 37 42:58 - - 
10 P(3-ethylphenyl)3 99 66:34 - - 
11 P(3-F-phenyl)3 99 45:55 - - 
12 P(3,5-di-ethylphenyl)3 90 87:13 - - 
13 P(o-tolyl)3 17 53:47 - - 
14 P(m-tolyl)3 99 75:25 - - 
15 P(p-F-C6H4)3 99 41:59 - - 
16 PCy3 24 52:48 - - 
17 PPh3 99 51:49 - - 
18 P(p-MeO-C6H4)3 99 46:54 - - 
19 P(m-MeO-C6H4)3 93 53:47 - - 
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Table 2-20. Solvent Screening with 3,5-xylyl-BoPhoz  
Entry Solvent Co-solvent Ratio conv (%) er (R:S) 
1 
t
BuOH None - 98 91.6:8.4 
2 
t
BuOH heptane 50:50 34 ND 
3 
t
BuOH toluene 50:50 21 ND 
4 
t
BuOH trifluorotoluene 50:50 43 ND 
5 
t
BuOH 
n
BuOH 50:50 98 91.2:8.8 
6 
t
BuOH MTBE 50:50 39 ND 
7 
t
BuOH EtOAc 50:50 <5 ND 
8 
t
BuOH CH2Cl2 50:50 74 90.0:10.0 
9 
t
BuOH 
i
PrOH 50:50 94 91.3:8.7 
10 
t
BuOH trifluoroethanol 50:50 <5 ND 
11 
t
BuOH hexafluoroIPA 50:50 <5 ND 
12 
t
BuOH t-AmylOH 50:50 81 90.3:9.7 
13 
t
BuOH EtOH 50:50 97 90.9:9.1 
14 
t
BuOH 2-Me-THF 50:50 24 ND 
15 
t
BuOH NMP 50:50 16 ND 
16 
t
BuOH 
n
BuOH 75:25 99 91.5:8.5 
17 
t
BuOH 
n
BuOH 25:75 82 90.8:9.2 
18 
i
PrOH None - 99 90.9:9.1 
19 
t
BuOH 
i
PrOH 75:25 100 90.9:9.1 
20 
t
BuOH 
i
PrOH 25:75 100 91.2:8.8 
21 EtOH None - 27 89.5:10.5 
22 
t
BuOH EtOH 75:25 100 91.5:8.5 
23 
t
BuOH EtOH 25:75 61 90.4:9.6 
24 CH2Cl2 None - 26 69.4:30.6 
25 t-AmylOH None - 32 87.0:13.0 
26 
i
PrOH 
t
BuOH 95:5 94 91.0:9.0 
27 
i
PrOH 
t
BuOH 90:10 96 91.2:8.8 
28 
i
PrOH 
t
BuOH 80:20 97 91.2:8.8 
29 
i
PrOH 
t
BuOH 60:40 97 91.1:8.9 
30 
i
PrOH 
t
BuOH 40:60 97 91.2:8.8 
31 
n
BuOH 
t
BuOH 95:5 52 90.2:9.8 
32 
n
BuOH 
t
BuOH 90:10 52 90.3:9.7 
33 
n
BuOH 
t
BuOH 80:20 68 90.5:9.5 
34 
n
BuOH 
t
BuOH 60:40 91 91.2:8.8 
35 
n
BuOH 
t
BuOH 40:60 98 91.5:8.5 
 
Temperature Optimization 
To a stainless steel, HEL Chemscan reaction vessel was added copper acetate (11.7 mg, 0.064 mmol, 
1.5 mol%), (R,S)-N-Me-3,5-xylyl-BoPhoz (42.8 mg, 0.064 mmol, 1.5 mol%), tris(3,5-xylyl)phosphine (22.2 
mg, 0.064 mmol, 1.5 mol%), potassium tert-butoxide (108 mg, 0.963 mmol, 0.23 equiv), isopropanol (2.5 
80 
mL), and ketone (4.28 mmol, 1.0 equiv)). The vessel was attached to the HEL Chemscan apparatus 
whose reactor block was maintained at ~9 °C and supported the Teflon coated magnetic stir bar. The 
vessel was purged with N2 (3x, 5 bar) and H2 (3x, 5 bar) followed by reaction pressurization (H2, vide 
infra), temperature regulation (vide infra) and stirring (1200 rpm). The reaction was stirred for the 
specified amount of time, vented, cooled to ~9 °C, and purged with N2 (3x, 5 bar). The reactor and stir bar 
assembly were washed with methyl tert-butyl ether and the resulting solution washed with 1M HCl. The 
aqueous layer was extracted a second time with methyl tert-butyl ether. A sample of the crude reaction 
mixture was used to determine the enantioselectivity. 
Table 2-21. Temperature Optimization 
 
entry
a
 T (°C) 
pressure 
(bar) 
t (h) er (R:S)
b
 
1 30 20 16 89.5:10.5 
2 25 20 24 90.5:9.5 
3 20 20 24 90.7:9.3 
4 15 20 24 92.1:7.9 
5 10 20 24 92.3:7.7 
6 25 5 28 90.6:9.4 
 
J. Scope of Asymmetric Ketone Reductions 
General Hydrogenation Procedure A: To a stainless steel, HEL Chemscan reaction vessel was added 
copper acetate (11.7 mg, 0.064 mmol, 1.5 mol%), (R,S)-N-Me-3,5-xylyl-BoPhoz (42.8 mg, 0.064 mmol, 
1.5 mol%), tris(3,5-xylyl)phosphine (22.2 mg, 0.064 mmol, 1.5 mol%), potassium tert-butoxide (108 mg, 
0.963 mmol, 0.23 equiv), isopropanol (2.5 mL), and ketone (4.28 mmol, 1.0 equiv)). The vessel was 
attached to the HEL Chemscan apparatus whose reactor block was maintained at ~9 °C and supported 
the Teflon coated magnetic stir bar. The vessel was purged with N2 (3x, 5 bar) and H2 (3x, 5 bar) followed 
by reaction pressurization (H2, 20 bar), temperature regulation (15 °C) and stirring (1200 rpm). When H2 
uptake ceased, the reaction vessel was vented, cooled to ~9 °C, and purged with N2 (3x, 5 bar). The 
reactor and stir bar assembly were washed with methyl tert-butyl ether and the resulting solution washed 
with 1M HCl. The aqueous layer was extracted a second time with methyl tert-butyl ether. The combined 
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organic extracts were dried (Na2SO4), concentrated, and purified by flash chromatography on silica gel to 
yield the desired alcohol product. 
General Hydrogenation Procedure B: Same as Procedure A except the following amounts were used: 
copper acetate (23.4 mg, 0.128 mmol, 3.0 mol%), (R,S)-N-Me-3,5-xylyl-BoPhoz (85.6 mg, 0.128 mmol, 
3.0 mol%), tris(3,5-xylyl)phosphine (44.4 mg, 0.128 mmol, 3.0 mol%), potassium tert-butoxide (216 mg, 
1.93 mmol, 0.45 equiv).  
Table 2-10 Entry 1: Following General Hydrogenation Procedure A except tert-butanol (2.5 mL) in place 
of isopropanol, acetophenone (1a, 500 µL, 4.28 mmol) was reduced in 16 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2a (357 mg, 68% yield, 92.7:7.3 er (R:S)). Selectivity 
was determined by chiral HPLC (Chiracel OJ-RH column, acetonitrile:water (20:80), 0.5 mL/min flow rate, 
25 °C, detector: 210 nm; (S) 20.0 min and (R) 22.5 min). 
Table 2-10 Entry 2: Following General Hydrogenation Procedure A except P(3,5-CF3-C6H3)3 (43.3 mg, 
0.065 mmol, 1.5 mol%) instead of P(3,5-xylyl)3, tert-butanol (2.5 mL) in place of isopropanol and 30 ºC, 
acetophenone (1a, 500 µL, 4.28 mmol) was reduced in 16 h and flash chromatography (EtOAc:heptanes 
5:95 to 10:90) on silica gel yielded ent-2a (355 mg, 68% yield, 11.6:88.4 er (R:S)). Selectivity was 
determined by chiral HPLC (Chiracel OJ-RH column, acetonitrile:water (20:80), 0.5 mL/min flow rate, 25 
°C, detector: 210 nm; (S) 20.0 min and (R) 22.5 min). 
Table 2-10 Entry 3: (R)-1-phenylethanol, 2a: Following General Hydrogenation Procedure A, 
acetophenone (1a, 500 µL, 4.28 mmol) was reduced in 24 h and flash chromatography (EtOAc:heptanes 
5:95 to 10:90) on silica gel yielded 2a (488 mg, 93% yield, 92.3:7.7 er (R:S)). Selectivity was determined 
by chiral HPLC (Chiracel OJ-RH column, acetonitrile:water (20:80), 0.5 mL/min flow rate, 25 °C, detector: 
210 nm; (S) 20.0 min and (R) 22.5 min). 
Table 2-10 Entry 4: (R)-1-(4-methoxyphenyl)ethanol, 2b: Following General Hydrogenation Procedure 
B, 4'-methoxyacetophenone (1b, 653 mg, 4.35 mmol) was reduced in 24 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2b (677 mg, 102% yield, 92.8:7.2 er (R:S)). 
Selectivity was determined by chiral HPLC (Chiracel OD-H column, isopropanol:heptane (2:98), 1.0 
mL/min flow rate, 22.0 °C, detector: 220 nm; (R) 24.3 min and (S) 29.0 min). 
82 
Table 2-10 Entry 5: (R)-1-(4-fluorophenyl)ethanol, 2c: Following General Hydrogenation Procedure A, 
4'-fluoroacetophenone (1c, 520 µL, 4.28 mmol) was reduced in 24 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2c (528 mg, 88% yield, 90.9:9.1 er (R:S)). Selectivity 
was determined by chiral HPLC (Chiralpak AD-H column, isopropanol:heptane (3:97), 1.0 mL/min flow 
rate, 22.0 °C, detector: 210 nm; (R) 10.1 min and (S) 11.4 min). 
Table 2-10 Entry 6: (R)-1-(4-trifluoromethylphenyl)ethanol, 2d: Following General Hydrogenation 
Procedure A, 4'-trifluoromethylacetophenone (1d, 812 mg, 4.32 mmol) was reduced in 12 h and flash 
chromatography (EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2d (626 mg, 76% yield, 92.9:7.1 er 
(R:S)). Selectivity was determined by chiral HPLC (Chiralpak AS-RH column, acetonitrile:water (20:80), 
0.5 mL/min flow rate, 25 °C, detector: 210 nm; (R) 52.3 min and (S) 56.4 min). 
Table 2-10 Entry 7: (R)-1-(3-methylphenyl)ethanol, 2e: Following General Hydrogenation Procedure A, 
3'-methylacetophenone (1e, 582 µL, 4.28 mmol) was reduced in 38 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2e (522 mg, 90% yield, 94.6:5.4 er (R:S)). Selectivity 
was determined by chiral HPLC (Chiracel OJ-RH column, acetonitrile:water (20:80), 0.5 mL/min flow rate, 
25 °C, detector: 210 nm; (S) 30.4 min and (R) 34.3 min). 
Table 2-10 Entry 8: (R)-1-(3-bromophenyl)ethanol, 2f: Following General Hydrogenation Procedure A, 
3'-bromoacetophenone (1f, 566 µL, 4.28 mmol) was reduced in 24 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2f (769 mg, 89% yield, 92.2:7.8 er (R:S)). Selectivity 
was determined by chiral HPLC (Chiracel OD-H column, isopropanol:heptane (2:98), 1.0 mL/min flow 
rate, 22.0 °C, detector: 220 nm; (S) 16.6 min and (R) 18.8 min). 
Table 2-10 Entry 9: (R)-1-(3-trifluoromethylphenyl)ethanol, 2g: Following General Hydrogenation 
Procedure A, 3'-trifluoromethylacetophenone (1g, 652 µL, 4.28 mmol) was reduced in 10 h and flash 
chromatography (EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2g (686 mg, 84% yield, 89.4:10.6 er 
(R:S)). Selectivity was determined by chiral HPLC (Chiracel OJ-RH column, acetonitrile:water (30:70), 25 
°C, 0.5 mL/min flow rate, detector: 210 nm; (S) 15.2 min and (R) 17.0 min). 
Table 2-10 Entry 10: (R)-1-(2-methylphenyl)ethanol, 2h: Following General Hydrogenation Procedure 
B, 2'-methylacetophenone (1h, 560 µL, 4.28 mmol) was reduced in 30 h flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2h (586 mg, 101% yield, 87.8:12.2 er (R:S)). 
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Selectivity was determined by chiral HPLC (Chiralpak AD-H column, isopropanol:heptane (2:98), 0.5 
mL/min flow rate, 22.0 °C, detector: 220 nm; (R) 16.7 min and (S) 19.2 min). 
Table 2-10 Entry 11: (R)-1-(2-bromophenyl)ethanol, 2i: Following General Hydrogenation Procedure A, 
2'-bromoacetophenone (1i, 577 µL, 4.28 mmol) was reduced in 30 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2i (634 mg, 74% yield, 86.1:13.9 er (R:S)). 
Selectivity was determined by chiral HPLC (Chiracel OD-H column, isopropanol:heptane (2:98), 1.0 
mL/min flow rate, 22.0 °C, detector: 210 nm; (R) 12.8 min and (S) 14.0 min). 
Table 2-10 Entry 12: (R)-1-(2-naphthyl)ethanol, 2j: Following General Hydrogenation Procedure A, 2-
acetylnaphthone (1j, 733 mg, 4.31 mmol) was reduced in 33 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2j (740 mg, 100% yield, 93.0:7.0 er (R:S)). 
Selectivity was determined by chiral HPLC (Chiracel OJ-RH column, acetonitrile:water (35:65), 0.5 
mL/min flow rate, 25 °C, detector: 220 nm; (S) 27.6 min and (R) 31.0 min). 
Table 2-10 Entry 13: (R)-1-phenylpropanol, 2k: Following General Hydrogenation Procedure A except at 
25 °C, propiophenone (1k, 569 µL, 4.28 mmol) was reduced in 24 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2k (565 mg, 97% yield, 94.7:5.3 er (R:S)). Selectivity 
was determined by chiral HPLC (Chiracel OD-H column, isopropanol:heptane (2:98), 1.0 mL/min flow 
rate, 22.0 °C, detector: 210 nm; (R) 14.3 min and (S) 16.7 min). 
Table 2-10 Entry 14: (R)-2-methyl-1-phenylpropanol, 2l: Following General Hydrogenation Procedure 
A, isobutyrophenone (1l, 733 µL, 4.28 mmol) was reduced in 18 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2l (597 mg, 93% yield, 96.9:3.1 er (R:S)). Selectivity 
was determined by chiral HPLC (Chiracel OD-H column, isopropanol:heptane (2:98), 1.0 mL/min flow 
rate, 22.0 °C, detector: 220 nm; (S) 12.2 min and (R) 13.9 min). 
Table 2-10 Entry 15: (R)-4-phenyl-2-butanol, 2m: Following General Hydrogenation Procedure A, 4-
phenyl-2-butanone (1m, 641 µL, 4.28 mmol) was reduced in 16 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2m (644 mg, 100% yield, 76.6:23.4 er (R:S)). 
Selectivity was determined by chiral HPLC (Chiracel OD-H column, isopropanol:heptane (8:92), 1.0 
mL/min flow rate, 22.0 °C, detector: 210 nm; (R) 7.9 min and (S) 11.6 min). 
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Table 2-10 Entry 16: (R)-1-(2-thiophenyl)ethanol, 2n: Following General Hydrogenation Procedure B, 2-
acetylthiophene (1n, 462 µL, 4.28 mmol) was reduced in 24 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2n (549 mg, 103% yield, 84.4:15.6 er (R:S)). 
Selectivity was determined by chiral HPLC (Chiracel OJ-RH column, acetonitrile:water (20:80), 0.5 
mL/min flow rate, 25.0 °C, detector: 220 nm; (S) 15.5 min and (R) 17.5 min). 
Table 2-10 Entry 17: (R)-1-(2-furanyl)ethanol, 2o: Following General Hydrogenation Procedure A, 2-
acetylfuran (1o, 490 mg, 4.45 mmol) was reduced in 14 h and flash chromatography (EtOAc:heptanes 
5:95 to 10:90) on silica gel yielded 2o (344 mg, 69% yield, 82.5:17.5 er (R:S)). Selectivity was determined 
by chiral HPLC (Chiracel OJ column, isopropanol:heptane (5:95), 0.6 mL/min flow rate, 22.0 °C, detector: 
220 nm; (S) 19.0 min and (R) 21.7 min). 
Table 2-10 Entry 18: (R)-1-(2-(5-methyl)furan)ethanol, 2p: Following General Hydrogenation Procedure 
A, 2-acetyl-5-methylfuran (1p, 498 µL, 4.28 mmol) was reduced in 24 h and flash chromatography 
(EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2p (485 mg, 90% yield, 85.0:15.0 er (R:S)). 
Selectivity was determined by chiral HPLC (Chiracel OJ column, isopropanol:heptane (5:95), 0.6 mL/min 
flow rate, 22.0 °C, detector: 220 nm; (S) 14.1 min and (R) 15.3 min). 
Table 2-10 Entry 19: (R)-1-(3-(2,5-dimethyl)thiophene)ethanol, 2q: Following General Hydrogenation 
Procedure B, 3-acetyl-2,5-dimethylthiophene (1q, 608 µL, 4.28 mmol) was reduced in 24 h and flash 
chromatography (EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2q (652 mg, 97% yield, 98.7:1.3 er 
(R:S)). Selectivity was determined by chiral HPLC (Chiralpak AD-H column, isopropanol:heptane (2:98), 
0.5 mL/min flow rate, 22.0 °C, detector: 220 nm; (S) 16.6 min and (R) 19.0 min). 
Table 2-10 Entry 20: (R)-1-(3-(2,5-dimethyl)furan)ethanol, 2r: Following General Hydrogenation 
Procedure B, 3-acetyl-2,5-dimethylfuran (1r, 570 µL, 4.28 mmol) was reduced in 27 h and flash 
chromatography (EtOAc:heptanes 5:95 to 10:90) on silica gel yielded 2r (547 mg, 91% yield, 96.6:3.4 er 
(R:S)). Selectivity was determined by chiral HPLC (Chiracel OJ column, isopropanol:heptane (5:95), 0.6 
mL/min flow rate, 22.0 °C, detector: 220 nm; (S) 13.0 min and (R) 14.8 min). 
Table 2-10 Entry 21: (R)-1-(ferrocenyl)ethanol, 2s: Following General Hydrogenation Procedure B, 
acetylferrocene (1s, 995 mg, 4.36 mmol) was reduced in 45 h. The product was purified directly without 
acidic work-up by flash chromatography (CH2Cl2) on silica gel to give 2s (1106 mg, 101% yield, 92.1:7.9 
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er (R:S)). Selectivity was determined by chiral HPLC (Chiracel OJ column, isopropanol:heptane (5:95), 
0.6 mL/min flow rate, 22.0 °C, detector: 220 nm; (R) 18.4 min and (S) 20.5 min). 
ChenPhos Derivatives Prepared
14 
 
General Procedure C for One-Pot Sequential Acetoxylation/Amination of ChenPhos Derivatives 
 
 To a flame-dried round-bottomed flask under nitrogen were added (Sc, RFc, RP)-Chenphos 
derivatives 17a-d and acetic anhydride.
14
 The resulting mixture was heated to 100 °C for 1.5 h, cooled to 
rt, and concentrated in vacuo to give a sticky red/orange residue. Isopropanol and MeNH2 were added 
under nitrogen and the resulting mixture heated to 50 °C. When the intermediate acetate was consumed 
(measured by TLC analysis), the reaction was concentrated to a minimum volume and Et2O was added. 
The resulting mixture was washed with aqueous saturated NaHCO3 (2x) and the combined aqueous 
washes were extracted with Et2O to remove orange color. The combined organic extracts were dried 
(Na2SO4) and concentrated in vacuo. Flash chromatography on silica gel provided chiral amines 18a-e. 
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Following General Procedure C with amounts: ChenPhos derivative 17a (410 mg, 0.559 
mmol, 1.0 equiv), Ac2O (3.0 mL), 
i
PrOH (7.0 mL), MeNH2 (1.4 mL, 40% soln in H2O). 
Flash chromatography (EtOAc/hexanes/Et3N, 20/75/65 to 40/55/5) provided compound 
18a (309 mg, 0.430 mmol, 77%) as an orange foam. Analytical data for 18a: 
1
H NMR (600 
MHz, CDCl3):  7.47 (td, J = 7.7, 2.0 Hz, 2H), 7.35 – 7.17 (m, 13H), 4.47-4.46 (m, 1H), 4.35 – 4.19 (m, 
4H), 4.14-4.11 (m, 2H), 4.08-4.06 (m, 1H), 4.05 (s, 5H), 3.75 (qd, J = 6.6, 2.8 Hz, 1H), 3.71 – 3.66 (m, 
1H), 3.65 – 3.57 (m, 2H), 1.71 (s, 3H), 1.32 (d, J = 6.5 Hz, 3H). 
31
P NMR (162 MHz, CDCl3):  -16.56, -
35.47. 
Following General Procedure C with amounts: ChenPhos derivative 17b (450 mg, 0.604 
mmol, 1.0 equiv), Ac2O (5.0 mL), 
i
PrOH (6.0 mL), MeNH2 (1.2 mL, 40% soln in H2O). 
Flash chromatography (EtOAc/hexanes/Et3N, 20/75/65 to 40/55/5) provided compound 
18b (300 mg, 0.410 mmol, 68%) as an orange foam. Analytical data for 18b: 
1
H NMR 
(600 MHz, CDCl3):  7.60 – 7.54 (m, 2H), 7.37 – 7.32 (m, 3H), 4.52-4.51 (m, 1H), 4.42-
4.41 (m, 1H), 4.33 – 4.29 (m, 1H), 4.27 – 4.24 (m, 1H), 4.26-4.20 (m, 1H), 4.16 (t, J = 2.5 Hz, 1H), 4.10 – 
4.06 (m, 6H), 4.01 (s, 1H), 3.84 – 3.79 (m, 1H), 3.78 (m, 1H), 3.75 (m, 2H), 1.75 (s, 3H), 1.37 (d, J = 6.6 
Hz, 2H). The product would not be efficiently isolated from minor cyclohexane containing impurities 
including excess ClPCy2 derivatives from the preparation of 17b. The actual shifts of the cyclohexyl 
protons could not be determined. 
31
P NMR (162 MHz, CDCl3):  -7.00, -35.61. 
Following General Procedure C with amounts: ChenPhos derivative 17c (150 mg, 
0.190 mmol, 1.0 equiv), Ac2O (1.5 mL), 
i
PrOH (2.0 mL), MeNH2 (0.4 mL, 40% soln in 
H2O). Flash chromatography (EtOAc/hexanes/Et3N, 20/75/65 to 40/55/5) provided 
compound 18c (300 mg, 0.410 mmol, 68%, 4:1 mixture with x, the dimethylamino 
precurosor to x could not be removed from the starting material) as an orange foam. 
Analytical data for 18c: 
1
H NMR (400 MHz, CDCl3):  7.52-7.48 (m, 2H), 7.28 (m, 3H), 6.97 – 6.87 (m, 
6H), 4.49 (s, 1H), 4.36 (s, 1H), 4.33 – 4.29 (m, 1H), 4.25 (d, J = 6.8 Hz, 2H), 4.19 – 4.14 (m, 2H), 4.08 (s, 
4H), 4.05 (s, 1H), 4.02 (s, 1H), 3.81-3.71 (m, 1H), 3.74 (s, 1H), 3.68 (d, J = 10.8 Hz, 2H), 2.26 (s, 6H), 
2.25 (s, 6H), 1.74 (s, 3H), 1.36 (d, J = 6.4 Hz, 4H).
31
P NMR (162 MHz, CDCl3):  -16.58, -35.52. 
31
P NMR 
for x (162 MHz, CDCl3):  -34.82.  
87 
Following General Procedure C with amounts: ChenPhos derivative 17d (150 mg, 
0.190 mmol, 1.0 equiv), Ac2O (1.5 mL), 
i
PrOH (2.0 mL), MeNH2 (0.4 mL, 40% soln in 
H2O). Flash chromatography (EtOAc/hexanes/Et3N, 20/75/65 to 40/55/5) provided 
compound 18d (300 mg, 0.410 mmol, 68%, 4:1 mixture with x, the dimethylamino 
precurosor to x could not be removed from the starting material) as an orange foam. Analytical data for 
18d: 
1
H NMR (400 MHz, CDCl3):  7.43-7.38 (m, 2H), 7.29 – 7.16 (m, 7H), 7.01-6.94 (m, 4H), 4.54-4.53 
(m, 1H), 4.34-4.32 (m, 1H), 4.31-4.29 (m, 1H), 4.23-4.21 (m, 2H), 4.18-4.17 (m, 1H), 4.13-4.10 (m, 2H), 
4.02 (s, 1H), 4.00 (s, 4H), 3.98 (s, 1H), 3.84 – 3.80 (m, 1H), 3.67 – 3.63 (m, 1H), 3.44-3.43 (m, 1H), 1.49 
(d, J = 15.7 Hz, 7H). 
31
P NMR (162 MHz, CDCl3):  -18.79, -35.58. 
31
P NMR for x (162 MHz, CDCl3):  -
34.74. 
Following General Procedure C with amounts: ChenPhos derivative 17a (150 mg, 0.205 
mmol, 1.0 equiv), Ac2O (1.5 mL), 
i
PrOH (3.0 mL), EtNH2 (0.5 mL, 68% soln in H2O). Flash 
chromatography (EtOAc/hexanes/Et3N, 20/75/65 to 30/655/5) provided compound 18e 
(122 mg, 0.166 mmol, 81%) as an orange foam. Analytical data for 18e: 
1
H NMR (400 
MHz, CDCl3):  7.50 (t, J = 7.5 Hz, 2H), 7.29 (q, J = 8.4, 6.3 Hz, 13H), 4.50 (s, 1H), 4.34 
(s, 2H), 4.30 (s, 1H), 4.27 (s, 1H), 4.16 (s, 2H), 4.11 (s, 1H), 4.08 (s, 5H), 3.91-3.87 (m, 1H), 3.72 (s, 1H), 
3.66 (s, 1H), 3.59 (s, 1H), 2.31 – 1.94 (m, 3H), 1.40 (d, J = 6.5 Hz, 3H), 0.31 (t, J = 7.1 Hz, 3H).
31
P NMR 
(162 MHz, CDCl3):  -16.49, -35.82. 
General Procedure D for Aminophosphorylation of 18a-e 
 
To a flame-dried round-bottomed flask under under N2 were added 18a-e, toluene, R2PCl, and Et3N. The 
resulting solution was stirred at room O/N. The resulting mixture was concentrated in vacuo and purified 
by flash chromatography on silica gel (EtOAc/hexanes/Et3N, 10:85:5) to give an orange oil/foam 
containing 19a-l. Trituration with MeOH (10 min stir) followed by suction filtration provided 19a-l generally 
as orange foams. 
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Following General Procedure D with amounts: 18a (555 mg, 0.771 mmol, 1.0 equiv), 
chlorodiphenylphosphine (182 L, 0.984 mmol, 1.28 equiv), Et3N (457 L, 3.28 mmol, 
4.25 equiv), toluene (1.6 mL). Flash chromatography on silica gel (EtOAc/hexanes/Et3N, 
10/85/5) followed by trituration with methanol provided 19a (597 mg, 0.661 mmol, 86%) 
as an orange foam. Analytical data for 19a: 
1
H NMR (400 MHz, CDCl3):  7.48 (t, J = 7.4 
Hz, 2H), 7.34 – 7.08 (m, 17H), 7.03 (t, J = 7.3 Hz, 4H), 6.74 (t, J = 6.9 Hz, 2H), 4.64 (ddd, J = 13.2, 6.8, 
3.8 Hz, 1H), 4.57 (s, 1H), 4.44 (s, 1H), 4.29 (s, 1H), 4.25 (s, 1H), 4.22 (d, J = 7.1 Hz, 2H), 4.15 – 4.04 (m, 
3H), 3.99 (s, 5H), 3.98 – 3.91 (m, 2H), 3.63 (s, 1H), 3.52 (s, 1H), 2.00 (d, J = 3.6 Hz, 3H), 1.48 (d, J = 6.9 
Hz, 3H).
31
P NMR (162 MHz, CDCl3) δ 54.12 (d, J = 6.1 Hz), -17.10 , -39.08 (d, J = 6.0 Hz). 
Following General Procedure D with the following amounts: 18a (50 mg, 0.070 mmol, 
1.0 equiv), (o-tol)2PCl (18 L, 0.083 mmol, 1.2 equiv), Et3N (39 L, 0.28 mmol, 4.0 
equiv), toluene (0.15 mL). Flash chromatography on silica gel (EtOAc/hexanes/Et3N, 
10/85/5) followed by trituration with methanol provided 19b (48 mg, 0.052 mmol, 74%) 
as an orange powder. Analytical data for 19b: 
1
H NMR (600 MHz, CDCl3):  7.58-7.55 
(m, 3H), 7.38 – 7.20 (m, 22H), 4.56 (bs, 1H), 4.50 (bs, 1H), 4.30 (bs, 1H), 4.23 (bs, 1H), 4.20 – 4.16 (m, 
3H), 4.13 – 4.10 (m, 2H), 3.96 (s, 5H), 3.94 (d, J = 1.3 Hz, 1H), 3.92 (bs, 1H), 3.78 – 3.75 (m, 1H), 3.50 
(bs, 1H), 2.05 (s, 3H), 2.00 (d, J = 2.7 Hz, 3H), 1.69 (s, 3H), 1.67 (s, 3H). 
31
P NMR (243 MHz, CDCl3) δ 
51.81, -17.14, -38.07. 
Following General Procedure D with the following amounts: 18a (70 mg, 0.097 
mmol, 1.0 equiv), (3,5-xylyl)2PCl (32.3 mg, 0.117 mmol, 1.2 equiv), Et3N (41 L, 
0.29 mmol, 3.0 equiv), toluene (1.0 mL). Flash chromatography on silica gel 
(EtOAc/hexanes/Et3N, 10/85/5) provided 19c (58 mg, 0.060 mmol, 62%) as an 
orange foam. Analytical data for 19c: 
1
H NMR (400 MHz, CDCl3):  7.40 (t, J = 7.6 
Hz, 2H), 7.36 – 7.19 (m, 10H), 7.07 – 6.96 (m, 3H), 6.88 (s, 1H), 6.80 (s, 1H), 6.75 (d, J = 7.4 Hz, 2H), 
6.56 (d, J = 7.1 Hz, 2H), 4.57 (s, 1H), 4.46 (s, 1H), 4.30 (s, 1H), 4.24 (s, 1H), 4.21 (s, 1H), 4.18 (s, 1H), 
4.14 (s, 1H), 4.11 (s, 1H), 4.01 (s, 5H), 3.92 (s, 2H), 3.69 (s, 1H), 3.50 (s, 1H), 2.21 (s, 6H), 2.16 (s, 6H), 
1.91 (d, J = 3.5 Hz, 3H), 1.62 (d, J = 6.9 Hz, 3H). 
31
P NMR (162 MHz, CDCl3) δ 53.46 (d, J = 6.7 Hz), -
17.05, -38.11 (d, J = 6.2 Hz). 
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Following General Procedure D with the following amounts: 18a (50 mg, 0.070 mmol, 1.0 
equiv), Cy2PCl (18.4 L, 0.083 mmol, 1.2 equiv), Et3N (39 L, 0.28 mmol, 4.0 equiv), 
toluene (0.15 mL). Flash chromatography on silica gel (EtOAc/hexanes/Et3N, 20/75/5) 
followed by trituration with methanol provided 19d (22.8 mg, 0.024 mmol, 36%) as an 
orange foam. Analytical data for 19d: 
1
H NMR (400 MHz, CDCl3):  7.49 (td, J = 7.9, 1.3 Hz, 2H), 7.36 – 
7.20 (m, 11H), 7.15 (td, J = 7.4, 1.3 Hz, 2H), 6.98 (d, J = 7.6 Hz, 2H), 6.93 (dd, J = 8.1, 6.7 Hz, 2H), 6.88 
– 6.81 (m, 2H), 6.65 (dd, J = 8.1, 6.5 Hz, 2H), 4.64-4.60 (m, 1H), 4.58 (bs, 1H), 4.44 (bs, 1H), 4.30 (bs, 
1H), 4.26 – 4.20 (m, 3H), 4.14 (s, 1H), 4.13 – 4.08 (m, 1H), 4.00 (s, 5H), 3.98 (m, 1H), 3.94 (bs, 1H), 3.64 
– 3.60 (m, 1H), 3.53 (bs, 1H), 2.31 (s, 3H), 2.27 (s, 3H), 1.99 (d, J = 3.6 Hz, 3H), 1.48 (d, J = 6.9 Hz, 
3H).
31
P NMR (162 MHz, CDCl3) δ 53.27 (d, J = 6.0 Hz), -17.10 , -39.03 (d, J = 6.0 Hz). 
Following General Procedure D with the following amounts: 18a (50 mg, 0.070 mmol, 
1.0 equiv), (2-furyl)2PCl (12.9 L, 0.083 mmol, 1.2 equiv), Et3N (39 L, 0.28 mmol, 4.0 
equiv), toluene (0.15 mL). Flash chromatography on silica gel (EtOAc/hexanes/Et3N, 
20/75/5) followed by trituration with methanol provided 19e (31.2 mg, 0.035 mmol, 
51%) as an orange solid. Analytical data for 19e: 
1
H NMR (400 MHz, CDCl3):  7.51 
(t, J = 1.3 Hz, 1H), 7.45 (d, J = 1.7 Hz, 1H), 7.38 – 7.20 (m, 12H), 7.17 – 7.09 (m, 1H), 7.07-7.03 (m, 2H), 
6.34-6.33 (m, 1H), 6.30-6.27 (m, 3H), 4.77-4.70 (m, 1H), 4.54 (bs, 1H), 4.34 (bs, 1H), 4.32 – 4.23 (m, 3H), 
4.19 (t, J = 2.5 Hz, 1H), 4.10 – 4.08 (m, 1H), 4.06-4.05 (m, 1H), 4.03 (s, 5H), 3.81 (bs, 1H), 3.61 (bs, 1H), 
3.49 (bs, 2H), 3.47 – 3.43 (m, 1H), 1.92 (d, J = 4.6 Hz, 3H), 1.45 (d, J = 6.8 Hz, 3H). 
31
P NMR (162 MHz, 
CDCl3) δ 8.48 (d, J = 7.0 Hz), -16.35 , -38.00 (d, J = 6.8 Hz). 
Following General Procedure D with the following amounts: 18a (50 mg, 0.070 
mmol, 1.0 equiv), (3,5-diCF3-C6H3)2PCl (40.9 mg, 0.083 mmol, 1.2 equiv), Et3N 
(39 L, 0.28 mmol, 4.0 equiv), toluene (0.15 mL). Flash chromatography on 
silica gel (EtOAc/hexanes/Et3N, 20/75/5) followed by trituration with methanol 
provided 19f (24.9 mg, 0.021 mmol, 30%) as an orange solid. Analytical data for 19f: 
1
H NMR (400 MHz, 
CDCl3):  7.91 (d, J = 7.6 Hz, 2H), 7.80 (s, 1H), 7.70 (s, 1H), 7.41 (d, J = 6.3 Hz, 2H), 7.33 – 7.24 (m, 9H), 
7.23-7.21 (m, 3H), 6.88-6.84 (m, 1H), 6.81-6.77 (m, 2H), 4.66-4.60 (m, 1H), 4.56 (bs, 2H), 4.40 (s, 1H), 
4.29 (s, 1H), 4.20 (s, 1H), 4.17 (s, 1H), 4.08 (s, 2H), 4.02 (s, 5H), 3.82 (s, 1H), 3.72 (s, 1H), 3.49 (s, 1H), 
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3.39 (s, 1H), 1.87 (d, J = 3.2 Hz, 3H), 1.74 (d, J = 7.0 Hz, 3H).
31
P NMR (162 MHz, CDCl3) δ 50.20 (d, J = 
8.0 Hz), -16.68 , -38.83 (d, J = 8.4 Hz). 
Following General Procedure D with the following amounts: 18a (50 mg, 0.070 mmol, 
1.0 equiv), (
I
Pr)2PCl (13.2 L, 0.083 mmol, 1.2 equiv), Et3N (39 L, 0.28 mmol, 4.0 
equiv), toluene (0.15 mL). Flash chromatography on silica gel (EtOAc/hexanes/Et3N, 
20/75/5) followed by trituration with methanol provided 19g (46 mg, 0.055 mmol, 85%) 
as an orange foam. Analytical data for 19g: 
1
H NMR (400 MHz, CDCl3):  7.58-7.54 (m, 
2H), 7.37 – 7.13 (m, 13H), 4.57 (bs, 1H), 4.49 (s, 1H), 4.31 (s, 1H), 4.24 (s, 1H), 4.20 (d, J = 2.6 Hz, 1H), 
4.17 (s, 1H), 4.10 (d, J = 6.2 Hz, 1H), 4.05 – 3.98 (m, 2H), 3.97 (s, 6H), 3.93 (s, 1H), 3.75 (s, 1H), 3.51 (s, 
1H), 2.09 (d, J = 2.6 Hz, 2H), 1.65 (d, J = 6.9 Hz, 2H), 0.87 – 0.78 (m, 6H), 0.56 (dd, J = 15.0, 7.0 Hz, 
3H), 0.40 (dd, J = 11.7, 7.1 Hz, 3H). 
31
P NMR (162 MHz, CDCl3) δ 63.49, -16.59, -37.74. 
Following General Procedure D with the following amounts: 18b (54 mg, 0.074 mmol, 1.0 
equiv), Ph2PCl (16.4 L, 0.089 mmol, 1.2 equiv), Et3N (41 L, 0.30 mmol, 4.0 equiv), 
toluene (0.15 mL). Flash chromatography on silica gel (EtOAc/hexanes/Et3N, 20/75/5) 
followed by trituration with methanol provided 19h (55 mg, 0.060 mmol, 81%) as an 
orange solid. Analytical data for 19h: 
1
H NMR (400 MHz, CDCl3):  7.57 (t, J = 8.1 Hz, 
2H), 7.25 – 7.12 (m, 7H), 7.08-7.04 (m, 4H), 6.80 – 6.73 (m, 2H), 4.70-4.65 (m, 1H), 4.59 (s, 1H), 4.46 (s, 
1H), 4.39 (s, 1H), 4.26 (s, 1H), 4.25 (s, 1H), 4.21 – 4.17 (m, 2H), 4.02 (s, J = 2.0 Hz, 6H), 3.97 – 3.94 (m, 
1H), 3.74 – 3.70 (m, 1H), 3.67 (s, 1H), 2.03 (d, J = 3.7 Hz, 2H), 1.88 – 1.55 (m, 10H), 1.49 (d, J = 6.9 Hz, 
3H), 1.33 – 1.10 (m, 10H), 0.91 – 0.80 (m, 2H). 
31
P NMR (162 MHz, CDCl3) δ 54.38 (d, J = 6.0 Hz), -7.37, 
-38.89. 
Following General Procedure D with the following amounts: 18c (60 mg, 0.077 mmol, 
1.0 equiv, 4:1 mixture with P(3,5-xylyl)2 substituted by H which was inseperable in 
preparation), Ph2PCl (17.2 L, 0.093 mmol, 1.2 equiv), Et3N (43 L, 0.31 mmol, 4.0 
equiv), toluene (0.15 mL). Flash chromatography on silica gel (EtOAc/hexanes/Et3N, 
20/75/5) followed by trituration with methanol provided 19k (56.7 mg, 0.060 mmol, 
75% as a 4:1 mixture with P(3,5-xylyl)2 substituted by H which was inseperable) as an orange solid. 
Analytical data for 19k: 
1
H NMR (400 MHz, CDCl3):  7.50 (t, J = 7.6 Hz, 2H), 7.20 (m, 8H), 7.08-7.04 (m, 
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4H), 6.98 – 6.88 (m, 5H), 6.79-6.75 (m, 2H), 4.70 – 4.62 (m, 1H), 4.58 (s, 1H), 4.47 (s, 1H), 4.32 (s, 1H), 
4.27 (s, 1H), 4.23 (s, 1H), 4.19 (s, 1H), 4.17 (s, 1H), 4.03 (d, J = 4.4 Hz, 5H), 3.95 (s, 1H), 3.68 (s, 1H), 
3.55 (s, 1H), 2.27 (s, 12H), 2.02 (d, J = 3.4 Hz, 3H), 1.50 (d, J = 7.1 Hz, 3H).
31
P NMR (162 MHz, CDCl3) δ 
54.52 (d, J = 5.8 Hz), -16.53 , -38.39 (d, J = 5.8 Hz). 
31
P NMR (162 MHz, CDCl3, proto impurity) δ 54.82 
(d, J = 6.4 Hz), -37.79 (d, J = 6.0 Hz). 
Following General Procedure D with the following amounts: 18d (55 mg, 0.073 mmol, 
1.0 equiv, 4:1 mixture with P(4-F-C6H4)2 substituted by H which was inseperable in 
preparation), Ph2PCl (16.1 L, 0.093 mmol, 1.2 equiv), Et3N (41 L, 0.29 mmol, 4.0 
equiv), toluene (0.15 mL). Flash chromatography on silica gel (EtOAc/hexanes/Et3N, 
20/75/5) followed by trituration with methanol provided 19l (51.6 mg, 0.055 mmol, 
75% as a 4:1 mixture with P(4-F-C6H3)2 substituted by H which was inseperable) as an orange solid. 
Analytical data for 19l: 
1
H NMR (400 MHz, CDCl3):  7.48 (t, J = 7.6 Hz, 2H), 7.28-7.13 (m, 11H), 7.08-
6.97 (m, 8H), 6.74 (t, J = 7.2 Hz, 2H), 4.65 (m, 1H), 4.60 (s, 1H), 4.46 (s, 1H), 4.33 (s, 1H), 4.27 (s, 1H), 
4.25 (s, 1H), 4.22 (s, 1H), 4.20 (s, 1H), 4.08 (s, 1H), 4.02 (s, 5H), 3.96 (s, 1H), 3.60 (s, 1H), 3.39 (s, 1H), 
2.01 (d, J = 3.7 Hz, 3H), 1.49 (d, J = 6.8 Hz, 3H).
 31
P NMR (162 MHz, CDCl3) δ 55.05 (d, J = 6.3 Hz), -
18.98 , -38.59 (d, J = 6.2 Hz).
31
P NMR (162 MHz, CDCl3, proto impurity) δ 54.81 (d, J = 6.4 Hz), -37.80 
(d, J = 6.2 Hz). 
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CHAPTER THREE: ASYMMETRIC TOTAL SYNTHESES OF MEGACEROTONIC ACID AND 
SHIMOBASHIRIC ACID A
*
 
 
3.1 Introduction 
 
 The total synthesis of natural products continues to be an important aspect of organic chemistry 
because it elucidates the shortcomings of the field, resulting in the development of new methodologies, 
can provide quantities of natural product unavailable from nature, and allows the synthesis of unnatural 
congeners which may exhibit remarkably different bioactivity.  Natural products containing an -
benzylidene--butyrolactone
 
elicit a wide variety of biological responses, causing them to be excellent 
targets for total synthesis.
1
 In this chapter, we present the total syntheses of two structurally unique -
benzylidene--butyrolactones: megacerotonic acid (1a) and shimobashiric acid A (1b).  Each synthesis 
follows the same general route with key steps including an asymmetric dynamic kinetic resolution 
asymmetric transfer hydrogenation (DKR-ATH), lactonization via Dieckmann cyclization, and ketone 
reduction/alcohol elimination to form the -benzylidene (Scheme 3-1). 
Scheme 3-1. Total Synthesis of Megacerotonic Acid and Shimobashiric Acid A 
 
 
                                                          
*
Reproduced in part by permission of the American Chemical Society: Krabbe, S. W.; Johnson, J. S. Org. 
Lett. 2015, 17, 1188. 
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3.2 Background 
3.2.1 Occurrence and Biological Activity of -Methylidene-, -Alkylidene- and -Benzylidene--
Butyrolactones 
 -Methylidene-, -alkylidene-, and -benzylidene--butyrolactones are present in approximately 
3% of known natural products with nearly 6500 reported to date.
2
 The vast majority of these structures 
are -methylidene--butyrolactones. Nearly 2000 of these reported natural products exhibit biological 
responses including anticancer, anti-inflammatory, antibacterial, anticoagulant, antifungal, antiprotozoal, 
antiparasitic, and insect antifeedant activities.
1,3
 Some of the most notable examples include anti-
inflammatory agent helenalin 2 used in ointments for muscle pain and bruises;
4
 parthenolide 3 which 
exhibits anti-inflammatory, anticancer, and antiviral activities;
5
 hispitolide A 4 which has shown activity 
against hepatitis C;
6
 and the tumor inhibitor arglabin 5 (Figure 3-1).
7
 -Methylidene--butyrolactones are 
excellent Michael acceptors and conjugate addition of amino acid side chains within proteins/enzymes is 
believed to underlie much of their bioactivity,
8
 including a number of allergenic properties.
9
 
Figure 3-1. Selected Biologically Active -Methylidene--Butyrolactones 
 
Although much less common than -methylidene--butyrolactones, a number of -alkylidene--
butyrolactone natural products have been reported to exhibit biological responses including scabrolide E 
6
10
 and andrographolide 7
11
 (Figure 3-2).
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Figure 3-2. Selected Biologically Active -Alkylidene--Butyrolactones 
 
Naturally occurring -benzylidene--butyrolactones show high propensity to elicit biological 
responses with 58 of the 105 known showing bioactivity despite their relative structural simplicity in 
comparison to biologically active -methylidene--butyrolactones.
12
 Biological responses include 
anticancer, anti-HIV, antifungal, and anti-inflammatory activities (Figure 3-3).
13
  
Figure 3-3. Selected Biologically Active Natural -Benzylidene--Butyrolactones 
 
In addition to the naturally occurring -benzylidene--butyrolactones, a few semi-synthetic 
compounds derived from -methylidene lactones micheliolide 14 and dehydrocostus lactone 16 have 
exhibited anticancer activities against acute myeloid leukemia cell line (HL-60) and doxorubicin-resistant 
cell line (HL-60/A) similar to those of their parent structures (Figure 3-4).
14
 Additionally, -benzylidene 
derivatives of parthenolide 3 exhibited anticancer activity against a cervical cancer cell line (HeLa).
15
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Figure 3-4 Comparison of Anticancer Activities of Selected Natural -Methylidene--Butyrolactones and 
Semi-Synthetic -Benzylidene--Butyrolactones 
 
3.2.2 Isolation of Megacerotonic Acid and Shimobashiric Acid A 
 Megacerotonic acid 1a
16
 and shimobashiric acid A 1b
17
 represent the only known members of a 
structurally unique subclass of -benzylidene--butyrolactones which have C3-aryl and C4-carboxylic acid 
substitution. Although no investigation of their bioactivity has been reported to date, a similarly substituted 
natural product 12 has exhibited anti-HIV properties (Figure 3-3).
13d
 Takeda and coworkers isolated 1a 
from Megaceros flagellaris in 1990. The isolation was reported in two separate papers, each with a 
different -benzylidene--butyrolactone structure for 1a (Figure 3-5). Papin and coworkers carried out a 
racemic total synthesis (vide infra), which unambiguously assigned the structure as 1a.
18
 At the time of its 
isolation, 1a was the only known -butyrolactone natural product to contain the C2-arylidene-C3-aryl-C4-
carboxylic acid substitution pattern. Over two decades later, the only other natural -butyrolactone known 
with this substituent array, 1b, was isolated by Murata and coworkers from Keiskea japonica after its 
extracts showed hyaluronidase inhibitory activity (Figure 3-5).
17
 Although a number of other natural 
products isolated from these extracts showed biological activity, the isolation of 1b in a small quantity (1.2 
mg) precluded the investigation of its biological activity. 
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Figure 3-5. Structures of 1a and 1b 
 
3.2.3 Racemic Total Synthesis of 1a 
 Prompted by the ambiguity in structural assignment and uniqueness of 1a, Papin and coworkers 
completed a racemic total synthesis shortly after its isolation (Scheme 3-2).
18
 Their synthesis commenced 
with Knoevenagel condensation of ethyl acetoacetate and piperonal 20 followed addition of a second 
equivalent of ethyl acetoacetate to the resulting benzylidene. Subsequent intramolecular aldol reaction 
provides tertiary alcohol 21. Ring opening hydrolysis followed by methyl esterification provided dimethyl 
ester 22. Stobbe condensation of dimethyl ester 22 with p-anisaldehyde followed by esterification 
provided benzylidene 23. -Hydroxylation utilizing Vedejs reagent
19
 followed by intramolecular 
lactonization provided a near-equal mixture of trans- and cis--benzylidene--butyrolactones 24 and 25. 
Methoxide promoted epimerization/hydrolysis of 25 followed by boron tribromide-mediated demethylation 
provided racemic 1a, while boron tribromide-mediated demethylation of trans-lactone 24 provided 1a in a 
combined overall yield of 5.1%.  
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Scheme 3-2. Papin and Coworkers’ Racemic Total Synthesis of 1a 
3.2.4 Rapid, Atom Economical Access to -Butyrolactones via Ruthenium-Catalyzed DKR-ATH of 
-Substituted -Keto Esters 
 Our laboratory recently disclosed access to highly enantioenriched -butyrolactones
20
 which we 
believed could provide rapid access to not only 1a and 1b, but also be amenable to the modular synthesis 
of unnatural congeners for investigation of structure activity relationships. The three step route to lactones 
functionalized with a C2-functional handle for installation of the benzylidene and the required C3-aryl/C4-
carboxylate functionality begins with Knoevenagel condensation between an aryl aldehyde 26 and 
dimethylmalonate 27 (Scheme 3-3). N-Heterocyclic carbene
21
 catalyzed Stetter reaction of the resulting 
benzylidene 28 and ethyl glyoxylate provides racemic -aryl--keto ester 29. DKR-ATH catalyzed by 
(arene)RuCl(monosulfonamide) followed by in situ diastereoselective lactonization provides lactone 30 in 
a highly atom economical and environmentally benign route producing only water, methanol and carbon 
dioxide as stoichiometric by-products.  
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Scheme 3-3. Atom Economical Access to -Butyrolactones via DKR-ATH 
 Achieving high stereocontrol in DKR-ATH of -substituted--keto esters relies on several kinetic 
considerations (Scheme 3-4).
22
 The ruthenium catalyst must preferentially (k1>>k2) and irreversibly (k-
1=0) reduce one enantiomer of -substituted--keto ester (31). Racemization of 31 via an achiral enol 
intermediate 32 must be fast on the timescale of the transfer hydrogenation to maintain a 1:1 ratio of 
starting material enantiomers throughout the reaction. Furthermore, the conditions utilized for 
racemization of the -keto ester cannot result in epimerization of -hydroxy ester product (k3=0). When all 
of these conditions were met, the DKR-ATH of -substituted--keto esters provided products with 
excellent diastereo- and enantioselectivity. 
Scheme 3-4. Key Factors of DKR-ATH 
 
3.3 Results and Discussion 
3.3.1 Preliminary Retrosynthetic Analysis 
 Approaching the retrosynthetic analysis of these natural products (Scheme 3-5), we considered 
-benzylidene--butyrolactone 34 a key intermediate, since phenol deprotection and epimerization at C4 
to form the more stable trans configuration had been utilized in the racemic synthesis of 1a by Papin and 
coworkers.
18
 We envisioned arylidene 34 arising via Heck coupling of -methylene lactone 35 with an 
appropriate haloarene, allowing late-stage installation of a variety of benzylidene substituents and 
providing a modular approach to this class of natural products. Synthetic access to 35 would be achieved 
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by a known three-step procedure from -aryl--keto ester 36 which is synthesized in two steps from 
simple, commercially available starting materials.
 
Scheme 3-5. Preliminary Retrosynthetic Analysis 
  
3.3.2 Proposed Application of DKR-ATH in Preliminary Route to Intermediate 34a 
 Initial investigations focused on the optimization of a route to 1a, as we believed the same 
pathway would also be applicable to 1b. DKR-ATH of -aryl--keto ester 36 with concomitant 
lactonization smoothly provided -butyrolactone 37 in high diastereo- and enantioselectivity following a 
single recrystallization (Scheme 3-6).
20
 Bromomethylation using dibromomethane followed by LiCl-
promoted Krapcho dealkoxycarbonylation/elimination
23
 provided -methylene lactone 35 for investigation 
of the projected Heck coupling.
 
Scheme 3-6. DKR-ATH/Bromomethylation/Krapcho Dealkoxylcarbonylation/Elimination Route to 35  
 
3.3.3 Application of Heck Coupling and Cross Metathesis in the Synthesis of 34a  
Extant methodologies for Heck couplings which deliver exocyclic alkenes are generally limited to 
-unsubstituted- or -alkyl--methylidene lactones, with little precedent for the -aryl coupling required for 
our synthesis. Arcadi and coworkers disclosed the Heck coupling of -unsubstituted--butyrolactones with 
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a variety of aryl and vinyl pronucleophiles (Scheme 3-7).
24
 They observed  both endo- and exocyclic -
hydride elimination when a palladium/phosphine catalyst system was used. Removal of phosphine and 
substitution of potassium acetate for triethylamine, resulted in high selectivity for the butenolide. In 
addition to this work, Genêt and coworkers have reported highly selective access to -benzylidene--
butyrolactones utilizing aryldiazonium salts and a heterogeneous Pd catalyst, with little selectivity for 
olefin geometry.
25 
Scheme 3-7. Heck Coupling of -Unsubstituted--Butyrolactones 
 
In the case of -alkyl--methylidene lactones, three reports have utilized Heck coupling to access semi-
synthetic natural product derivatives (Scheme 3-8). Belovodskii and coworkers disclosed the coupling of 
isoalantolactone 39 with a variety of aryl iodides catalyzed by phosphine ligated palladium providing -
benzylidene lactones with good selectivity for exocyclic -hydride elimination.
26
 The method reported for 
coupling of parthenolide 3 and a variety of aryl iodides by Colby and coworkers showed excellent 
selectivity for exocyclic alkene formation,
15
 while Chen disclosed coupling of micheliolide 14 and 
dehydrocostus lactone 16 with a variety of aryl iodides.
14
 It is important to note that all of these cases 
used a C3-C4 fused ring system likely leaving the ring hydrogen less accessible for syn--hydride 
elimination and accounting for selective formation of exocyclic olefins.   
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Scheme 3-8. Heck Coupling for the Preparation of Semi-Synthetic -Benzylidene--Butyrolactones 
 
Kim and co-workers reported the only Heck coupling using -aryl--methylidene lactones 40 
where formation of the butenolide was heavily favored over exocyclic alkene (Scheme 3-9).
27
 For this 
system, it is proposed that the observed selectivity arises from chelation of the C4-carboxylate to Pd and 
subsequent endocyclic olefin formation via -hydride elimination is proposed. In the absence of a C4-
carboxylate, non-stereoselective carbopalladation leading to a mixture of endo- and exocyclic alkenes is 
observed.
 
Scheme 3-9. Palladium Catalyzed Oxidative Arylation of -Aryl--Methylidene Lactones 
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Despite the lack of literature precedent for the desired Heck coupling, easy access to -methylidene--
butyrolactone 35 prompted an investigation of its feasibility. We began our investigation of the proposed 
Heck coupling utilizing conditions similar to those reported by Belovodskii (Table 3-1).
26
 Full consumption 
of the starting material was observed but a low yield of the desired -benzylidene--butyrolactone 34a 
was obtained (entry 1). Substituting K2CO3 for Et3N resulted in consumption of the starting material 
without desired product formation (entry 2). Utilizing a more sterically encumbered phosphine ligand, 
P
t
Bu3, led to partial conversion without formation of desired product (entry 3). A modest increase in yield 
was observed when no phosphine ligand was used and the reaction was run under air (entry 4). 
Substitution of Pd(OAc)2 for Pd(Ph3)4 or Pd(dba)2 showed no increase in the amount of 34a concurrent 
with observed formation of butenolide 41 (entries 5 and 6). In all Heck coupling attempts, a significant 
(~50% or more), unidentified by-product incorporating two units of starting -methylidene lactone was 
observed.  
Table 3-1. Heck Coupling Attempts for the Preparation of 34a 
 
Entry
 
Pd source Additive Base (equiv) Conv. (%) Yield 34a (%)
a,b 
1 Pd(OAc)2 P(o-tol)3 Et3N (1.4) 100   14
c 
2 Pd(OAc)2 P(o-tol)3 K2CO3 (1.4) 100  0
c 
3 Pd(OAc)2 P(
t
Bu)3 Et3N (1.4) 75  0
c 
4 Pd(OAc)2 None Et3N (3.0) 100     19
d,e
 
5 Pd(dba)2 None Et3N (2.0) 65 <20
f 
6 Pd(Ph3)4 None Et3N (2.0) 100   20
g 
a 
In all cases a significant byproduct incorporating two units of 35 was observed; 
b 
Refers to isolated yield 
unless otherwise noted; 
c
 4 mol % Pd, 16 mol % PR3 
d
 12 mol % Pd; 
e 
Under atmosphere of air; 
f 
Messy 
reaction with multitude of byproducts; 
g 
Yield of inseparable mixture of 34a and 41 (1:1). 
 
Based on the low yields of 34a obtained via Heck coupling, we briefly investigated cross-metathesis of 35 
with styrenes. Extant methodologies for cross-metathesis of -methylidene lactones were limited to those 
without -substitution (Scheme 3-10a).
28
 Unfortunately, methylidene 35 was completely unreactive under 
the conditions reported (Scheme 3-10b). 
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Scheme 3-10. Extant Methodology for Cross-Metathesis of -Methylidene Lactones and Styrenes and 
Attempted Application to Methylidene 35 
 
3.3.4 Application of Krapcho Dealkoxycarbonylation/Aldol/Elimination Sequence 
Consequently, we turned our attention to an alternative route to access 34a from 37 which would 
still allow late stage installation of different benzylidene substituents. Krapcho dealkoxycarbonylation of 
lactone 37 smoothly provided lactone 42 in good yield (Scheme 3-11).
29
  
Scheme 3-11. Krapco Dealkoxycarbonylation 
 
Initial investigation of the aldol reaction using 2.2 equivalents of LDA and allowing the reaction to 
warm to rt after addition of p-anisaldehyde resulted in an intractable mixture of products (Table 3-2, entry 
1).
30
 Reducing the equivalency of LDA gave poor conversion of 37 and did not alter the composition of 
products formed (entry 2). Maintaining cryogenic reaction conditions throughout the reaction allowed the 
isolation of alcohol 43 in modest yield as a mixture of diastereomers, and reducing the amount of p-
anisaldehyde in tandem with shortening the reaction time provided a modest increase in isolated yield of 
43 (entries 3 and 4). Reaction products which showed incorporation of multiple equivalents of p-
anisaldehyde implicated C4 deprotonation despite the kinetic conditions used. With 43a in hand, we 
chose to push forward and investigate avenues for the preparation of 34a. 
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Table 3-2. Aldol/Elimination Sequence in the Synthesis of 43a 
 
Entry
 
LDA equiv p-anisaldehyde equiv T (°C) Result 
1 2.2 1.5 -78 to rt Mess 
2 1.1 1.5 -78 to rt <50% Conv. 
3 2.2 1.5 -78 (30 min) 36% isolated 43a 
4 2.2 1.1 -78 (10 min) 44% isolated 43a 
 
Because 43a was formed as a near equivalent mixture of diastereomers, the two step 
mesylation/elimination approach to 34a would likely yield a mixture of E and Z alkene isomers (Scheme 
3-12).
31
 This hypothesis was confirmed when a 1:1.3 E:Z mixture of isomers was obtained. Acid catalyzed 
elimination of alcohol 43a provided a 4:1 E:Z mixture of alkene isomers. The desired E isomer was 
obtained in 52% yield resulting in a disappointing three step overall yield of just 20% from lactone 37. 
However, the viability of alcohol elimination prompted us to consider an alternative retrosynthetic analysis 
for 43a. 
Scheme 3-12. Approaches to 34a Via Elimination 
 
3.3.5 Revised Route to Alcohol 43a 
 Our early synthetic difficulties suggested that early installation of benzylidene group precursors 
was likely necessary (Scheme 3-13). With this in mind we envisioned that access to 43a would be 
achieved via reduction of -keto lactone 44a which would arise from DKR-ATH of -keto ester 45, 
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synthesized via a proposed extension of previously reported glyoxylate Stetter reaction with benzylizene 
46.
20 
Scheme 3-13. Retrosynthetic Analysis of Alcohol 43a 
 
The proposed DKR-ATH was similar to those previously reported by our laboratory, but contained 
additional complexity (Scheme 3-14)
20
 in the form of a -keto ester in substrate 45. As this moiety is the 
prototypical Noyori DKR-ATH substrate,
22a
 our method would require unique chemoselective reduction of 
the -keto ester followed by lactonization to 44a. In situ reduction of the resulting -keto lactone could 
provide remarkably rapid access to 43a. 
Scheme 3-14. Complexity of Proposed DKR-ATH of 45 
 
 Access to diketone 45 proved remarkably facile (Scheme 3-15). Claisen condensation of p-
methoxyacetophenone and demethylcarbonate promoted by sodium hydride provided 49 that smoothly 
underwent Knoevenagel condensation with piperonal to yield 46. The proposed extension of known 
glyoxylate Stetter reaction to 46 also proceeded smoothly yielding 45 as a mixture of diastereomers.
20
 
Submitting 45 to previously reported conditions for DKR-ATH in DMSO resulted in partial conversion to -
keto lactone 44a upon heating to 70 °C. However this reaction was not selective for a single reaction 
product with poor mass recovery of a mixture of 45 and 44a (1.4:1, 44a as a single diastereomer) after 
purification by flash chromatography. Switching to DMF as a solvent, resulted in complete conversion of 
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starting material to a 1:4:1 mixture of -keto lactone diastereomers contaminated with significant 
impurities. Flash chromatography allowed isolation of 44a in poor yield, but diastereomer 50 could not be 
isolated from the impurities present. Based on the poor yield of -keto lactone obtained, we again chose 
to investigate a new avenue for the synthesis of 43a. 
Scheme 3-15. Synthesis of 45 and Application in DKR-ATH 
 
3.3.6 Revised Retrosynthetic Analysis 
In a second generation retrosynthetic analysis, access to 43a would again be provided by 
reduction of -keto lactone 44a, which would arise from (4+1)-annulation between a synthetic equivalent 
of 51 and a phosgene surrogate 52 (Scheme 3-16). Previously reported DKR-ATH of α,-diketo--aryl 
ester 53 would establish the absolute stereochemistry.
20
 Although this route removed the modularity 
achieved with previously investigated routes, the short synthetic sequence should still allow rapid 
generation of unnatural congeners of 1a and 1b. 
Scheme 3-16. Revised Retrosynthetic Analysis of 43a 
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3.3.7 Optimization of the Synthesis of ,-Diketo--Aryl Ester 53a 
Access to α,-diketo--aryl esters 53 via NHC-catalyzed glyoxylate Stetter reaction has been 
previously reported by our laboratory (Table 3-3).
20
 The near complete insolubility of enone 53 in toluene 
demanded a solvent swap from that reported (entry 1). Switching to CH2Cl2 provided homogeneous 
conditions and modest conversion, but the product could not be efficiently separated from enone 54a by 
flash chromatography resulting in a poor isolated yield (entry 2). Increasing the reaction temperature, 
resulted only in lower conversion (entries 3 and 4). We postulated that the increased electron density of 
enone 54a, relative to the examples previously reported, was resulting in slower addition of the Breslow 
intermediate
32
 on a timescale such that monomeric ethyl glyoxylate was re-dimerizing resulting in 
incomplete conversion. Ethyl glyoxylate exists as a trimer/polymer in solution and must be cracked by 
distillation immediately prior to use. Simple bulb-to-bulb vacuum distillation with heating can provide 35-
45% ethyl glyoxylate solutions in toluene while higher concentrations (up to 90%) can be achieved by 
fractional distillation in the absence of vacuum.
33
   We anticipated that increasing the relative electron 
density of the NHC catalyst would obviate the problem of slow addition to enone 54a, but the opposite 
was observed in practice (entry 5). An alternative method to address this issue was to ensure the 
presence of monomeric glyoxylate via multiple additions during the reaction period. However, only a slight 
increase in conversion was observed (entry 6). Increasing the catalyst loading was also beneficial though 
we were reluctant to rely on high loading percentages (entry 7). After further optimization we found that 
reducing the amount of added toluene by increasing the ethyl glyoxylate solution concentration, adding 
ethyl glyoxylate in three portions, and increasing the triethylamine loading provided acceptable 
conversion to the desired ,-diketo--aryl ester 53a (entries 8 and 9). 
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Table 3-3. Optimization of Glyoxylate Stetter Reaction 
 
Entry 
Ethyl Glyoxylate 
% in toluene 
Ethyl Glyoxylate 
equiv 
# of  
additions 
Conv. %  
(isolated yield %)
a 
  1 35 2 1 NDP; SM insoluble
b 
  2 35 2 1 65 (49) 
  3
 
35 2 1 62
c 
  4
 
35 2 1 34
d 
  5
 
35 2 1 26
e 
  6 35 1.5 2 78 
  7 35 1.5 2 85
f 
  8 88 1 3 85 
  9
 
88 1 3 95
g
 
a 
R = C6F5 unless otherwise noted; 
b 
Toluene instead of CH2Cl2; 
c
 40 °C; 
d 
DCE, 80 °C; 
e 
R = Mesityl; 
f
 0.35 
equiv NHC catalyst; 
g 
1.5 equiv Et3N; 
 
3.3.8 Investigation of Proposed Dieckmann Cyclization 
Reduction of 53a catalyzed by (arene)RuCl(monosulfonamide) proceeded as expected providing 
highly diastereo- and enantioenriched alcohol 55a (Scheme 3-17).
20
 The catalyst robustness is 
showcased as the reaction proceeded to completion even at much lower catalyst loadings than previously 
reported (2% vs. 0.3%) albeit in longer reaction times. With alcohol 55a in hand, we began investigation 
of the proposed formal (4+1)-annulation. This annulation required the installation of a “phosgene 
equivalent” prone to Dieckmann cyclization upon base promoted enolate formation. We initially chose 
ethyl cyanoformate (Mander’s reagent) to fill this need which provided carbonate 56 in quantitative yield.
34 
Scheme 3-17. DKR-ATH of ,-Diketo--Aryl Ester 53a and Formation of Carbonate 56 
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 Investigation of the proposed Dieckmann condensation
35
 commenced with the use of three 
common, non-nucleophilic bases under kinetic conditions (Table 3-4). LDA provided partial conversion to 
a mixture of three products while NaHMDS and KHMDS provided complete conversion to the same set of 
products (entires 1-3). The desired product, lactone 44a, is formed via ketone enolate formation followed 
by Dieckmann cyclization resulting in the liberation of ethoxide (Scheme 3-18). Alcohol 55a is likely 
formed by nucleophilic attack of this ethoxide on carbonate 56, and epimerized carbonate 58 is likely 
formed as a result of slow Dieckmann cyclization allowing proton transfer to form the more 
thermodynamically stable enolate. We postulated that a greater ratio of 44a to all other products could be 
obtained if the “phosgene equivalent” was not only more electrophilic thereby reducing the potential for 
anion “walking” but also liberated a less nucleophilic anion upon Dieckmann cyclization. Switching to an 
acyl imidazole activator, which could be formed in excellent yield utilizing 1,1-carbonyldiimidazole,
36
 
provided more acceptable ratios of desired product to undesired side products (entries 4 and 5). Careful 
control of reaction conditions further increased the amount of desired product formed allowing its isolation 
in high yield and >20:1 dr (entry 7). 
Table 3-4. Optimization of Dieckmann Cyclization 
 
Entry R = Base Conditions Result: 44a:55a:58 Isolated Yields (%) 
1 OEt LDA A
 
4:1:0.7 -
a 
2 OEt NaHMDS A 1:1:0 44a (33%) 58 (31%) 
3 OEt KHMDS A 2:1:1 - 
4 im NaHMDS A 4:1:2 - 
5 im KHMDS A 17:3:1 - 
6 im NaHMDS B 3:1:1 - 
7 im KHMDS B 8:1:0 44a (88%) 
Conditions A: -78 °C to rt as the dewar warmed; Conditions B: -78 °C (15 min), 0 °C (1 h), rt (30 min); 
a
 90% conversion; 
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Scheme 3-18. Proposed Mechanism for Formation of 44a, 55a, and 58 
 
3.3.9 Reduction/Elimination Sequence for Installation of -Benzylidene 
Having developed a reliable, high yielding route to -keto lactone 44a, we required a method for 
its reduction to 43a. Conditions previously reported by Pohmakotr and coworkers for the reduction of 
similar -ketoaryl-lactones provided no reaction, but modification of the solvent system to increase 
starting material solubility smoothly provided 43a in high yield (Scheme 3-19).
31
 Formation of 34a via 
elimination proceeded in higher yield than our previous attempt when reaction temperature was 
optimized. Although this method provided 34a in acceptable yield, we also investigated solid-supported 
acid catalysts to eliminate the need for an aqueous work-up. Both Nafion
®
 SAC-13 (polymer supported 
perfluorosulfonic acid) and Amberlyst-15 (polymer supported sulfonic acid) provided full conversion, but 
Nafion
®
 SAC-13 generally provided better yields. 
Scheme 3-19. Preparation of -Benzylidene--Butyrolacone 34a 
 
 
3.3.10 Optimization of Ester Epimerization/Hydrolysis  
With key intermediate 34a in hand, we commenced investigation of the C4-ester 
epimerization/hydrolysis reported by Papin and coworkers in their racemic total synthesis of 1a (Table 3-
5).
18
 For simplicity, optimization results are reported as the ratio of desired product to summation of all 
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other piperonyl containing products excluding starting material 34a. In our hands, the previously reported 
conditions resulted in undesired side products (entry 1). Switching to NaOMe or NaOEt provided 
essentially identical results (entry 2 and 3). Increasing the loading of NaOMe provided a slight increase in 
desired product (entry 4), while use of NaO
t
Bu resulted in a slower reaction, but a more desirable ratio of 
product to side products (entry 5). Optimization of the reaction solvent further increased the ratio of 
desired product to side products and lengthening the reaction time provided full conversion (entries 6 and 
7). An interesting effect was observed when the combination of NaO
t
Bu and 
t
AmylOH was used for 
epimerization. Although this system provided full consumption of the starting material, the products 
initially isolated were a mixture of lactone 59a and ring opened diacid 60. After numerous attempts to 
reform the lactone by heating in solution or by acid catalysis, we discovered that allowing the mixture to 
sit at room temperature overnight under vacuum cleanly provided ring closure. Flash chromatography 
provided acid 59a as a chromatographically inseparable 14:1 mixture of diastereomers. 
Table 3-5. Optimization of C4 Epimerization 
 
Entry Base (equiv) Solvent T (°C) t (h) Result (59a:X:60) Yield 59a (%)
a 
1 LiOMe (1.2) MeOH 65 1 1.5:1:0 - 
2 NaOMe (1.2) MeOH 65 1 1.5:1:0 - 
3
 
NaOEt (1.2) EtOH 78 1 1.5:1:0 47 
4
 
NaOMe (5.0) MeOH 65 1 2:1:0 - 
5
 
NaO
t
Bu (1.2) 
i
PrOH rt 5 8:1:0 79
b 
6 NaO
t
Bu (2.0) 
t
AmylOH rt 3.5 10:1:0 71
b 
7 NaO
t
Bu (2.0) 
t
AmylOH rt 12 1.4:0:1.0 74 (14:1 dr) 
 a 
Isolated yield unless otherwise noted. 
b 
Conversion. 
3.3.11 Completion of the Total Synthesis of 1a 
The total synthesis of 1a was completed by boron tribromide demethylation of 59a (Scheme 3-
20). Purification by flash chromatography as well as aqueous workup were unsuccessful due to the 
presence of carboxylic acid impurities. These impurities also precluded purification via dicyclohexylamine 
salt formation. Ultimately, purification by reverse phase HPLC provided 1a in nine steps and 11% overall 
yield from simple, commercially available starting materials. 
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Scheme 3-20. Completion of Route to 1a 
 
3.3.12 Total Synthesis of 1b 
 The route to 1b followed an identical route to that used for 1a through the synthesis of alcohol 
43b which was obtained in 28% yield over seven steps from commercially available starting materials. 
(Scheme 3-21). When 43b was submitted to the elimination conditions optimized for 43a, only partial Boc 
deprotection was observed, even at elevated temperatures (100 °C) with no formation of the desired 
benzylidene 34b.  
Scheme 3-21. Preparation of 43b and Failed Extension of Elimination Conditions 
 
Considering the structural differences between 43b and 43a, the mechanism of elimination likely relied on 
resonance stabilization of the benzylic cation formed. In this regard, the aryl methyl ether of 43a would 
provide better stabilization than the electron withdrawing Boc group (Figure 3-6a). The absence of 34b, 
even when partial Boc deprotection had occurred, indicated that deprotection of the Boc group prior to 
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submission to the elimination conditions would likely not provide sufficient stabilization of the benzylic 
cation. We sought a solution to this problem that would obviate the necessity of electron rich arenes 
thereby providing a route more amenable to the synthesis of analogs. The Burgess reagent
37
 fit this need 
providing 34b as well as less electron rich -benzylidene--butyrolactones 34c and 34d, prepared via the 
same synthetic route (Figure 3-6b).
 
Figure 3-6. Structural Differences in 43a and 43b Leading to Reduced Reactivity and Use of the Burgess 
Reagent for Less Electron Rich Arenes 
 
An unexpected hurdle was encountered when 34b was submitted to the epimerization conditions 
optimized for 34a (Table 3-6). These conditions provided incomplete conversion, even over an extended 
reaction period (entry 1). Increasing the amount of base led to the formation of myriad products, likely due 
to varying degrees of Boc deprotection, making accurate determination of reaction outcome difficult (entry 
2). Increasing the reaction temperature still provided a complex mixture of products, but upon submission 
of the mixture to p-TsOH under thermal conditions two major products were observed: acid 59b and 
phenol 34e. Isolation of 34e clearly indicated that the epimerization had not gone to full conversion. 
Based on the fact that varying degrees of Boc deprotection was occurring during the reaction and 
hypothesizing this fact could negatively affect reaction outcome, we performed the reaction in the 
presence of added Boc2O to re-protect any free phenol formed (entry 4). Surprisingly, poor conversion 
was observed, leading us to postulate that Boc deprotection to phenol 34e followed by epimerization was 
the likely reaction course. Submitting phenol 34e to the epimerization conditions with additional base, 
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accounting for the phenol, resulted in complete conversion and isolation of the desired acid 59b as a 14:1 
mixture of chromatographically inseparable diastereomers without the need for p-TsOH hydrolysis step 
(entry 5). 
Table 3-6. Optimization of Conditions for C4 Epimerization 
 
Entry Cmpd NaO
t
Bu (equiv) T (°C) t (h) Result (59b:34e) 
1
a 
34b 2 rt 22 Incomplete conversion
a 
2
a 
34b 3 rt 18 Mess
a 
3 34b 2 40 4 3:1
 
4
a 
34b 2 40 6.5 1:0
a,b 
5 34e 3 40 6.5 1:0
a,c
 
 a
Not submitted to p-TsOH; 
b
 27% conversion 
c 
73%, 14:1 dr. 
The total synthesis of 1b was completed by acid promoted piperonyl deprotection (Scheme 3-22) 
and purification of the residue by reverse phase HPLC providing shimobashiric acid A in eleven steps and 
5% overall yield from simple, commercially available starting materials.  
Scheme 3-22. Completion of Route to 1b 
 
3.4 Conclusion 
 The first asymmetric total syntheses of structurally unique -benzylidene--butyrolactones 
megacerotonic acid and shimobashiric acid A have been reported via a route amenable to the synthesis 
of analogs. This route utilized DKR-ATH to set the absolute stereochemistry in excellent enantio- and 
diastereoselectivity, and diastereoselective Dieckmann cyclization formed the lactone core in high overall 
yield. Selective ketone reduction and subsequent elimination formed the -benzylidene with excellent E:Z 
selectivity. Epimerization at C4, hydrolysis, and phenol deprotection concluded the total syntheses. 
117 
3.5 Experimental Details 
Methods: Infrared (IR) spectra were obtained using a Jasco 260 Plus Fourier transform infrared 
spectrometer. Proton and carbon nuclear magnetic resonance spectra (
1
H NMR and 
13
C NMR) were 
recorded on a Bruker DRX 400 or 600 (
1
H NMR at 400 MHz or 600 MHz and 
13
C NMR at 100 or 150 
MHz) spectrometer with solvent resonance as the internal standard (
1
H NMR: CDCl3 at 7.26 ppm, 
acetone-d6 at 2.05 ppm, methanol-d4 at 3.30 ppm, D2O at 4.79 ppm; 
13
C NMR: CDCl3 at 77.0 ppm, 
acetone-d6 at 29.8 ppm, methanol-d4 at 49.0) or tetramethylsilane as the internal standard at 0.00 ppm. 
1
H NMR data are reported as follows: chemical shift, multiplicity (s = singlet, bs = broad singlet, d = 
doublet, dd = doublet of doublet, dt = doublet of triplets, ddd = doublet of doublet of doublets, t = triplet, q 
= quartet, m = multiplet), coupling constants (Hz), and integration. Supercritical fluid chromatography was 
performed on a Berger SFC system equipped with Chiralcel AD, AS, OD, and WO columns (φ 4.6 mm x 
250 mm). Samples were eluted with SFC grade CO2 at the indicated percentage of MeOH with an oven 
temperature of 40 °C. HPLC analysis was performed on an Agilent Technologies 1200 System equipped 
with Chiralpak IA, IB, and IC columns (constant flow at 1.00 mL/min). Optical rotations were measured 
using a 2 mL cell with a 1 dm path length on a Jasco DIP 1000 digital polarimeter. Mass spectra were 
obtained using a Thermo Scientific LTQ FT Ultra instrument with electrospray ionization (Note: All 
samples prepared in methanol with ammonium acetate, formic acid, or cesium acetate additives). Melting 
point data was collected on a Thomas Hoover Capillary Melting Point Apparatus and are uncorrected. 
Analytical thin layer chromatography (TLC) was performed on Sorbent Technologies Silica G 0.20 mm 
silica gel plates. Visualization was accomplished with UV light, aqueous basic potassium permanganate 
solution, or Seebach’s TLC stain followed by heating. Flash chromatography was performed using Silia-P 
flash silica gel (40-63 μm) purchased from Silicycle. Yield refers to isolated yield of analytically pure 
material unless otherwise noted.  
Materials: Triethylamine (Et3N) and tert-amyl alcohol (
t
AmylOH) were freshly distilled from calcium 
hydride prior to use. Sodium tert-amylate (NaO
t
Amyl) solution was prepared by reaction of sodium metal 
(cut into thin strips) with freshly distilled tert-amyl alcohol at 50 °C.  Dichloromethane (CH2Cl2), diethyl 
ether (Et2O), tetrahydrofuran (THF), and toluene were dried by passage through a column of neutral 
alumina under nitrogen prior to use. Ethyl glyoxylate was purchased from Sigma Aldrich or Alfa Aesar and 
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distilled according to a literature procedure immediately before use (the concentration after distillation was 
determined by 
1
H NMR spectroscopy).
33
 (R,R)-1,2-di(naphthyl)-1,2-ethanediamine-dihydrochloride salt
38
 
and m-terphenyl sulfonyl chloride
20
 were prepared according to literature procedures. All other reagents 
were purchased from commercial sources and used as received unless otherwise noted. Anhydrous 
dimethylformamide (DMF) and dimethylsulfoxide (DMSO) were purchased from Sigma Aldrich or Fisher 
Scientific.  
Preparation of (R,R)-N-(2-amino-1,2-di(naphthalene-1-yl)ethyl)-[m-terphenyl]-2-sulfonamide, L1 
 
To a 100 mL round-bottomed flask equipped with oversized magnetic stir bar containing 3M NaOH (18 
mL) and dichloromethane (18 mL) was added (R,R)-1,2-di(naphthyl)-1,2-ethanediamine-dihydrochloride 
salt (1.38 g, 3.58 mmol, 1.0 equiv). The resulting mixture was stirred vigorously for 14 h. The reaction was 
cooled to 0 °C and m-terphenyl sulfonyl chloride (1.18 g, 3.58 mmol, 1.0 equiv) was added. The reaction 
was allowed to warm to room temperature over 30 min. After 1.5 h at room temperature, the reaction was 
diluted with water (15 mL) and extracted with ethyl acetate (2 x 20 mL). The combined organic extracts 
were washed with brine, dried (Na2SO4) and concentrated. Flash chromatography (50% EtOAc/hexanes) 
provided L1 (1.04 g, 1.72 mmol, 48%) as an off-white solid. Analytical data for L1 matched that previously 
reported.
20 
Preparation of -Butyrolactone 37 
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To a flame-dried 250 mL round-bottomed flask equipped with magnetic stir bar were added [RuCl2(p-
cymene)]2 (65.6 mg, 0.107 mmol, 0.005 equiv), ligand L1 (259 mg, 0.428 mmol, 0.02 equiv), and 
anhydrous DMF (30 mL). The resulting solution was stirred under a N2 atmosphere at 70 °C. After 1 h, the 
reaction solution was cooled to room temperature and a solution of -keto--aryl ester 36 (7.85 g, 21.4 
mmol, 1.0 equiv) in DMF (20 mL) was added. The reaction solution was diluted with DMF (57 mL) and 
formic acid:triethylamine azeotrope (5:2, 9.3 mL, 107 mmol, 5.0 equiv) was added. The resulting solution 
was heated to 70 °C. After 20 h, the reaction was cooled to room temperature and diluted with water (200 
mL) and extracted with ethyl acetate (250 mL, 50 mL). The combined organic extracts were washed with 
water (2 x 150 mL), brine (75 mL), dried (Na2SO4) and concentrated to give crude -butyrolactone 37 as a 
19:1 mixture of diastereomers. The diastereomer ratio was determined by 
1
H NMR spectroscopic analysis 
of the crude reaction mixture by comparison of the integration of resonances at  5.11 (major 
diastereomer) and  4.82 (minor diastereomer). HPLC Analysis: Chiralpak IB column, 15% 
Isopropanol/Hexanes, 1.0 mL/min, 210 nm; tmajor = 15.2 min tminor = 18.4 min, 90:10 er.  
The crude product was eluted over a plug of silica gel with a mixture of ethyl acetate/hexanes (30/70, 300 
mL). The resulting oil was recrystallized from diethyl ether/hexanes to yield -butyrolactone 37 (3.55 g, 
10.6 mmol, 49% yield, >20:1 dr) as white crystalline solid. Analytical data for 37: 
1
H NMR (600 MHz, 
CDCl3):  6.76 (d, J = 7.8 Hz, 1H), 6.68-6.66 (m, 2H), 5.95 (s, 2H), 5.12 (d, J = 8.5 Hz, 1H), 4.41 (dd, J = 
11.5, 8.5 Hz, 1H), 4.13 (d, J = 11.5 Hz, 1H), 4.00-3.94 (m, 1H), 3.92-3.87 (m, 1H), 3.79 (s, 3H), 0.97 (t, J 
= 7.1 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  170.3, 167.7, 167.2, 148.2, 147.8, 126.1, 120.9, 108.6, 
107.8, 101.4, 78.9, 61.8, 53.3, 49.1, 47.6, 13.7; IR (thin film, cm
-1
): 1793, 1741, 1507, 1143, 1038; m.p. 
85-87 °C; TLC (30% EtOAc/hexanes) Rf : 0.26; HRMS (ESI): Calculated for [M+Na]+ C16H16NaO8: 
359.0743, Found: 359.0738; HPLC Analysis: Chiralpak IB column, 15% Isopropanol/Hexanes, 1.0 
mL/min, 210 nm; tmajor = 15.2 min tminor = 18.4 min, 93:7 er; []D
25
 +195.8 (c = 0.25, MeOH). 
Preparation of -Butyrolactone 38 
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To a 1-dram vial were added -butyrolactone 37, potassium carbonate (51.4 mg, 0.372 mmol, 2.5 equiv), 
18-crown-6 (2.0 mg, 0.007 mmol, 0.05 equiv), and dibromomethane (0.5 mL). The resulting slurry was 
stirred vigorously. After 4.5 days, the reaction was partitioned between ethyl acetate (5 mL) and water (5 
mL). The aqueous layer was separated and extracted with ethyl acetate (5 mL). The combined organic 
extracts were washed with brine (5 mL), dried (Na2SO4) and concentrated to give crude -butyrolactone 
38 as a single diastereomer. Flash chromatography (25-30% ethyl acetate/hexanes) provided -
butyrolactone 38 (55.8 mg, 0.130 mmol, 87% yield) as white solid.  Analytical data for 38: 
1
H NMR (600 
MHz, CDCl3):  6.71-6.69 (m, 1H), 6.64-6.63 (m, 2H), 5.93 (d, J = 1.3 Hz, 1H), 5.36 (d, J = 8.4 Hz, 1H), 
4.14 (d, J = 8.4 Hz, 1H), 4.02-3.94 (m, 3H), 3.90 (d, J = 10.8 Hz, 1H), 3.43 (s, 3H), 0.97 (t, J = 7.1 Hz, 
3H); 
13
C NMR (150 MHz, CDCl3):  170.3, 166.3, 166.2, 147.8, 147.6, 127.3, 122.8, 109.2, 108.1, 101.4, 
78.1, 61.7, 61.6, 52.9, 52.3, 33.1, 13.7; IR (thin film, cm
-1
): 2983, 1799, 1742, 1490, 1447, 1038, 736; 
m.p. 130-132 °C; TLC (30% EtOAc/hexanes) Rf : 0.21; HRMS (ESI): Calculated for [M+Na]+ 
C17H17BrNaO8: 451.0004, Found: 451.0001; []D
25
 +110.3 (c = 0.20, MeOH). 
Preparation of -Methylidene--Butyrolactone 35 
 
To a 20 mL scintillation vial were added -butyrolactone 38 (639.5 mg, 1.49 mmol, 1.0 equiv), lithium 
chloride (126 mg, 2.98 mmol, 2.0 equiv), and anhydrous DMSO (10 mL). The reaction vial was purged 
with N2 and heated to 130 °C. After 5.5 h the reaction was cooled to room temperature and partitioned 
between ethyl acetate (25 mL) and water (25 mL). The aqueous layer was separated and extracted with 
ethyl acetate (15 mL). The combined organic extracts were washed with water (10 mL), brine (10 mL), 
dried (Na2SO4) and concentrated. Flash chromatography (20-30% ethyl acetate/hexanes) provided -
methylidene--butyrolactone 35 (245 mg, 0.844 mmol, 57% yield) as a viscous very pale orange oil. 
Analytical data for 35: 
1
H NMR (600 MHz, CDCl3):  6.77 (d, J = 8.0 Hz, 1H), 6.68 (dd, J = 8.0, 1.8 Hz, 
1H), 6.64 (d, J = 1.8 Hz, 1H), 6.51 (d, J = 3.3 Hz, 1H), 5.95 (d, J = 1.8 Hz, 2H), 5.62 (d, J = 3.0 Hz, 1H), 
5.13 (d, J = 9.3 Hz, 1H), 4.52, (dt, J = 9.3, 3.1 Hz, 1H), 3.94-3.89 (m, 1H), 3.84-3.79 (m, 1H), 0.97 (t, J = 
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7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  169.2, 167.7, 148.0, 147.6, 135.9, 128.6, 125.0, 122.7, 108.9, 
108.4, 101.3, 78.4, 61.6, 48.3, 13.7; IR (thin film, cm
-1
): 2985, 2904, 1780, 1746, 1490, 1446, 1095, 1068, 
1038, 736; TLC (30% EtOAc/hexanes) Rf : 0.26; HRMS (ESI): Calculated for [M+H]+ C15H15O6: 291.0869, 
Found: 291.0864 []D
25
 +256.2 (c = 0.13, MeOH). 
Preparation of -Benzylidene--Butyrolactone 34a Via Heck Coupling 
 
To a flame-dried 1-dram vial equipped with magnetic stir bar were added -methylene--butyrolactone 35 
(26 mg, 0.09 mmol, 1.0 equiv), 4-iodoanisole (23.4 mg, 0.10 mmol, 1.1 equiv), palladium(II) acetate (3.0 
mg, 0.013 mmol, 15 mol %) and DMF (400 L) under an atmosphere of air. Triethylamine (38 L, 0.27 
mmol, 3.0 equiv) was added and the resulting mixture heated to 70 °C. After 20 h, the reaction was 
cooled to rt and diluted with ethyl acetate (5 mL), washed with water (2 x 5 mL), brine (5 mL), dried 
(Na2SO4) and concentrated. The crude product was purified by flash chromatography to yield 34a (6.6 
mg, 0.017 mmol, 19%) as a clear oil. Analytical data for 34a matched that reported above. 
Attempt 1 at Preparation of -Benzylidene--Butyrolactone 34a Via Cross Metathesis 
 
To a flame-dried 1-dram vial sealed with Teflon puncture cap under N2 equipped with magnetic stir bar 
containing Grubbs second generation catalyst (1.8 mg, 0.002 mmol, 2.5 mol %) was added a solution of 
-methylene--butyrolactone 35 (25 mg, 0.09 mmol, 1.0 equiv) and 4-vinylanisole (17 g, 0.13 mmol, 1.5 
equiv) in dichloromethane (200 L) at room temperature. The resulting solution was heated to 50 °C. 
After 20 h the reaction was concentrated on rotary evaporator. 
1
H NMR of the crude product showed no 
conversion of -methylene--butyrolactone 35 to desired product 34a. 
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Attempt 2 at Preparation of -Benzylidene--Butyrolactone 34a Via Cross Metathesis 
 
To a flame-dried 1-dram vial sealed with Teflon puncture cap under N2 equipped with magnetic stir bar 
containing Grubbs second generation catalyst (3.6 mg, 0.004 mmol, 5.0 mol %) and 
chlorodiphenylphosphine (1.2 L, 0.10 mmol, 10 mol %) was added a solution of -methylene--
butyrolactone 35 (25 mg, 0.09 mmol, 1.0 equiv) and 4-vinylanisole (17 g, 0.13 mmol, 1.5 equiv) in 
dichloromethane (200 L) at room temperature. The resulting solution was heated to 50 °C. After 20 h the 
reaction was concentrated on rotary evaporator. 
1
H NMR of the crude product showed no conversion of 
-methylene--butyrolactone 35 to desired product 34a. 
Preparation of -Butyrolactone 42 
 
To a 100 mL round-bottomed flask were added -butyrolactone 37 (1.00 g, 2.97 mmol, 1.0 equiv), lithium 
chloride (252 mg, 5.95 mmol, 2.0 equiv), anhydrous DMSO (30 mL), and water (0.6 mL). The reaction 
flask was purged with N2 and heated to 140 °C. After 19 h, the reaction was cooled to room temperature 
and partitioned between ethyl acetate (50 mL) and water (50 mL). The aqueous layer was separated and 
extracted with ethyl acetate (25 mL). The combined organic extracts were washed with water (2 x 20 mL), 
brine (15 mL), dried (Na2SO4) and concentrated. Flash chromatography (30% ethyl acetate/hexanes) 
provided -butyrolactone 42 (723 mg, 2.60 mmol, 87% yield) as a pale yellow solid. Analytical data for 42: 
1
H NMR (600 MHz, CDCl3):  6.75 (d, J = 7.9 Hz, 1H), 6.68-6.65 (m, 2H), 5.94 (s, 2H), 5.07 (d, J = 8.2 Hz, 
1H), 4.03-3.98 (m, 2H), 3.98-3.92 (m, 1H), 3.90-3.85 (m, 1H), 2.98 (dd, J = 17.3, 10.1 Hz, 1H), 2.81 (dd, J 
= 17.3, 8.7 Hz, 1H), 0.97 (t, J = 7.1 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  175.1, 167.9, 148.0, 147.4, 
128.4, 120.8, 108.4, 107.8, 101.3, 80.1, 61.4, 43.8, 32.5, 13.7; IR (thin film, cm
-1
): 2984, 2904, 1793, 
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1742, 1506, 1447, 1038, 818; m.p. 80-81 °C; TLC (30% EtOAc/hexanes) Rf : 0.21; HRMS (ESI): 
Calculated for [M+H]+ C14H15O6: 279.0869, Found: 279.0866; []D
25
 +118.5 (c = 0.22, MeOH). 
Preparation of -Butyrolactone 43a Via Aldol Reaction 
 
To a flame-dried 1 dram vial equipped with magnetic stir bar containing diisopropylamine (53 L, 0.38 
mmol, 2.1 equiv) at 0 °C was added a solution of n-butyl lithium in hexanes (0.21 mL, 2.0 equiv). After 15 
min, tetrahydrofuran (0.4 mL) was added. The resulting solution was cooled to -78 °C and a solution of -
butyrolactone 42 (50 mg, 0.180 mmol, 1.0 equiv) in tetrahydrofuran (1.0 mL) was added dropwise. After 
15 min, neat p-anisaldehyde (22 L, 0.180 mmol, 1.0 equiv) was added dropwise. After 10 min, the 
reaction was quenched with aqueous saturated ammonium chloride (2 mL) and allowed to warm to room 
temperature. The resulting mixture was diluted with water (2 mL) and extracted with ethyl acetate (2 x 5 
mL). The combined organic extracts were washed with brine, dried (Na2SO4) and concentrated. Flash 
chromatography (20-40% ethyl acetate/hexanes) provided 43a (33 mg, 0.079 mmol, 44%) as a 2:1 
mixture of diastereomers. 
Preparation of -Benzylidene--Butyrolactone 34a Via Elimination 
 
To a solution of alcohol 43a (27 mg, 0.065 mmol, 1.0 equiv) in toluene (5 mL) was added p-
toluenesulfonic acid (5 mg, 20 wt%). The resulting mixture was heated to 160 °C under nitrogen. After 1 h 
the reaction was cooled to room temperature and concentrated.  Flash chromatography (30% ethyl 
acetate/hexanes) provided 34a (13.4 mg, 0.034 mmol, 52%, >20:1 E:Z) as a clear oil. Analytical data for 
34a matched that shown above. 
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Preparation of -Keto Ester 49 
 
To a flame dried 50 mL 2-neck round bottomed flask fitted with reflux condensor under nitrogen were 
added sodium hydride (60% in mineral oil, unwashed, 800 mg, 20.0 mmol, 2.0 equiv) and THF (4 mL). To 
the resulting suspension was added a solution of 4-methoxyacetophenone (1.5 g, 10 mmol, 1.0 equiv) in 
THF (8 mL) in a single portion. After stirring for 30 min, dimethylcarbonate (4.63 mL, 55.0 mmol, 5.5 
equiv) was added and the reaction heated to reflux. After 9 h, the reaction was cooled to room 
temperature, brought to pH = 4 with 3M AcOH, and extracted with Et2O (2x). The combined organic 
extracts were washed with aqueous saturated NaHCO3, brine, dried (Na2SO4) and concentrated in vacuo 
to give a biphasic mixture of clear oil and orange colored oil. The neat mixture was washed with hexanes 
(3x) to give 49 (1.93 g, 9.27 mmol, 93%) as an orange oil. Analytical data for 49: 
1
H NMR (400 MHz, 
CDCl3):  7.93 (d, J = 8.9 Hz, 2H), 6.95 (d, J = 8.9 Hz, 2H), 3.96 (s, 2H), 3.88 (s, 3H), 3.75 (s, 3H). 
Preparation of Benzylidene 46 
 
To a flame dried round bottomed flask fitted with Dean-Stark trap were added -keto ester 49 (1.00 g, 
4.80 mmol, 1.0 equiv), piperonal (865 mg, 5.76 mmol, 1.2 equiv), piperidine (3 drops) and acetic acid (3 
drops). The resulting solution was heated to reflux for 21 h. After cooling to and diluting with H2O, the 
mixture was extracted with EtOAc. The organic extract was washed with brine, dried (Na2SO4) and 
concentrated to give an orange oil. Flash chromatography (EtOAc/hexanes 20/80 to 30/70) provide 46 
(1.28g, 3.76 mmol, 78%, 25:1 E:Z) as an off-white solid. Analytical data for 46: 
1
H NMR (400 MHz, 
CDCl3):   7.93 (d, J = 8.9 Hz, 2H), 7.83 (s, 1H), 6.96 – 6.92 (m, 1H), 6.91 (d, J = 8.9 Hz, 2H), 6.80 (d, J = 
1.8 Hz, 1H), 6.70 (d, J = 8.1 Hz, 1H), 5.91 (s, 3H), 3.85 (s, 4H), 3.74 (s, 4H). 
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Preparation of ,-Diketo Ester 45 
 
To a flame-dried round-bottomed flask equipped with magnetic stir bar were added benzylidene 46 (300 
mg, 0.881 mmol, 1.0 equiv), triazolium salt (64 mg, 0.18 mmol, 0.2 equiv), and freshly distilled ethyl 
glyoxylate solution (492 mg, 1.76 mmol, 2.0 equiv, 43% in toluene). The flask was sealed with a rubber 
septum and purged with nitrogen. Dichloromethane (1.7 mL, 0.5 M) followed by triethylamine (123 L, 
0.88 mmol, 1.0 equiv) were then added. After 14 h, the reaction was diluted with H2O and CH2Cl2. The 
organic extract was washed with brine, dried (Na2SO4), and concentrated in vacuo to give a red/orange 
oil (1.8:1 dr). Flash chromatography (EtOAc/hexanes 25/75) provided 45 (362 mg, 0.818 mmol, 93%, 
1.8:1 dr). Analytical data for 45: Major diastereomer: 
1
H NMR (400 MHz, CDCl3):  8.04 (d, J = 9.0, 2H), 
6.94 (d, J = 9.0, 2H), 6.82 – 6.74 (m, 3H), 5.96 (q, J = 1.4 Hz, 2H), 5.39 (d, J = 11.4 Hz, 1H), 5.03 (d, J = 
11.4, 1H), 4.38 – 4.13 (m, 2H), 3.87 (s, 2H), 3.47 (s, 3H), 1.30 (t, J = 7.1, 3H). Minor diastereomer: 
1
H 
NMR (400 MHz, CDCl3):  7.92 – 7.82 (m, 2H), 6.86 (dd, J = 8.9, 1.2 Hz, 2H), 6.71 (d, J = 1.7 Hz, 1H), 
6.66 (dd, J = 8.0, 1.6 Hz, 1H), 6.62 – 6.54 (m, 1H), 5.83 (s, 2H), 5.47 – 5.40 (m, 1H), 5.24 (d, J = 
11.6,1H), 4.38-4.13 (m, 2H) 3.84 (s, 2H), 3.66 (s, 2H), 1.30 (t, J = 7.1 Hz, 6H). 
 
Preparation of Enone 54a 
 
To a solution of piperonal (12.29 g, 81.9 mmol, 1.0 equiv) and 4-methoxyacetophenone (12.29 g, 81.9 
mmol, 1.0 equiv) in ethanol (40 mL) was added 10% aqueous sodium hydroxide (2.4 mL). After 22 h, the 
yellow suspension was diluted with ethanol/water (50/50, 50 mL). Suction filtration and washing with 
ethanol/water (50/50, 150 mL) provided 54a (22.7 g, 80.3 mmol, 98% yield) as a yellow solid. Analytical 
data for 54a: 
1
H NMR (600 MHz, CDCl3):  8.06 – 7.96 (m, 2H), 7.72 (d, J = 15.5 Hz, 1H), 7.38 (d, J = 
126 
15.5 Hz, 1H), 7.16 (d, J = 1.7 Hz, 1H), 7.14 – 7.09 (m, 1H), 6.97 (d, J = 8.8 Hz, 2H), 6.83 (d, J = 8.0 Hz, 
1H), 6.02 (s, 2H), 3.88 (s, 3H).; 
13
C NMR (150 MHz, CDCl3)  188.5, 163.3, 149.7, 148.3, 143.8, 131.2, 
130.7, 129.5, 125.0, 119.8, 113.8, 108.6, 106.6, 101.6, 55.5; IR (thin film, cm
-1
): 1652, 1602, 1506, 1036; 
m.p. 130-131 °C; TLC (20% EtOAc/hexanes) Rf : 0.22; HRMS (ESI): Calculated for [M+H]+ C17H15O4: 
283.0970, Found: 283.0965. 
Preparation of Enone S1 
 
To a solution of piperonal (750 mg, 5.0 mmol, 1.0 equiv) and acetovanillone (830 mg, 5.0 mmol, 1.0 
equiv) in methanol (15 mL) was added 40% aqueous sodium hydroxide (5 mL). After 25 h, the reaction 
was diluted with water (20 mL) and brought to pH = 0 with concentrated hydrochloric acid resulting in 
warming of the reaction solution. After cooling to room temperature and stirring for 4.5 h, suction filtration 
provided S1 (692 mg, 2.3 mmol, 46% yield) as a bright yellow solid. Analytical data for S1 matched that 
previously reported.
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Preparation of Enone 54c 
 
To a solution of piperonal (2.25 g, 15.0 mmol, 1.0 equiv) and 4-ethylacetophenone (2.22 g, 15.0 mmol, 
1.0 equiv) in ethanol (40 mL) was added 40% aqueous sodium hydroxide (1.5 mL). After 15 h, the yellow 
suspension was diluted with water (30 mL). Suction filtration and washing with ethanol/water (50/50, 40 
mL) provided 54c (3.95 g, 14.1 mmol, 94% yield) as a yellow solid. Analytical data for 54c: 
1
H NMR (600 
MHz, CDCl3)  7.98 – 7.93 (m, 2H), 7.73 (d, J = 15.6 Hz, 1H), 7.38 (d, J = 15.5 Hz, 1H), 7.34 – 7.30 (m, 
2H), 7.17 (d, J = 1.7 Hz, 1H), 7.12 (dd, J = 8.0, 1.7 Hz, 1H), 6.85 (d, J = 8.0 Hz, 1H), 6.03 (s, 2H), 2.73 (q, 
J = 7.6 Hz, 2H), 1.28 (t, J = 7.6 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):
 
 189.9, 149.8, 149.6, 148.4, 144.2, 
136.0, 129.5, 128.6, 128.1, 125.1, 120.2, 108.6, 106.6, 101.6, 29.0, 15.2; IR (thin film, cm
-1
): 1652, 1580, 
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1500, 1362, 991; m.p. 105-106 °C; TLC (20% EtOAc/hexanes) Rf : 0.38; HRMS (ESI): Calculated for 
[M+H]+ C18H17O3: 281.1178, Found: 281.1173. 
Preparation of Enone 54d 
 
To a solution of piperonal (1.50 g, 9.99 mmol, 1.0 equiv) and 2-fluoroacetophenone (1.38 g, 9.99 mmol, 
1.0 equiv) in ethanol (15 mL) was added 40% aqueous sodium hydroxide (1 mL). After 5 h, the yellow 
suspension was diluted with water (45 mL). Suction filtration provided 54d (2.56 g, 9.47 mmol, 95% yield) 
as a yellow solid. Analytical data for 54d: 
1
H NMR (600 MHz, CDCl3):  7.80 (td, J = 7.5, 1.9 Hz, 1H), 7.66 
(dd, J = 15.7, 1.8 Hz, 1H), 7.51 (dddd, J = 8.3, 7.1, 5.0, 1.8 Hz, 1H), 7.28 – 7.13 (m, 4H), 7.12 – 7.09 (m, 
1H), 6.84 (d, J = 8.0 Hz, 1H), 6.02 (s, 2H); 
13
C NMR (150 MHz, CDCl3):  188.9 (d, J = 2.4 Hz), 161.1 (d, 
J = 253.0 Hz), 150.1, 148.4, 144.8, 133.7 (d, J = 8.8 Hz), 130.9 (d, J = 2.7 Hz), 129.2, 127.3 (d, J = 13.4 
Hz), 125.5, 124.5 (d, J = 3.4 Hz), 123.7 (d, J = 6.6 Hz), 116.5 (d, J = 23.2 Hz), 108.7, 106.8, 101.6; IR 
(thin film, cm
-1
): 1655, 1454, 930, 766; m.p. 127-128 °C; TLC (20% EtOAc/hexanes) Rf : 0.35; HRMS 
(ESI): Calculated for [M+H]+ C16H12FO3: 271.0770, Found: 271.0765. 
Tert-Butoxycarbonylation of Enone 54b 
 
To 50 mL round-bottomed flask equipped with magnetic stir bar containing a semi-solution of enone S1 
(676 mg, 2.27 mmol, 1.0 equiv) and 18-crown-6 (60 mg, 0.23 mmol, 0.10 equiv) in ethyl acetate (10 mL) 
was added potassium carbonate (471 mg, 3.41 mmol, 1.5 equiv) followed by di-tert-butyl dicarbonate 
(495 mg, 2.27 mmol, 1.0 equiv). The resulting orange suspension was stirred at room temperature. After 
27 h, the reaction was partitioned between ethyl acetate (25 mL) and water (25 mL). The aqueous layer 
was extracted with ethyl acetate (10 mL). The combined organic extracts were washed with brine (15 
mL), dried (Na2SO4) and concentrated to provide 54b (904 mg, 2.27 mmol, 100% yield) as a crystalline, 
yellow solid. Analytical data for 54b:  
1
H NMR (600 MHz, CDCl3):  7.74 (d, J = 15.5 Hz, 1H), 7.64 (d, J = 
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1.9 Hz, 1H), 7.60 (dd, J = 8.2, 1.9 Hz, 1H), 7.33 (d, J = 15.5 Hz, 1H), 7.24 (d, J = 8.2 Hz, 1H), 7.16 (d, J = 
1.7 Hz, 1H), 7.12 (dd, J = 8.2, 1.7 Hz, 1H), 6.85 (d, J = 8.0 Hz, 1H), 6.03 (s, 2H), 3.94 (s, 3H), 1.56 (s, 
9H); 
13
C NMR (150 MHz, CDCl3)  189.0, 151.6, 150.8, 150.0, 148.4, 144.9, 143.8, 137.0, 129.3, 125.3, 
122.3, 121.5, 119.7, 112.1, 108.7, 106.6, 101.6, 83.9, 56.1, 27.6; IR (thin film, cm
-1
): 1761, 1661, 1585, 
1506, 805; m.p. 141-143 °C; TLC (20% EtOAc/hexanes) Rf : 0.22; HRMS (ESI): Calculated for [M+H]+ 
C22H23O7: 399.1444, Found: 399.1440. 
General Procedure A for the Preparation of -Substituted-,-Diketo Esters 53a-d 
 
To a flame-dried round-bottomed flask equipped with magnetic stir bar were added enone 54a-d (1.0 
equiv), triazolium salt (0.2 equiv), and freshly distilled ethyl glyoxylate solution (1.0 equiv, ~90% in 
toluene). The flask was sealed with a rubber septum and purged with nitrogen. Dichloromethane (0.5 M) 
followed by triethylamine (1.5 equiv) were then added. After 1.5 h and 5 h additional ethyl glyoxylate 
solution (1.0 equiv, respectively) was added. After 24 h, the reaction was concentrated in vacuo and 
purified by flash chromatography using the indicated solvent system. 
Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-5-(4-methoxyphenyl)-2,5-
dioxopentanoate (53a): The title compound was prepared according to 
General Procedure A: enone 54a (5.00 g, 17.7 mmol), triazolium salt (1.28 g, 
3.53 mmol), ethyl glyoxylate (3 x 2.0 g, 3 x 17.7 mmol), dichloromethane (35.3 
mL), triethylamine (3.69 mL, 26.5 mmol). Flash chromatography (20-40% EtOAc/hexanes) provided 53a 
(6.70 g, contained 4% enone which could not be efficiently separated) as a clear, viscous oil. This 
material was reduced in its entirety (vide infra). In another experiment an analytically pure sample was 
obtained by careful selection of a clean fraction. Analytical data for 53a: 
1
H NMR (600 MHz, CDCl3):  
7.98 – 7.70 (m, 2H), 6.98 – 6.87 (m, 2H), 6.83 (d, J = 1.7 Hz, 1H), 6.81 – 6.70 (m, 2H), 6.01 – 5.86 (m, 
2H), 5.04 (dd, J = 10.6, 3.9 Hz, 1H), 4.43 – 4.20 (m, 2H), 3.91 (dd, J = 17.9, 10.6 Hz, 1H), 3.86 (d, J = 1.6 
129 
Hz, 3H), 3.36 (dd, J = 17.9, 3.9 Hz, 1H), 1.32 (t, J = 7.2 Hz, 2H). 
13
C NMR (150 MHz, CDCl3):  195.8, 
192.0, 163.8, 160.4, 148.2, 147.3, 130.4, 128.9, 128.8, 122.3, 113.7, 109.1, 108.7, 101.2, 62.5, 55.5, 
47.8, 42.9, 13.9; IR (thin film, cm
-1
): 2906, 1728, 1670, 1601, 1488, 1171, 1038; TLC (30% 
EtOAc/hexanes) Rf : 0.29; HRMS (ESI): Calculated for [M+Cs]+ C21H20CsO7: 517.0263, Found: 517.0265. 
Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-5-(4-((tert-butoxycarbonyl)oxy)-3-
methoxyphenyl)-2,5-dioxopentanoate (53b): The title compound was 
prepared according to General Procedure A: enone 54b (850 mg, 2.13 mmol), 
triazolium salt (155 mg, 0.426 mmol), ethyl glyoxylate (3 x 242 mg, 3 x 0.426 
mmol), dichloromethane (4.2 mL), triethylamine (0.45 mL, 3.2 mmol). Flash 
chromatography (20-25% EtOAc/hexanes) provided 53b (1.01 g, 2.02 mmol, 95% yield) as pale yellow 
solid. Analytical data for 53b: 
1
H NMR (600 MHz, CDCl3):  7.56 – 7.53 (m, 2H), 7.22 – 7.14 (m, 1H), 6.81 
(d, J = 1.5 Hz, 1H), 6.80 – 6.74 (m, 2H), 5.94 (d, J = 2.6 Hz, 2H), 5.04 (dd, J = 10.4, 4.0 Hz, 1H), 4.33 – 
4.24 (m, 2H), 3.91 (dd, J = 18.1, 10.4 Hz, 1H), 3.88 (s, 3H), 3.38 (dd, J = 18.1, 4.0 Hz, 1H), 1.54 (s, 9H), 
1.32 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  196.2, 191.8, 160.3, 151.5, 150.6, 148.2, 147.4, 
144.4, 134.5, 128.4, 122.4, 122.4, 121.5, 111.5, 109.0, 108.8, 101.2, 84.0, 62.5, 56.0, 47.9, 42.9, 27.5, 
13.9; IR (thin film, cm
-1
): 2982, 1762, 1730, 1683, 1506, 1488, 1146, 1039, 738; m.p. 108-109 °C TLC 
(30% EtOAc/hexanes) Rf : 0.29; HRMS (ESI): Calculated for [M+H]+ C26H29O10: 501.1761, Found: 
501.1758. 
Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-5-(4-ethylphenyl)-2,5-dioxopentanoate 
(53c): The title compound was prepared according to General Procedure A: 
enone 54c (3.90 g, 13.9 mmol), triazolium salt (1.01 g, 2.78 mmol), ethyl 
glyoxylate (3 x 1.58 g, 3 x 13.9 mmol), dichloromethane (28 mL), triethylamine 
(2.9 mL, 21 mmol). Flash chromatography (10-15% EtOAc/hexanes) provided 53c (5.30 g, 13.9 mmol, 
99% yield) as a viscous yellow oil. Analytical data for 53c: 
1
H NMR (600 MHz, CDCl3):  7.87 (d, J = 8.3 
Hz, 2H), 7.28 – 7.26 (d, J = 8.4 Hz, 2H), 6.83 (d, J = 1.8 Hz, 1H), 6.81 – 6.73 (m, 2H), 5.94 (d, J = 3.0 Hz, 
2H), 5.05 (dd, J = 10.5, 3.9 Hz, 1H), 4.35 – 4.24 (m, 2H), 3.94 (dd, J = 18.1, 10.5 Hz, 1H), 3.39 (dd, J = 
18.1, 4.0 Hz, 1H), 2.69 (q, J = 7.6 Hz, 2H), 1.32 (t, J = 7.2 Hz, 3H), 1.24 (t, J = 7.6 Hz, 3H); 
13
C NMR (150 
MHz, CDCl3):  197.0, 191.9, 160.4, 150.5, 148.2, 147.3, 133.6, 128.7, 128.4, 128.1, 122.3, 109.1, 108.7, 
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101.2, 62.5, 47.8, 43.0, 28.9, 15.1, 13.9; IR (thin film, cm
-1
): 2968, 2935, 2905, 1729, 1678, 1607, 1488, 
1038, 766; TLC (30% EtOAc/hexanes) Rf : 0.28; HRMS (ESI): Calculated for [M+H]+ C22H23O6: 383.1495, 
Found: 383.1492. 
Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-5-(2-fluorophenyl)-2,5-dioxopentanoate 
(53d): The title compound was prepared according to General Procedure A: 
enone 54d (500 mg, 1.85 mmol), triazolium salt (134 mg, 0.37 mmol), ethyl 
glyoxylate (3 x 230 mg, 3 x 1.85 mmol), dichloromethane (3.7 mL), triethylamine 
(0.39 mL, 2.8 mmol). Flash chromatography (15-20% EtOAc/hexanes) provided 53d (685 mg, 1.84 mmol, 
99% yield) as a viscous yellow oil. Analytical data for 53d: 
1
H NMR (600 MHz, CDCl3):  7.86 (td, J = 7.6, 
1.9 Hz, 1H), 7.57 – 7.48 (m, 1H), 7.23 – 7.19 (m, 1H), 7.12 (ddd, J = 11.3, 8.3, 1.1 Hz, 1H), 6.80 (d, J = 
1.7 Hz, 1H), 6.78 – 6.74 (m, 2H), 5.94 – 5.92 (m, 2H), 5.05 (dd, J = 10.8, 3.7 Hz, 1H), 4.33 – 4.22 (m, 
2H), 3.95 (ddd, J = 18.9, 10.8, 3.3 Hz, 1H), 3.39 (dt, J = 18.9, 3.6 Hz, 1H), 1.32 (t, J = 7.2 Hz, 3H); 
13
C 
NMR (150 MHz, CDCl3):  195.4 (d, J = 4.1 Hz), 191.7, 162.2 (d, J = 255.7 Hz), 160.4, 148.1, 147.4, 
135.1 (d, J = 9.1 Hz), 130.6 (d, J = 2.3 Hz), 128.4, 124.5 (d, J = 3.3 Hz), 124.3 (d, J = 12.6 Hz), 122.4, 
116.7 (d, J = 23.7 Hz), 109.0, 108.7, 101.2, 62.5, 47.8 (d, J = 2.3 Hz), 47.6 (d, J = 8.5 Hz), 13.9; IR (thin 
film, cm
-1
): 2984, 2904, 1739, 1683, 1610, 1487, 1453, 1038, 768; TLC (20% EtOAc/hexanes) Rf : 0.21; 
HRMS (ESI): Calculated for [M+H]+ C20H18FO6: 373.1087, Found: 373.1087. 
General Procedure B for Preparation of Racemic -Keto--Hydroxy Esters ()-55a-d 
 
Lithium triethylborohydride (1.0 equiv, 1.0 M solution in THF) was added to a solution of -substituted ,-
diketo ester 53a-d (1.0 equiv) in THF (0.5 M concentration) at -78 °C. The reaction was allowed to stir at 
this temperature for 10 min and quenched with saturated ammonium chloride. The reaction was further 
diluted with diethyl ether and water. The organic layer was washed with brine, dried over sodium sulfate 
and concentrated in vacuo to give -keto -hydroxy esters ()-55a-d which were purified by flash 
chromatography using the indicated solvent systems. 
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General Procedure C for Preparation of Enantioenriched -Keto--Hydroxy Esters 55a-d 
 
To a flame-dried 20 mL scintillation vial equipped with magnetic stir bar were added [RuCl2(p-cymene)]2 
(0.3-0.4 mol %) and L1 (1.2-1.6 mol %). The vial was purged with nitrogen and DMSO (0.01 M) was 
added. The resulting solution was heated to 70 C. After 1 h, the red solution was cooled to room 
temperature and transferred via cannula to a solution of -keto ester 53a-d (1.0 equiv) in DMSO (0.6 M) 
under nitrogen. Formic acid/triethylamine azeotrope (5:2, 5.0 equiv) was added. After the indicated time 
period the reaction was diluted with water and extracted with ethyl acetate (2x). The combined organic 
extracts were washed with brine, dried (Na2SO4) and concentrated in vacuo. The crude product was 
purified by flash chromatography using the indicated solvent systems. 
(2S,3S)-Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-2-hydroxy-5-(4-methoxyphenyl)-
5-oxopentanoate (55a): The title compound was prepared according to 
General Procedure C: [RuCl2(p-cymene)]2 (32.5 mg, 0.053 mmol, 0.3 mol %), 
L1 (128 mg, 0.212 mmol, 12 mol %), DMSO (5.3 mL); -keto ester 53a (6.70 g, 
contained 4% enone from preparation, vide supra), DMSO (30 mL), formic acid/triethylamine azeotrope 
(5:2, 7.64 mL, 88.4 mmol, 5.0 equiv); 24 h. The diastereomer ratio (>20:1 dr) was determined by 
1
H NMR 
spectroscopic analysis of the crude reaction mixture in which no diastereomer was observed. Flash 
chromatography provided 55a (6.31 g, 16.3 mmol, 92% yield over 2 steps, >20:1 dr) as a pale yellow, 
viscous oil. Analytical data for 55a: 
1
H NMR (600 MHz, CDCl3):  7.98 – 7.95 (m, 2H), 6.95 – 6.89 (m, 
2H), 6.84 (d, J = 1.7 Hz, 1H), 6.75 – 6.67 (m, 2H), 5.90 (q, J = 1.6 Hz, 2H), 4.50 (dd, J = 6.1, 3.1 Hz, 1H), 
4.14 (qq, J = 7.4, 3.6 Hz, 2H), 3.86 (s, 4H), 3.62 (dd, J = 17.5, 8.1 Hz, 1H), 3.34 (dd, J = 17.5, 6.1 Hz, 
1H), 2.88 (d, J = 6.1 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  196.7, 173.7, 163.5, 
147.4, 146.6, 132.7, 130.3, 130.0, 121.8, 113.7, 108.9, 108.0, 100.9, 72.6, 61.8, 55.4, 43.4, 40.2, 14.2; IR 
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(thin film, cm
-1
): 3503, 2903, 1733, 1673, 1601, 1506, 1489, 1037; TLC (30% EtOAc/hexanes) Rf : 0.19; 
HRMS (ESI): Calculated for [M+H]+ C21H23O7: 387.1444, Found: 387.1440; SFC Analysis: AD column, 
20% MeOH, 1.5 mL/min, 150 bar, 210 nm; tmajor = 10.1 min, tminor = 13.5 min, 96:4 er; []D
25
 -17.9 (c = 
0.26, MeOH). 
(2S,3S)-Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-5-(4-((tert-butoxycarbonyl)oxy)-
3-methoxyphenyl)-2-hydroxy-5-oxopentanoate (55b): The title compound 
was prepared according to General Procedure C: [RuCl2(p-cymene)]2 (14.8 
mg, 0.024 mmol, 0.4 mol %), L1 (58.6 mg, 0.097 mmol, 16 mol %), DMSO 
(2.4 mL); -keto ester 53b (3.03 g, 6.06 mmol, 1.0 equiv), DMSO (9.7 mL), formic acid/triethylamine 
azeotrope (5:2, 2.62 mL, 30.3 mmol, 5.0 equiv); 28 h. The diastereomer ratio (>20:1 dr) was determined 
by 
1
H NMR spectroscopic analysis of the crude reaction mixture in which no diastereomer was observed. 
Flash chromatography provided 55b (2.92 g, 5.81 mmol, 96%, >20:1 dr) as a sticky, yellow foam. 
Analytical data for 55b: 
1
H NMR (600 MHz, CDCl3):  7.63 – 7.56 (m, 2H), 7.19 (d, J = 8.2 Hz, 1H), 6.82 
(d, J = 1.7 Hz, 1H), 6.74 – 6.67 (m, 2H), 5.90 (s, 2H), 4.49 (dd, J = 5.9, 3.1 Hz, 1H), 4.14 (qq, J = 7.4, 3.6 
Hz, 2H), 3.88 (s, 3H), 3.84 (ddd, J = 7.6, 6.4, 3.1 Hz, 1H), 3.61 (dd, J = 17.6, 7.7 Hz, 1H), 3.39 (dd, J = 
17.6, 6.4 Hz, 1H), 2.90 (d, J = 6.0 Hz, 1H), 1.54 (s, 9H), 1.25 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, 
CDCl3):  197.0, 173.5, 151.4, 150.7, 147.5, 146.7, 144.2, 135.5, 132.4, 122.4, 121.8, 121.4, 111.5, 
108.9, 108.0, 100.9, 83.9, 72.6, 61.8, 56.0, 43.4, 40.5, 27.5, 14.2; IR (thin film, cm
-1
): 3503, 2981, 1762, 
1684, 1506; TLC (30% EtOAc/hexanes) Rf : 0.19; HRMS (ESI): Calculated for [M+H]+ C26H31O10: 
503.1917, Found: 503.1921; SFC Analysis: AD column, 15% MeOH, 1.5 mL/min, 150 bar, 210 nm; tmajor 
= 7.4 min, tminor = 8.8 min, 97:3 er; []D
25
 +3.2 (c = 0.34, MeOH). 
(2S,3S)-Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-5-(4-ethylphenyl)-2-hydroxy-5-
oxopentanoate (55c): The title compound was prepared according to General 
Procedure C: [RuCl2(p-cymene)]2 (9.0 mg, 0.015 mmol, 0.3 mol %), L1 (35.5 mg, 
0.059 mmol, 12 mol %), DMSO (1.5 mL); -keto ester 53c (1.87 g, 4.89 mmol, 
1.0 equiv), DMSO (8.3 mL), formic acid/triethylamine azeotrope (5:2, 2.12 mL, 24.5 mmol, 5.0 equiv); 22 
h. The diastereomer ratio (>20:1 dr) was determined by 
1
H NMR spectroscopic analysis of the crude 
reaction mixture in which no diastereomer was observed. Flash chromatography provided 55c (1.84 g, 
133 
4.79 mmol, 98%, >20:1 dr) as a viscous pale yellow oil. Analytical data for 55c: 
1
H NMR (600 MHz, 
CDCl3):  7.91 (d, J = 8.3 Hz, 2H), 7.27 (d, J = 8.2 Hz, 2H), 6.84 (d, J = 1.7 Hz, 1H), 6.77 – 6.65 (m, 2H), 
5.90 (q, J = 1.5 Hz, 2H), 4.51 (dd, J = 6.1, 3.1 Hz, 1H), 4.15 (qq, J = 7.2, 3.6 Hz, 2H), 3.87 (ddd, J = 8.0, 
6.1, 3.1 Hz, 1H), 3.65 (dd, J = 17.7, 8.0 Hz, 1H), 3.38 (dd, J = 17.7, 6.1 Hz, 1H), 2.90 (d, J = 6.1 Hz, 1H), 
2.69 (q, J = 7.6 Hz, 2H), 1.25 (td, J = 7.4, 6.3 Hz, 6H); 
13
C NMR (150 MHz, CDCl3):  197.8, 173.7, 150.2, 
147.4, 146.6, 134.6, 132.6, 128.3, 128.0, 121.8, 108.9, 108.0, 100.9, 72.6, 61.8, 43.3, 40.5, 28.9, 15.1, 
14.2; IR (thin film, cm
-1
): 3502, 2968, 1733, 1683, 1505, 1489, 1038, 813; TLC (30% EtOAc/hexanes) Rf : 
0.28; HRMS (ESI): Calculated for [M+H]+ C22H25O6: 385.1651, Found: 385.1648; SFC Analysis: AD 
column, 20% MeOH, 1.5 mL/min, 150 bar, 210 nm; tmajor = 8.6 min, tminor = 10.6 min, 97:3 er; []D
25
 -11.8 
(c = 0.12, MeOH). 
(2S,3S)-Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-5-(2-fluorophenyl)-2-hydroxy-5-
oxopentanoate (14d): The title compound was prepared according to General 
Procedure C: [RuCl2(p-cymene)]2 (14.4 mg, 0.023 mmol, 0.3 mol %), L1 (56.8 mg, 
0.094 mmol, 12 mol %), DMSO (2.3 mL); -keto ester 53d (2.91 g, 7.82 mmol, 1.0 
equiv), DMSO (13.3 mL), formic acid/triethylamine azeotrope (5:2, 3.38 mL, 39.1 mmol, 5.0 equiv); 23 h. 
The diastereomer ratio (>20:1 dr) was determined by 
1
H NMR spectroscopic analysis of the crude 
reaction mixture in which no diastereomer was observed. Flash chromatography provided 55d (2.77 g, 
7.40 mmol, 95%, >20:1 dr) as a viscous pale yellow oil. Analytical data for 55d: 
1
H NMR (600 MHz, 
CDCl3):  7.82 (td, J = 7.6, 1.9 Hz, 1H), 7.51 (dddd, J = 8.3, 7.1, 5.0, 1.9 Hz, 1H), 7.20 (ddd, J = 8.0, 7.3, 
1.1 Hz, 1H), 7.13 (ddd, J = 11.3, 8.3, 1.1 Hz, 1H), 6.81 (d, J = 1.5 Hz, 1H), 6.74 – 6.65 (m, 2H), 5.91 – 
5.89 (m, 2H), 4.52 (dd, J = 6.2, 3.2 Hz, 1H), 4.15 (qq, J = 7.1, 3.6 Hz, 2H), 3.85 (dddd, J = 7.5, 6.2, 3.3, 
1.0 Hz, 1H), 3.67 (ddd, J = 18.5, 7.9, 2.9 Hz, 1H), 3.43 (ddd, J = 18.5, 6.2, 2.9 Hz, 1H), 2.84 (d, J = 6.3 
Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  196.5 (d, J = 4.3 Hz), 173.7, 161.9 (d, J = 
255.2 Hz), 147.4, 146.6, 134.6 (d, J = 9.0 Hz), 132.4, 130.5 (d, J = 2.6 Hz), 125.6 (d, J = 12.9 Hz), 124.4 
(d, J = 3.4 Hz), 121.9, 116.7 (d, J = 23.7 Hz), 109.0, 108.0, 100.9, 72.6, 61.8, 45.5 (d, J = 7.7 Hz), 43.1, 
14.2; IR (thin film, cm
-1
): 3502, 2983, 2902, 1733, 1685, 1609, 1488, 1452, 1098, 1038, 766; TLC (20% 
EtOAc/hexanes) Rf : 0.21; HRMS (ESI): Calculated for [M+H]+ C20H19FNaO6: 397.1063, Found: 
134 
397.1060; SFC Analysis: AD column, 20% MeOH, 1.5 mL/min, 150 bar, 210 nm; tminor = 6.8 min, tmajor = 
8.5 min, 98:2 er; []D
25
 -17.0 (c = 0.22, MeOH). 
Preparation of Carbonate 56 
 
To a flame-dried round-bottomed flask equipped with magnetic stir bar under nitrogen were added alcohol 
56 (787 mg, 2.04 mmol, 1 equiv), ethyl cyanoformate (323 L, 3.26 mmol, 1.6 equiv) and THF (10 mL). 
To the resulting solution was added Et3N (568 L, 4.07 mmol, 2.0 equiv) and the reaction immediately 
became turbid. The reaction was stirred for 12 h, quenched with aqueous saturated NH4Cl and diluted 
with H2O. The resulting mixture was extracted with Et2O (2x). The combined organic extracts were 
washed with brine, dried (MgSO4) and concentrated in vacuo to give 56 (971 mg, 2.11 mmol, >100%, 
contained small amount of residual THF and ethyl cyanoformate) as a clear oil. Analytical data for 55d: 
1
H 
NMR (400 MHz, CDCl3):  7.96 – 7.87 (m, 2H), 6.91 (d, J = 8.9 Hz, 2H), 6.88 (d, J = 1.7 Hz, 1H), 6.77 
(dd, J = 8.0, 1.8 Hz, 1H), 6.69 (d, J = 8.0 Hz, 1H), 5.91 (q, J = 1.5 Hz, 2H), 5.27 (d, J = 4.5 Hz, 1H), 4.25 – 
4.14 (m, 2H), 4.13 – 3.99 (m, 3H), 3.86 (s, 3H), 3.46 (dd, J = 17.5, 7.4 Hz, 1H), 3.35 (dd, J = 17.5, 6.7 Hz, 
1H), 1.31 (t, J = 7.1 Hz, 3H), 1.16 (t, J = 7.1 Hz, 3H). 
Preparation of -Keto Ester 44a from Carbonate 56 
 
To a flame-dried, round-bottomed flask equipped with magnetic stir bar under nitrogen was added a 
solution of sodium bis(trimethylsilyl)amide (0.055 mL, 0.109 mmol, 2.0 M in THF) followed by THF (200 
L). The flask was cooled to -78 °C and a solution of 56 (50 mg, 0.109 mmol, 1 equiv) in anhydrous 
tetrahydrofuran (0.1 M) was added dropwise. (Note: In a previous attempt, after 2 h at -78 °C the reaction 
was quenched with aqueous saturated NH4Cl at -78 °C: only starting material was recovered indicating 
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deprotonation does not occur at -78 °C) After 2 h, the reaction was allowed to warm to -50 °C for 30 min, 
to -30 °C for 30 min and finally to 0 °C for 2 h. The reaction was quenched with aqueous saturated NH4Cl, 
diluted with H2O, and extracted with Et2O. The combined organic extracts were washed with brine, dried 
(Na2SO4) and concentrated in vacuo to give a mixture of 44a and 58. Flash chromatography 
(acetone/petroleum ether 20/80) provided 44a (15 mg, 0.036 mmol, >20:1 dr, 33%) as a clear oil and 58 
(15.5 mg, 0.034 mmol, 31%) as a clear oil. Analytical data for 44a matched that shown below. Analytical 
data for 58: 
1
H NMR (600 MHz, CDCl3): 8.01 (d, J = 8.9 Hz, 2H), 6.98 – 6.91 (m, 2H), 6.87 (d, J = 1.6 Hz, 
1H), 6.79 (dd, J = 8.0, 1.7 Hz, 1H), 6.74 (d, J = 8.0 Hz, 1H), 5.94 (d, J = 1.4 Hz, 2H), 5.50 (d, J = 4.6 Hz, 
1H), 4.14 – 4.01 (m, 4H), 3.91 – 3.88 (m, 1H), 3.87 (d, J = 1.2 Hz, 3H), 2.93 – 2.69 (m, 2H), 1.16 (q, J = 
6.9 Hz, 6H). 
13
C NMR (150 MHz, CDCl3):  189.5, 171.1, 168.0, 164.5, 148.0, 147.6, 132.0, 128.3, 128.0, 
121.1, 114.0, 108.5, 108.0, 101.3, 79.3, 61.6, 55.6, 52.3, 46.7, 30.9, 29.6, 13.7. 
General Procedure D for Preparation of -Keto--Carboxy Imidazoles 57a-d 
 
To a flame-dried round-bottomed flask equipped with magnetic stir bar under nitrogen was added 1,1-
carbonyldiimidazole (1.5 equiv) and dichloromethane. To the resulting suspension was added a solution 
of -keto--hydroxy ester 55a-d (1.0 equiv) in dichloromethane. The reaction was stirred for the indicated 
time period then diluted with dichloromethane and water. The aqueous layer was extracted with 
dichloromethane. The combined organic extracts were dried (Na2SO4) and concentrated in vacuo. The 
crude product was purified by flash chromatography using the indicated solvent systems. 
(2S,3S)-3-(Benzo[d][1,3]dioxol-5-yl)-1-ethoxy-5-(4-methoxyphenyl)-1,5-
dioxopentan-2-yl 1H-imidazole-1-carboxylate (57a): The title compound was 
prepared according to General Procedure D: 1,1-carbonyldiimidazole (3.90 g, 
24.1 mmol), dichloromethane (32 mL), -keto--hydroxy ester 55a (6.20 g, 16.1 
136 
mmol); 19 h. Flash chromatography provided 57a (7.25 g, 15.1 mmol, 94% yield) as a white foam. 
Analytical data for 57a: 
1
H NMR (600 MHz, CDCl3):  8.11-8.10 (m, Hz, 1H), 7.93 – 7.88 (m, 2H), 7.39-
7.38 (m, 1H), 7.09 – 7.04 (m, 1H), 6.93 – 6.87 (m, 2H), 6.81 (d, J = 1.7 Hz, 1H), 6.80 – 6.70 (m, 2H), 5.92 
(s, 2H), 5.55 (d, J = 4.9 Hz, 1H), 4.23 – 4.02 (m, 3H), 3.84 (s, 3H), 3.50 (dd, J = 17.6, 8.0 Hz, 1H), 3.39 
(dd, J = 17.5, 6.0 Hz, 1H), 1.17 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  195.1, 167.3, 163.8, 
147.9, 147.8, 147.0, 137.0, 131.8, 130.8, 130.2, 129.3, 121.6, 117.1, 113.8, 108.4, 108.3, 101.1, 77.9, 
62.0, 55.4, 41.2, 39.8, 13.9; IR (thin film, cm
-1
): 2981, 1752, 1674, 1601, 1397, 1172, 1038, 733; TLC 
(50% EtOAc/hexanes) Rf : 0.11; HRMS (ESI): Calculated for [M-C3H3N2+MeOH]+ C23H25O9: 445.1499, 
Found: 445.1495; []D
25
 -6.3 (c = 0.26, MeOH). 
(2S,3S)-3-(Benzo[d][1,3]dioxol-5-yl)-5-(4-((tert-butoxycarbonyl)oxy)-3-
methoxyphenyl)-1-ethoxy-1,5-dioxopentan-2-yl 1H-imidazole-1-
carboxylate (57b): The title compound was prepared according to General 
Procedure D: 1,1-carbonyldiimidazole (248 mg, 1.53 mmol), dichloromethane 
(2.0 mL), -keto--hydroxy ester 55b (512 mg, 1.02 mmol); 2 h. Flash chromatography provided 57b (550 
mg, 0.93 mmol, 91% yield) as a white foam. Analytical data for 57b: 
1
H NMR (600 MHz, CDCl3):  8.12 (t, 
J = 1.0 Hz, 1H), 7.55 (d, J = 1.9 Hz, 1H), 7.53 (d, J = 8.2 Hz, 1H), 7.39 (t, J = 1.5 Hz, 1H), 7.19 (d, J = 8.2 
Hz, 1H), 7.08 (dd, J = 1.7, 0.8 Hz, 1H), 6.82 – 6.79 (m, 1H), 6.79 – 6.72 (m, 2H), 5.94 (s, 2H), 5.55 (d, J = 
5.0 Hz, 1H), 4.25 – 4.09 (m, 3H), 3.88 (s, 3H), 3.51 (dd, J = 17.8, 7.6 Hz, 1H), 3.45 (dd, J = 17.7, 6.4 Hz, 
1H), 1.54 (s, 9H), 1.20 (t, J = 7.1 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  195.5, 167.2, 151.6, 150.6, 
148.0, 147.9, 147.2, 144.5, 137.1, 134.9, 131.6, 131.0, 122.5, 121.7, 121.3, 117.1, 111.5, 108.4, 108.4, 
101.2, 84.1, 77.8, 62.1, 56.1, 41.2, 40.2, 27.5, 14.0; IR (thin film, cm
-1
): 2981, 1760, 164, 1506, 1396, 
1145, 737; TLC (50% EtOAc/hexanes) Rf : 0.19; HRMS (ESI): Calculated for [M-C3H3N2+MeOH]+ 
C28H30O12: 561.1972, Found: 561.1970; []D
25
 +10.8 (c = 0.32, MeOH). 
(2S,3S)-3-(Benzo[d][1,3]dioxol-5-yl)-1-ethoxy-5-(4-ethylphenyl)-1,5-
dioxopentan-2-yl 1H-imidazole-1-carboxylate (57c): The title compound was 
prepared according to General Procedure D: 1,1-carbonyldiimidazole (1.12 g, 
6.91 mmol), dichloromethane (9.2 mL), -keto--hydroxy ester 55c (1.77 g, 4.60 
137 
mmol); 3 h. Flash chromatography provided 57c (2.16 g, 4.51 mmol, 98% yield) as a white foam. 
Analytical data for 57c: 
1
H NMR (600 MHz, CDCl3):  8.11 (t, J = 1.0 Hz, 1H), 7.89 – 7.83 (m, 2H), 7.39 (t, 
J = 1.5 Hz, 1H), 7.30 – 7.23 (m, 2H), 7.08 (dd, J = 1.7, 0.8 Hz, 1H), 6.81 (d, J = 1.7 Hz, 1H), 6.80 – 6.73 
(m, 2H), 5.94 (s, 2H), 5.56 (d, J = 4.9 Hz, 1H), 4.27 – 4.05 (m, 3H), 3.54 (dd, J = 17.7, 7.9 Hz, 1H), 3.43 
(dd, J = 17.7, 6.1 Hz, 1H), 2.69 (q, J = 7.6 Hz, 2H), 1.24 (t, J = 7.6 Hz, 3H), 1.19 (t, J = 7.1 Hz, 3H); 
13
C 
NMR (150 MHz, CDCl3):  196.3, 167.3, 150.7, 148.0, 147.9, 147.1, 137.1, 134.1, 131.8, 130.9, 128.2, 
121.7, 117.1, 108.5, 108.4, 101.2, 77.9, 62.1, 41.2, 40.1, 28.9, 15.1, 14.0; IR (thin film, cm
-1
): 2969, 2935, 
1735, 1682, 1606, 1490, 1396, 1239, 1039, 735; TLC (30% EtOAc/hexanes) Rf : 0.08; HRMS (ESI): 
Calculated for [M-C3H3N2+MeOH]+ C24H27O8: 443.1706, Found: 443.1702; []D
25
 +1.8 (c = 0.29, MeOH). 
(2S,3S)-3-(Benzo[d][1,3]dioxol-5-yl)-1-ethoxy-5-(2-fluorophenyl)-1,5-
dioxopentan-2-yl 1H-imidazole-1-carboxylate (57d): The title compound was 
prepared according to General Procedure D: 1,1-carbonyldiimidazole (1.73 g, 10.7 
mmol), dichloromethane (14.2 mL), -keto--hydroxy ester 55d (2.66 g, 7.11 mmol); 
24 h. Flash chromatography provided 55d (3.19 g, 6.81 mmol, 96% yield) as a 
viscous pale yellow oil. Analytical data for 55d: 
1
H NMR (600 MHz, CDCl3):  8.10 (t, J = 1.1 Hz, 1H), 7.79 
(td, J = 7.6, 1.9 Hz, 1H), 7.54 – 7.46 (m, 1H), 7.38 (t, J = 1.5 Hz, 1H), 7.22 – 7.17 (m, 1H), 7.10 (ddd, J = 
11.4, 8.3, 1.1 Hz, 1H), 7.06 (dd, J = 1.7, 0.9 Hz, 1H), 6.79 (d, J = 1.7 Hz, 1H), 6.77 – 6.71 (m, 2H), 5.92 
(s, 2H), 5.53 (d, J = 5.0 Hz, 1H), 4.24 – 4.05 (m, 3H), 3.57 (ddd, J = 18.4, 7.7, 2.8 Hz, 1H), 3.46 (ddd, J = 
18.4, 6.4, 2.7 Hz, 1H), 1.19 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  195.0 (d, J = 3.9 Hz), 167.2 
, 161.8 (d, J = 254.2 Hz), 148.0 , 147.8 , 147.0 , 137.0 , 135.0 (d, J = 9.1 Hz), 131.5 , 130.8 , 130.6 (d, J = 
2.5 Hz), 124.9 (d, J = 12.6 Hz), 124.6 (d, J = 3.3 Hz), 121.7 , 117.0 , 116.7 (d, J = 24.0 Hz), 108.4 , 108.2 
, 101.1 , 77.8 , 62.0 , 45.2 (d, J = 8.2 Hz), 41.0 (d, J = 2.0 Hz), 13.9; IR (thin film, cm
-1
): 2905, 1749, 1685, 
1609, 1489, 1452, 1039, 765; TLC (30% EtOAc/hexanes) Rf : 0.08; HRMS (ESI): Calculated for [M-
C3H3N2+MeOH]+ C22H22FO8: 433.1299, Found:433.1295; []D
25
 -10.0 (c = 0.21, MeOH). 
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General Procedure E for Preparation of -Keto--Butyrolactones 44a-d 
 
To a flame-dried, oversized round-bottomed flask (500 mL-1000 mL) equipped with magnetic stir bar 
under nitrogen was added a solution of -keto--carboxy imidazole 57a-d (1 equiv) in anhydrous 
tetrahydrofuran (0.1 M). The flask was cooled to -78 °C and a solution of potassium 
bis(trimethylsilyl)amide (0.5 M in toluene) was added slowly as a steady stream. After 15 min, the reaction 
was warmed to 0 °C in an ice bath. After 1 h, the reaction was warmed to room temperature. After an 
additional 30 min, the reaction was quenched with aqueous saturated ammonium chloride, diluted with 
water, and extracted with diethyl ether (2x). The combined organic extracts were washed with brine, dried 
(MgSO4), and concentrated in vacuo. The crude product was purified by flash chromatography using the 
indicated solvent systems. 
 
Ethyl (2S,3S,4R)-3-(benzo[d][1,3]dioxol-5-yl)-4-(4-methoxybenzoyl)-5-
oxotetrahydrofuran-2-carboxylate (44a): The title compound was prepared 
according to General Procedure E: -keto--carboxy imidazole 57a (3.17 g, 6.60 
mmol), tetrahydrofuran (72 mL), potassium bis(trimethylsilyl)amide (13.2 mL, 
6.60 mmol). The diastereomer ratio (>20:1 dr) was determined by 
1
H NMR spectroscopic analysis of the 
crude reaction mixture in which no diastereomer was observed. Flash chromatography provided 44a 
(2.02 g, 4.90 mmol, 74% yield, >20:1 dr) as colorless viscous oil. Analytical data for 44a: 
1
H NMR (600 
MHz, CDCl3):  8.09 – 8.01 (m, 2H), 7.01 – 6.96 (m, 2H), 6.77 – 6.64 (m, 3H), 5.26 (d, J = 8.2 Hz, 1H), 
4.94 (d, J = 8.7 Hz, 1H), 4.66 (t, J = 8.4 Hz, 1H), 3.97 (ddq, J = 42.5, 10.8, 7.1 Hz, 2H), 3.88 (s, 3H), 1.00 
(t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  189.5, 171.1, 168.0, 164.5, 148.0, 147.6, 132.1, 128.3, 
128.1, 121.1, 114.1, 108.5, 108.0, 101.3, 79.3, 61.6, 55.6, 52.3, 46.8, 13.7; IR (thin film, cm
-1
): 2982, 
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1785, 1742, 1671, 1601, 1507, 1037; TLC (30% EtOAc/hexanes) Rf : 0.24; HRMS (ESI): Calculated for 
[M+H]+ C22H21O8: 413.1236, Found: 413.1237; []D
25
 +97.8 (c = 0.26, MeOH). 
 
Ethyl (2S,3S,4R)-3-(benzo[d][1,3]dioxol-5-yl)-4-(4-((tert-
butoxycarbonyl)oxy)-3-methoxybenzoyl)-5-oxotetrahydrofuran-2-
carboxylate (44b): The title compound was prepared according to General 
Procedure E: -keto--carboxy imidazole 57b (2.28 g, 3.83 mmol), 
tetrahydrofuran (38 mL), potassium bis(trimethylsilyl)amide (7.67 mL, 3.83 mmol); The diastereomer ratio 
(>20:1 dr) was determined by 
1
H NMR spectroscopic analysis of the crude reaction mixture in which no 
diastereomer was observed. Flash chromatography provided 44b (2.02 g, 4.90 mmol, 74% yield, >20:1 
dr) as a colorless solid. Analytical data for 44b: 
1
H NMR (600 MHz, CDCl3):  7.71 (dd, J = 8.3, 2.0 Hz, 
1H), 7.65 (d, J = 2.0 Hz, 1H), 7.30 – 7.24 (m, 1H), 6.72 (d, J = 8.0 Hz, 1H), 6.69 (d, J = 1.8 Hz, 1H), 6.65 
(dd, J = 8.1, 1.9 Hz, 1H), 5.93 (q, J = 1.4 Hz, 2H), 5.24 (d, J = 8.3 Hz, 1H), 4.97 (d, J = 9.2 Hz, 1H), 4.65 
(t, J = 8.7 Hz, 1H), 4.03 – 3.91 (m, 2H), 3.90 (s, 3H), 1.54 (s, 9H), 0.99 (t, J = 7.1 Hz, 3H); 
13
C NMR (150 
MHz, CDCl3):  190.4, 170.7, 168.0, 151.6, 150.5, 148.1, 147.7, 145.1, 133.9, 127.5, 123.4, 122.7, 121.0, 
112.6, 108.5, 107.9, 101.3, 84.1, 79.2, 61.7, 56.1, 52.4, 47.0, 27.5, 13.7; IR (thin film, cm
-1
): 2982, 1762, 
1684, 1507, 889; m.p. 68-70 °C; TLC (30% EtOAc/hexanes) Rf : 0.27; HRMS (ESI): Calculated for 
[M+Na]+ C27H28NaO11: 551.1529, Found: 551.1530; []D
25
 +156.0 (c = 0.14, MeOH). 
Ethyl (2S,3S,4R)-3-(benzo[d][1,3]dioxol-5-yl)-4-(4-ethylbenzoyl)-5-
oxotetrahydrofuran-2-carboxylate (44c): The title compound was prepared 
according to General Procedure E: -keto--carboxy imidazole 57c (2.08 g, 4.34 
mmol), tetrahydrofuran (47 mL), potassium bis(trimethylsilyl)amide (8.70 mL, 4.34 
mmol). The diastereomer ratio (>20:1 dr) was determined by 
1
H NMR spectroscopic analysis of the crude 
reaction mixture by comparison of the integration of resonances at  5.26 (major diastereomer) and  5.10 
(minor diastereomer). Flash chromatography provided 44c (1.23 g, 3.00 mmol, 69% yield, >20:1 dr) as a 
colorless, viscous oil. Analytical data for 44c: 
1
H NMR (600 MHz, CDCl3):  8.00 (d, J = 8.4 Hz, 1H), 7.36 
– 7.30 (m, 2H), 6.74 – 6.65 (m, 3H), 5.92 (t, J = 1.1 Hz, 2H), 5.25 (d, J = 8.3 Hz, 1H), 5.00 (d, J = 8.9 Hz, 
1H), 4.66 (t, J = 8.5 Hz, 1H), 3.97 (ddq, J = 41.5, 10.7, 7.1 Hz, 2H), 2.72 (q, J = 7.6 Hz, 2H), 1.25 (t, J = 
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7.6 Hz, 3H), 0.99 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  190.9, 170.9, 168.0, 151.6, 148.0, 
147.6, 133.0, 129.8, 128.4, 127.9, 121.0, 108.5, 108.0, 101.3, 79.2, 61.6, 52.3, 46.8, 29.0, 15.0, 13.7; IR 
(thin film, cm
-1
): 2969, 1787, 1741, 1680, 1606, 1505, 1038, 737; TLC (30% EtOAc/hexanes) Rf : 0.35; 
HRMS (ESI): Calculated for [M+H]+ C23H23O7: 411.1444, Found: 411.1441; []D
25
 +131.1 (c = 0.58, 
MeOH). 
Ethyl (2S,3S,4R)-3-(benzo[d][1,3]dioxol-5-yl)-4-(2-fluorobenzoyl)-5-
oxotetrahydrofuran-2-carboxylate (44d): The title compound was prepared 
according to General Procedure E: -keto--carboxy imidazole 57d (3.09 g, 6.60 
mmol), tetrahydrofuran (66 mL), potassium bis(trimethylsilyl)amide (13.2 mL, 6.60 
mmol);The keto/enol ratio (7:1) was determined by 
1
H NMR spectroscopic analysis by comparison of the 
integration of resonances at  5.94 (keto) and  5.79 (enol). The diastereomer ratio (>20:1 dr) was 
determined by 
1
H NMR spectroscopic analysis of the crude reaction mixture in which no diastereomer 
was observed. Flash chromatography provided 44d (1.62 g, 4.05 mmol, 61% yield, 4:1 mixture of keto 
(>20:1 dr) to enol tautomers) as a colorless, viscous oil. Analytical data for 44d: 
1
H NMR  (Keto tautomer, 
600 MHz, CDCl3):  7.89 (td, J = 7.6, 1.8 Hz, 1H), 7.63 – 7.57 (m, 1H), 7.30 – 7.25 (m, 1H), 7.19 (ddd, J = 
11.6, 8.3, 1.1 Hz, 1H), 6.77 – 6.68 (m, 3H), 5.94 (s, 2H), 5.17 (d, J = 8.4 Hz, 1H), 5.14 (dd, J = 10.1, 2.2 
Hz, 1H), 4.64 (ddd, J = 10.4, 8.4, 2.3 Hz, 1H), 3.98 (ddq, J = 47.0, 10.8, 7.2 Hz, 2H), 1.02 (t, J = 7.2 Hz, 
3H); 
1
H NMR  (Enol tautomer, 600 MHz, CDCl3):  11.66 (s, 1H), 7.02 (td, J = 7.6, 1.1 Hz, 1H), 6.86 (ddd, 
J = 10.6, 8.3, 1.1 Hz, 1H), 6.82 – 6.78 (m, 1H), 6.45 (d, J = 7.9 Hz, 1H), 6.42 – 6.36 (m, 2H), 5.79 (d, J = 
10.7 Hz, 1H), 5.25 (d, J = 9.5 Hz, 1H), 4.72 (d, J = 9.5 Hz, 1H), 3.78 (ddq, J = 69.5, 10.9, 7.2 Hz, 2H), 
0.91 (t, J = 7.1 Hz, 3H); 
13
C NMR (Keto tautomer, 150 MHz, CDCl3):  190.1 (d, J = 3.5 Hz), 170.5, 167.9, 
162.2 (d, J = 256.1 Hz), 148.1, 147.7, 136.0 (d, J = 9.5 Hz), 131.4 (d, J = 1.7 Hz), 127.3, 124.8 (d, J = 3.3 
Hz), 121.1, 117.1, 116.9, 108.5, 108.0, 101.3, 78.9, 61.7, 55.4 (d, J = 8.3 Hz), 46.5, 13.7; 
13
C NMR (Enol 
tautomer, 150 MHz, CDCl3):  175.5, 167.2, 164.4, 158.8 (d, J = 251.8 Hz), 147.7, 132.5 (d, J = 8.7 Hz), 
129.7, 129.3 (d, J = 2.6 Hz), 124.2 (d, J = 10.7 Hz), 124.0 (d, J = 3.4 Hz), 122.2, 115.7, 115.6, 108.7, 
107.6, 101.4, 100.9, 79.9, 61.4, 46.0 (d, J = 7.8 Hz), 13.6; IR (thin film, cm
-1
): 1791, 1747, 1685, 1609, 
1506, 1490, 1454, 1038, 766; TLC (30% EtOAc/hexanes) Rf : 0.27; HRMS (ESI): Calculated for [M+H]+ 
C21H18FO7: 401.1037, Found: 401.1033; []D
25
 +66.4 (c = 0.14, MeOH). 
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General Procedure F for Reduction of -Keto--Butyrolactones 43a-d 
 
To a round-bottomed flask equipped with magnetic stir bar containing a suspension of 10% palladium on 
carbon (100 mg/mmol) in absolute ethanol under nitrogen was added a solution of -keto--
butyrolactones 44a-d in ethyl acetate. The flask was either purged with hydrogen (balloon) and vigorously 
stirred at room temperature under a hydrogen atmosphere for 1 h or placed in Parr bomb, cycled with 
nitrogen (3 x 25 psi), hydrogen (3 x 50 psi), then held at 50 psi hydrogen and stirred vigorously for 1h. 
The crude reaction mixture was filtered over a plug of silica gel eluting with ethyl acetate and 
concentrated in vacuo. The alcohol was used without further purification unless otherwise noted.  
Ethyl (2S,3S,4R)-3-(benzo[d][1,3]dioxol-5-yl)-4-((R)-hydroxy(4-
methoxyphenyl)methyl)-5-oxotetrahydrofuran-2-carboxylate (43a): The title 
compound was prepared according to General Procedure F: Pd/C (153 mg), 
ethanol (6.0 mL), -keto--butyrolactone 44a (629 mg, 1.53 mmol), ethyl acetate 
(6.0 mL), hydrogen (balloon). Filtration and concentration provided 43a (620 mg, 1.50 mmol, 98%, 8:1 dr). 
The diastereomer ratio was determined by 
1
H NMR spectroscopic analysis of the crude reaction mixture 
by comparison of the integration of resonances at  4.95 (major diastereomer) and  4.97 (minor 
diastereomer).  Analytical data for 43a: 
1
H NMR (600 MHz, CDCl3):  7.15 (d, J = 8.7 Hz, 2H), 6.72 – 6.68 
(m, 2H), 6.60 (d, J = 8.0 Hz, 1H), 6.44 (dd, J = 8.0, 1.9 Hz, 1H), 6.39 (d, J = 1.8 Hz, 1H), 5.88 (d, J = 0.9 
Hz, 2H), 4.94 (d, J = 6.4 Hz, 1H), 4.83 (d, J = 8.8 Hz, 1H), 3.97 – 3.78 (m, 2H), 3.73 (s, 3H), 3.69 (dd, J = 
11.1, 8.8 Hz, 1H), 3.44 (dd, J = 11.1, 6.5 Hz, 1H), 0.94 (t, J = 7.1 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  
176.7, 168.1, 159.5, 147.5, 147.0, 131.4, 127.8, 127.6, 121.4, 113.7, 113.6, 108.1, 108.0, 101.1, 78.9, 
73.8, 61.6, 55.2, 49.6, 47.0, 13.7; IR (thin film, cm
-1
): 3503, 2903, 1781, 1613, 1513, 1446, 1038, 736; 
TLC (30% EtOAc/hexanes) Rf : 0.16; HRMS (ESI): Calculated for [M+Na]+ C22H22NaO8: 437.1212, 
Found: 437.1211; []D
25
 +158.2 (c = 0.18, MeOH). 
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Ethyl (2S,3S,4R)-3-(benzo[d][1,3]dioxol-5-yl)-4-((R)-(4-((tert-
butoxycarbonyl)oxy)-3-methoxyphenyl)(hydroxy)methyl)-5-
oxotetrahydrofuran-2-carboxylate (43b): The title compound was prepared 
according to General Procedure F: Pd/C (9.5 mg), ethanol (0.5 mL), -keto--
butyrolactone 44b (50 mg, 0.095 mmol), ethyl acetate (0.5 mL), hydrogen (50 psi). Filtration and 
concentration provided 43b (50 mg, 0.094 mmol, 99%, >20:1 dr). The diastereomer ratio was determined 
by 
1
H NMR spectroscopic analysis of the crude reaction mixture. Analytical data for 43b: 
1
H NMR (600 
MHz, CDCl3):  6.91 (d, J = 8.1 Hz, 1H), 6.88 (d, J = 2.0 Hz, 1H), 6.76 (dd, J = 8.2, 1.9 Hz, 1H), 6.60 (d, J 
= 7.9 Hz, 1H), 6.46 – 6.41 (m, 2H), 5.89 (s, 2H), 4.94 (d, J = 6.3 Hz, 1H), 4.83 (d, J = 8.9 Hz, 1H), 3.95 – 
3.77 (m, 2H), 3.74 (s, 3H), 3.72 (d, J = 2.6 Hz, 1H), 3.71 – 3.65 (m, 1H), 3.46 (dd, J = 11.5, 6.2 Hz, 1H), 
1.51 (s, 9H), 0.92 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  176.5, 168.1, 151.14, 151.06, 147.7, 
147.2, 139.9, 138.2, 127.1, 122.0, 121.2, 118.8, 110.8, 108.1, 107.7, 101.2, 83.3, 78.8, 73.7, 61.6, 55.8, 
49.0, 46.9, 27.5, 13.6; IR (thin film, cm
-1
): 3503, 2982, 1761, 1507, 1146, 1037, 738; TLC (30% 
EtOAc/hexanes) Rf : 0.14; HRMS (ESI): Calculated for [M+Na]+ C27H30NaO11: 553.1686, Found: 
553.1685; []D
25
 +110.7 (c = 0.18, MeOH). 
Ethyl (2S,3S,4R)-3-(benzo[d][1,3]dioxol-5-yl)-4-((R)-(4-
ethylphenyl)(hydroxy)methyl)-5-oxotetrahydrofuran-2-carboxylate (43c): The 
title compound was prepared according to General Procedure F: Pd/C (380 mg), 
ethanol (15 mL), -keto--butyrolactone 44c (1.56 g, 3.80 mmol), ethyl acetate (15 
mL), hydrogen (50 psi). Flash chromatography provided 43c (1.15 g, 2.79 mmol, 73%, 3:1 dr). Analytical 
data for 43c: 
1
H NMR (Major Diastereomer, 600 MHz, CDCl3):  7.13 (d, J = 7.9 Hz, 2H), 6.99 (d, J = 7.9 
Hz, 2H), 6.57 (d, J = 8.0 Hz, 1H), 6.43 – 6.38 (m, 2H), 5.86 (s, 2H), 4.94 (d, J = 6.5 Hz, 1H), 4.82 (d, J = 
8.9 Hz, 1H), 3.95 – 3.77 (m, 2H), 3.71 (dd, J = 11.1, 8.8 Hz, 1H), 3.65 – 3.63 (bs, 1H), 3.44 (dd, J = 11.1, 
6.5 Hz, 1H), 2.52 (q, J = 7.5 Hz, 3H), 1.12 (t, J = 7.6 Hz, 3H), 0.92 (t, J = 7.1 Hz, 3H); 
13
C NMR (Major 
Diastereomer, 150 MHz, CDCl3):  176.7, 168.1, 147.4, 146.9, 144.3, 136.4, 127.7, 126.5, 125.4, 121.3, 
108.02, 107.99, 101.0, 78.8, 73.9, 61.5, 49.4, 46.9, 28.4, 15.6, 13.6; IR (thin film, cm
-1
): 3504, 2965, 1781, 
1506, 1491, 1446, 1039, 737; TLC (30% EtOAc/hexanes) Rf : 0.27; HRMS (ESI): Calculated for [M+Na]+ 
C23H24NaO7: 435.1420, Found: 435.1416; []D
25
 +150.9 (c = 0.34, MeOH). 
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Ethyl (2S,3S,4R)-3-(benzo[d][1,3]dioxol-5-yl)-4-((R)-(2-
fluorophenyl)(hydroxy)methyl)-5-oxotetrahydrofuran-2-carboxylate (43d): The 
title compound was prepared according to General Procedure F: Pd/C (138 mg), 
ethanol (15 mL), -keto--butyrolactone 44d (1.38 g, 3.45 mmol), ethyl acetate (15 
mL), hydrogen (balloon). Filtration and concentration provided 43d (1.38 g, 3.42 mmol, 99%, 7:1 dr). 
Analytical data for 43d: 
1
H NMR (600 MHz, CDCl3):  7.47 (td, J = 7.5, 1.9 Hz, 1H), 7.09 – 7.03 (m, 1H), 
7.01 (td, J = 7.5, 1.3 Hz, 1H), 6.70 (ddd, J = 10.7, 8.1, 1.3 Hz, 1H), 6.54 (d, J = 7.9 Hz, 1H), 6.43 – 6.38 
(m, 2H), 5.85 (dd, J = 8.1, 1.5 Hz, 2H), 5.21 (dd, J = 7.6, 2.5 Hz, 1H), 4.96 (d, J = 8.9 Hz, 1H), 4.10 (d, J = 
2.8 Hz, 1H), 3.97 – 3.77 (m, 3H), 3.42 (dd, J = 12.1, 7.6 Hz, 1H), 0.92 (t, J = 7.1 Hz, 3H); 
13
C NMR (150 
MHz, CDCl3):  177.0, 168.1, 159.3 (d, J = 244.9 Hz), 147.4, 147.0, 129.5 (d, J = 8.6 Hz), 127.9 (d, J = 
3.8 Hz), 126.9 (d, J = 12.6 Hz), 126.3, 124.2 (d, J = 3.3 Hz), 121.2, 114.8 (d, J = 21.8 Hz), 108.0, 107.7, 
101.1, 78.9, 67.3 (d, J = 2.9 Hz), 61.6, 48.0, 47.0, 13.6; IR (thin film, cm
-1
): 3503, 2902, 1790, 1743, 1506, 
1490, 1454, 1038, 761; TLC (30% EtOAc/hexanes) Rf : 0.19; HRMS (ESI): Calculated for [M+Na]+ 
C21H20FO7: 403.1193, Found: 403.1193; []D
25
 +42.1 (c = 0.15, MeOH). 
Preparation of -Benzylidene--Butyrolactone 34a 
 
To a flame-dried 100 mL round-bottomed flask equipped with magnetic stir bar were added alcohol 43a 
(1.80 g, 4.34 mmol) and dry toluene (43.4 mL). To the resulting solution was added Nafion
®
 SAC-13 (434 
mg, 100 mg/mmol). The flask was sealed with a rubber septum, purged with nitrogen, stirred, and heated 
to 75 °C. After 23 h the reaction was filtered (sintered glass funnel, ethyl acetate rinse). Flash 
chromatography (25-30% ethyl acetate/hexanes) provided 34a (1.20 g, 3.03 mmol, 70%, >20:1 E:Z). 
Analytical data for 34a: 
1
H NMR (600 MHz, CDCl3):  7.73 (d, J = 2.1 Hz, 1H), 7.29 (d, J = 8.9 Hz, 2H), 
6.80 (d, J = 8.8 Hz, 2H), 6.70 (d, J = 1.2 Hz, 2H), 6.66 (d, J = 1.2 Hz, 1H), 5.90 (dd, J = 13.9, 1.5 Hz, 2H), 
5.16 (d, J = 8.1 Hz, 1H), 4.77 (dd, J = 8.1, 2.2 Hz, 1H), 3.95 – 3.79 (m, 2H), 3.78 (s, 3H), 1.03 (t, J = 7.2 
Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  171.4, 167.1, 161.3, 147.9, 147.4, 139.7, 132.8, 129.5, 125.9, 
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122.5, 122.3, 114.2, 108.8, 108.3, 101.2, 78.6, 61.4, 55.3, 47.0, 13.8; IR (thin film, cm
-1
): 1757, 1645, 
1602, 1558, 1166, 1037; m.p. 109-110 °C;  TLC (30% EtOAc/hexanes) Rf : 0.18; HRMS (ESI): Calculated 
for [M+H]+ C22H21O7: 397.1287, Found: 397.1284; []D
25
 +389.5 (c = 0.20, MeOH). 
General Procedure G for Preparation of -Benzylidene--Butyrolactones 34b-d 
 
To a flame-dried scintillation vial equipped with magnetic stir bar were added alcohol 43b-d (275 mg, 1.0 
equiv) and toluene. To the resulting solution was added methyl N-(triethylammoniumsulfonyl)carbamate 
(2.0 equiv). The resulting mixture was heated to 80 °C under nitrogen. After 1.5 h the reaction was 
concentrated and purified by flash chromatography using the indicated solvent systems. 
Ethyl (2S,3R)-3-(benzo[d][1,3]dioxol-5-yl)-4-((E)-4-((tert-
butoxycarbonyl)oxy)-3-methoxybenzylidene)-5-oxotetrahydrofuran-2-
carboxylate (34b): The title compound was prepared according to General 
Procedure G: alcohol 43b (275 mg, 0.518 mmol, 1.0 equiv), toluene (5.2 mL), 
methyl N-(triethylammoniumsulfonyl)carbamate (Burgess reagent, 247 mg, 1.04 mmol, 2.0 equiv). Flash 
chromatography (20% acetone/petroleum ether) provided 34b (163 mg, 0.318 mmol, 61%, >20:1 E:Z) as 
a white foam. Analytical data for 34b: 
1
H NMR (600 MHz, CDCl3):  7.74 (d, J = 2.2 Hz, 1H), 7.06 (d, J = 
8.2 Hz, 1H), 6.97 (dd, J = 8.3, 2.0 Hz, 1H), 6.85 (d, J = 2.0 Hz, 1H), 6.73 – 6.67 (m, 2H), 6.64 (d, J = 1.6 
Hz, 1H), 5.91 (dd, J = 6.6, 1.4 Hz, 2H), 5.16 (d, J = 8.0 Hz, 1H), 4.77 (dd, J = 8.0, 2.2 Hz, 1H), 3.87 (ddq, 
J = 59.4, 10.8, 7.1 Hz, 2H), 3.63 (s, 3H), 1.52 (s, 9H), 1.03 (t, J = 7.1 Hz, 3H); 
13
C NMR (150 MHz, 
CDCl3):  170.9, 166.9, 151.2, 150.9, 148.1, 147.6, 141.7, 139.4, 131.9, 129.4, 125.4, 124.5, 122.8, 
122.2, 113.9, 108.7, 108.3, 101.3, 83.9, 78.7, 61.5, 55.9, 47.0, 27.5, 13.8; IR (thin film, cm
-1
): 1761, 1507, 
1256, 1146, 1036, 737; TLC (30% EtOAc/hexanes) Rf : 018; HRMS (ESI): Calculated for [M+H]+ 
C27H29O10: 513.1761, Found: 513.1759; []D
25
 +133.3 (c = 0.14, MeOH). 
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Ethyl (2S,3R)-3-(benzo[d][1,3]dioxol-5-yl)-4-((E)-4-ethylbenzylidene)-5-
oxotetrahydrofuran-2-carboxylate (34c): The title compound was prepared 
according to General Procedure G: alcohol 43c (200 mg, 0.485 mmol, 1.0 equiv), 
toluene (4.9 mL), methyl N-(triethylammoniumsulfonyl)carbamate (Burgess 
reagent, 231 mg, 0.97 mmol, 2.00 equiv). Flash chromatography (15% acetone/petroleum ether) provided 
34c (80 mg, 0.203 mmol, 42%, >20:1 E:Z) as a white foam. Analytical data for 34c: 
1
H NMR (600 MHz, 
CDCl3):  7.76 (d, J = 2.1 Hz, 1H), 7.27 (d, J = 8.2 Hz, 2H), 7.12 (d, J = 8.0 Hz, 2H), 6.71 (d, J = 1.3 Hz, 
2H), 6.66 (t, J = 1.1 Hz, 1H), 5.90 (dd, J = 16.4, 1.4 Hz, 2H), 5.16 (d, J = 8.0 Hz, 1H), 4.78 (dd, J = 8.0, 
2.2 Hz, 1H), 3.88 (ddq, J = 55.3, 10.7, 7.2 Hz, 2H), 2.61 (q, J = 7.6 Hz, 2H), 1.19 (t, J = 7.6 Hz, 3H), 1.04 
(t, J = 7.1 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  171.2, 167.0, 147.9, 147.3, 147.3, 140.0, 131.0, 130.6, 
129.6, 128.3, 124.5, 122.3, 108.8, 108.3, 101.2, 78.7, 61.4, 47.1, 28.7, 15.1, 13.8; IR (thin film, cm
-1
): 
2968, 2932, 1760, 1645, 1488, 1171, 1038, 736; m.p. 106-107 °C;  TLC (30% EtOAc/hexanes) Rf : 0.26; 
HRMS (ESI): Calculated for [M+H]+ C23H23O6: 395.1495, Found: 395.1492; []D
25
 +333.7 (c = 0.17, 
MeOH). 
Ethyl (2S,3R)-3-(benzo[d][1,3]dioxol-5-yl)-4-((E)-2-fluorobenzylidene)-5-
oxotetrahydrofuran-2-carboxylate (34d): The title compound was prepared 
according to General Procedure G: alcohol 43d (402 mg, 1.00 mmol, 1.00 equiv), 
toluene (10 mL), methyl N-(triethylammoniumsulfonyl)carbamate (Burgess reagent, 
477 mg, 2.00 mmol, 2.00 equiv). Flash chromatography (20% acetone/petroleum ether) provided 34d 
(213 mg, 0.554 mmol, 55%, >20:1 E:Z) as a white foam. Analytical data for 34d: 
1
H NMR (600 MHz, 
CDCl3):  7.98 (d, J = 2.5 Hz, 1H), 7.29 – 7.24 (m, 1H), 7.16 (td, J = 7.6, 1.7 Hz, 1H), 7.03 – 6.94 (m, 2H), 
6.67 – 6.55 (m, 3H), 5.88 (dd, J = 17.4, 1.4 Hz, 2H), 5.18 (d, J = 8.4 Hz, 1H), 4.77 (dd, J = 8.4, 2.6 Hz, 
1H), 3.85 (ddq, J = 58.5, 10.8, 7.2 Hz, 2H), 1.00 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  170.4, 
167.1, 161.0 (d, J = 254.1 Hz), 147.8, 147.3, 132.0 (d, J = 8.7 Hz), 131.9 (d, J = 5.1 Hz), 130.2 (d, J = 2.0 
Hz), 128.7, 128.0, 123.9 (d, J = 3.7 Hz), 122.3, 121.5 (d, J = 12.1 Hz), 115.8, 115.7, 108.8, 108.2, 101.2, 
78.6, 61.5, 47.3 (d, J = 2.5 Hz), 13.7; IR (thin film, cm
-1
): 2984, 1764, 1653, 1488, 1445, 1238, 1198, 
1175, 1038, 760; m.p. 113-115 °C;  TLC (30% EtOAc/hexanes) Rf : 0.22; HRMS (ESI): Calculated for 
[M+H]+ C21H18FO6: 385.1087, Found: 385.1083; []D
25
 +151.5 (c = 0.20, MeOH). 
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Epimerization/Hydrolysis of -Benzylidene--Butyrolactone 59a 
 
To a flame-dried 25 mL round-bottomed flask were added -benzylidene--butyrolactone 34a (250 mg, 
0.631 mmol, 1.0 equiv) and tert-amyl alcohol (12.5 mL). To the resulting semi-solution under nitrogen was 
added sodium tert-butoxide (121 mg, 1.26 mmol, 2.0 equiv). The cream-colored suspension was stirred 
vigorously at room temperature. After 6 h, the reaction was cooled to 0 °C and quenched with 1M HCl (10 
mL). The reaction was extracted with ethyl acetate (2 x 15 mL). The combined organic extracts were 
washed with brine, dried (Na2SO4), and concentrated in vacuo. The crude product was purified by flash 
chromatography (96.5:3:0.5 dichloromethane:methanol:acetic acid). The residue obtained was taken up 
in ethyl acetate (20 mL) and washed with water (3 x 10 mL), brine (10 mL), dried (Na2SO4) and 
concentrated in vacuo to give acid 59a (172 mg, 0.467 mmol, 74%, 14:1 dr) as a cream colored foam. 
Analytical data for 59a: 
1
H NMR (600 MHz, acetone-d6):  7.70 (d, J = 2.0 Hz, 1H), 7.50 (d, J = 8.9 Hz, 
2H), 6.94 – 6.80 (m, 5H), 6.00 (dd, J = 12.5, 1.1 Hz, 2H), 4.88 (d, J = 2.3 Hz, 1H), 4.81 (t, J = 2.3 Hz, 1H), 
3.81 (s, 3H); 
13
C NMR (150 MHz, acetone-d6):  171.0, 170.3, 161.6, 148.6, 147.3, 139.0, 133.9, 132.9, 
126.0, 122.1, 120.3, 114.3, 108.6, 107.3, 101.5, 80.8, 54.9, 47.9; IR (thin film, cm
-1
): 2905, 1759, 1645, 
1601, 1514, 1168, 1038, 736; TLC (94.5:5:0.1 CH2Cl2:MeOH:AcOH) Rf : 0.36; HRMS (ESI): Calculated 
for [M+H]+ C20H17O7: 369.0974, Found: 369.0970; []D
25
 +275.2 (c = 0.10, MeOH). 
1
H NMR (600 MHz, 
CDCl3):  7.80 (d, J = 2.0 Hz, 1H), 7.30 (d, J = 8.6 Hz, 2H), 6.80 (d, J = 8.7 Hz, 2H), 6.79 – 6.74 (m, 3H), 
5.96 (dd, J = 12.8, 1.4 Hz, 2H), 4.85 (d, J = 2.3 Hz, 1H), 4.60 (d, J = 2.2 Hz, 1H), 3.78 (s, 3H). 
13
C NMR 
(150 MHz, CDCl3):  173.9, 171.6, 161.6, 148.7, 147.5, 141.1, 133.0, 132.8, 125.8, 120.2, 120.0, 114.4, 
109.0, 107.2, 101.4, 80.7, 55.4, 48.1. Data reported by Papin in coworkers: 
1
H NMR (400 MHz, CDCl3):  
7.80 (d, J = 1.5 Hz, 1H), 7.30 (d, J = 8.8 Hz, 2H), 6.81 (d, J = 8.8 Hz, 2H), 6.77 (m, 3H), 5.97-5.95 (2d, J = 
1.2 Hz, 2H), 4.84 (d, J = 2.1 Hz, 1H), 4.60 (s, 1H), 3.79 (s, 3H). 
13
C NMR not reported. 
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Preparation of Megacerotonic Acid 1a 
 
To a flame-dried 10 mL round-bottomed flask equipped with magnetic stir bar were added acid 59a (25.0 
mg, 0.068 mmol, 1.0 equiv) and dichloromethane (2.5 mL). To the resulting solution under nitrogen at 0 
°C was added dropwise boron tribromide (105 L, 272 mg, 1.09 mmol, 16 equiv). After 15 min the 
reaction was fitted with a reflux condenser and heated to 45 °C under nitrogen. After 6 h the reaction was 
cooled to room temperature, quenched through the condenser with dropwise addition of 0.1M NaOH (8 
mL), and stirred vigorously for 20 min. The resulting mixture was extracted with ethyl acetate (2 x 10 mL). 
The combined organic extracts were washed with brine, dried (Na2SO4) and concentrated in vacuo. A 
portion of the crude product (5/6) was purified by semi-preparative HPLC (A: 10 mM NH4OAc in water, B: 
90:10 acetonitrile:10 mM NH4OAc in water; A:B 90:10 to 50:50 over 41 min). The fractions collected were 
concentrated on rotatory evaporator to remove acetonitrile and extracted with ethyl acetate (10 mL). The 
aqueous layer was brought to pH = 0 with concentrated sulfuric acid and extracted with ethyl acetate (2 x 
10 mL). The combined organic extracts (excluding the first) were washed with brine, dried (Na2SO4) and 
concentrated to yield megacerotonic acid 1a (6.6 mg, 0.019 mmol, 34%) as colorless, amorphous solid. 
Analytical data for 1a: 
1
H NMR (600 MHz, D2O, referenced to TMS):  7.72 (s, 1H), 7.33 (d, J = 8.5 Hz, 
2H), 6.88 (s, 1H), 6.82 (d, J = 8.2 Hz, 1H), 6.77 (d, J = 8.7 Hz, 2H), 6.73 (d, J = 8.2 Hz, 1H) 4.79 
(overlapped with H2O, 1H), 4.65 (s, 1H); 
1
H NMR (600 MHz, MeOD):  7.67 (d, J = 2.0 Hz, 1H), 7.29 (d, J 
= 8.8 Hz, 2H), 6.74 (d, J = 8.1 Hz, 1H), 6.73 (d, J = 2.2 Hz, 1H), 6.70 (d, J = 8.7 Hz, 2H), 6.63 (dd, J = 8.2, 
2.2 Hz, 1H), 4.78 (d, J = 2.2 Hz, 1H), 4.51, (s, 1H); 
13
C NMR (150 MHz, D2O, referenced to TMS):  
176.4, 176.1, 159.1, 145.4, 144.4, 141.9, 134.3, 133.2, 126.2, 122.7, 120.3, 117.5, 116.6, 115.9, 84.5, 
49.0; IR (thin film, cm
-1
): 3420, 2360, 2341, 1733, 1717, 1636, 1603, 1517, 1254, 1191, 1171, 1058, 834; 
HRMS (ESI): Calculated for [M+Na]+ C18H14NaO7: 365.0637, Found: 365.0638; []D
26
 +171.9 (c = 0.14, 
5% AcOH/H2O). 
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Table 3-7. Comparison of Physiochemical Properties for Megacerotonic Acid 
Data 
Type 
Data Reported in 
Isolation Paper 
Our Synthetic Sample 
Data Reported for Papin 
Synthetic Sample 
1
H NMR 
(D2O) 
1
H NMR (300 MHz, D2O) 
 
4.52 (1H, dd, J= 1.6, 3.0 Hz) 
4.74 (1H, d, J= 3.0 Hz) 
6.53 (1H, dd, J= 2.0, 6.2 Hz) 
6.62 (2H, d, J= 6.6 Hz) 
6.70 (1H, d, J= 6.2 Hz) 
6.82 (1H, d, J= 2.0 Hz) 
7.14 (2H, d. J= 6.6 Hz) 
7.58 (1H, d, J= 1.6 Hz) 
1
H NMR (600 MHz, D2O, 
TMS) 
4.65 (s, 1H) 
Overlapped with H2O 
6.73 (d, J = 8.2 Hz, 1H) 
6.77 (d, J = 8.7 Hz, 2H) 
6.82 (d, J = 8.2 Hz, 1H) 
6.88 (s, 1H) 
7.33 (d, J = 8.5 Hz, 2H) 
7.72 (s, 1H) 
1
H NMR (400 MHz, D2O) 
 
4.63 (ddt, J = 2.5 Hz, 1H) 
4.83 (d, J = 3.1 Hz, 1H) 
6.66 (dd, J = 8.3, 2.2 Hz, 1H) 
6.72 (d, J =8.8 Hz, 2H) 
6.80 (d, J = 8.3 Hz, 1H) 
6.87 (d, J = 2.2 Hz, 1H) 
7.24 (d, J =8.8 Hz, 2H) 
7.66 (d, J = 2.0 Hz, 1H) 
1
H
 
NMR 
(MeOD) 
Not reported 4.51 (s, 1H) 
4.78 (d, J = 2.2 Hz, 1H) 
6.63 (dd, J = 8.2, 2.2 Hz, 
1H) 
6.70 (d, J = 8.7 Hz, 2H) 
6.73 (d, J = 2.2 Hz, 1H) 
6.74 (d, J = 8.1 Hz, 1H) 
7.29 (d, J = 8.8 Hz, 2H) 
7.67 (d, J = 2.0 Hz, 1H). 
Not reported 
13
C 
NMR 
 
13
C NMR (75.5MHz, D2O)  
177.6, 177.5, 161.0, 147.3, 
146.3, 144.0, 136.2, 134.8, 
127.8, 123.9, 122.0, 119.3, 
118.4, 117.8, 85.8, 50.6 
 
13
C NMR (150 MHz, D2O)  
176.4, 176.1, 159.1, 145.4, 
144.4, 141.9, 134.3, 133.2, 
126.2, 122.7, 120.3, 117.5, 
116.6, 115.9, 84.5, 49.0. 
13
C NMR (100 MHz, acetone-
d6) 
172.4, 171.5, 160.6, 146.6, 
145.7, 139.9, 134.1, 132.7, 
126.2, 122.5, 119.3, 116.8, 
116.7, 114.7, 82.0, 48.8 
Rotation 
(5% 
AcOH) 
+233.0 (c 1.66) +171.9 (c 0.14) NA 
IR 
1735 3420, 2360, 2341, 1733, 
1717, 1636, 1603, 1517, 
1254, 1191, 1058, 834 
1735 
MS 
343 (M+H) 360.1083 (M+Na = 
360.1086) 
Not reported 
 
The spectral properties of synthetic megacerotonic acid vary significantly from both those reported by 
Takeda in its isolation as well as that reported by Brown, et al. in their racemic total synthesis. We were 
unable to obtain either a natural sample or synthetic sample. We postulate based on our experience with 
shimobashiric acid A (vide infra) that the differences in NMR shifts observed are a result of concentration 
differences.  A concentration vs. chemical shift study (below) appears to support this hypothesis.  Finally, 
we note that our 
1
H NMR data for 59a matches that of the pentultimate intermediate in the published 
racemic synthesis (vide supra). 
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Table 3-8. 
1
H
 
NMR Shifts as a Function of Concentration 
1H NMR shifts of our synthetic sample as a function of concentration (600 MHz, D2O) 
Concentration Resonance () 
11.6 mg/mL 4.56, 4.73, 6.68, 6.73, 6.78, 6.86, 7.30, 7.67 
5.8 mg/mL 4.59, 4.74, 6.72, 6.77, 6.81, 6.87, 7.34, 7.70 
2.9 mg/mL 4.60, 4.75, 6.74, 6.78, 6.82, 6.87, 7.36, 7.72 
1.5 mg/mL 4.60, 4.75, 6.75, 6.80, 6.83, 6.87, 7.37, 7.73 
0.7 mg/mL 4.61, 4.75, 6.77, 6.80, 6.83, 6.87, 7.38, 7.73 
 
Hydrolysis of Tert-Butoxycarbonyl -Benzylidene--Butyrolactone 34e  
 
To a scintillation vial were added -benzylidene--butyrolactone 34b (50 mg, 0.098 mmol, 1.0 equiv) and 
toluene (2.0 mL). To the resulting solution was added p-toluenesulfonic acid monohydrate (37.1 mg, 
0.195 mmol, 2.0 equiv). The resulting mixture was heated to 75 °C. After 4 h the reaction was cooled to 
room temperature, diluted with 1M HCl (10 mL), and extracted with ethyl acetate (2 x 10 mL). The 
combined organic extracts were washed with brine, dried (Na2SO4) and concentrated in vacuo. The crude 
product was purified by flash chromatography (30-40% ethyl acetate/hexanes) to give -benzylidene--
butyrolactone 34e (36 mg, 0.087 mmol, 89%) as a pale yellow, viscous oil. Analytical data for 34e: 
1
H 
NMR (600 MHz, CDCl3):  7.71 (d, J = 2.2 Hz, 1H), 6.95 (dd, J = 8.3, 2.0 Hz, 1H), 6.83 (d, J = 8.2 Hz, 
1H), 6.77 (d, J = 2.0 Hz, 1H), 6.73 – 6.69 (m, 2H), 6.67 (d, J = 1.6 Hz, 1H), 5.98 (s, 1H), 5.90 (dd, J = 6.9, 
1.4 Hz, 2H), 5.17 (d, J = 8.2 Hz, 1H), 4.79 (dd, J = 8.3, 2.2 Hz, 1H), 3.95 – 3.76 (m, 2H), 3.67 (s, 3H), 
1.03 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  171.4, 167.2, 148.1, 148.0, 147.4, 146.5, 140.4, 
129.6, 126.7, 125.7, 122.3, 121.9, 114.7, 112.3, 108.8, 108.3, 101.3, 78.6, 61.4, 55.9, 47.0, 13.7; IR (thin 
film, cm
-1
): 3420, 2917, 1750, 1636, 1517, 1164, 736; TLC (50% EtOAc/hexanes) Rf : 0.18; HRMS (ESI): 
Calculated for [M+H]+ C22H21O8: 413.1236, Found: 413.1233; []D
25
 +426.0 (c = 0.11, MeOH). 
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Epimerization/Hydrolysis of -Benzylidene--Butyrolactone 59b 
 
To a flame-dried 10 mL round-bottomed flask were added -benzylidene--butyrolactone 34e (20 mg, 
0.048 mmol, 1.0 equiv) and tert-amyl alcohol (2.5 mL). To the resulting solution, after heating to 40 °C, a 
solution of sodium tert-amylate in tert-amyl alcohol (0.87 mL, 0.145 mmol, 3.0 equiv) was added 
dropwise. After 6.5 h, the reaction was cooled to 0 °C and quenched with 1M HCl (3 mL). The reaction 
was extracted with ethyl acetate (2 x 5 mL). The combined organic extracts were washed with brine, dried 
(Na2SO4), and concentrated in vacuo. The crude product was purified by flash chromatography (98:2:0.3 
dichloromethane:methanol:acetic acid). The residue obtained was taken up in ethyl acetate (10 mL) and 
washed with water (5 x 8 mL), brine (5 mL), dried (Na2SO4) and concentrated in vacuo to give acid 59b 
(13.7 mg, 0.036 mmol, 73%, 14:1 dr) as a clear oil. Analytical data for 59b: 
1
H NMR (600 MHz, Acetone-
d6)  7.67 (d, J = 1.5 Hz, 1H), 7.09 (dd, J = 8.3, 2.1 Hz, 1H), 7.02 (d, J = 2.0 Hz, 1H), 6.92 – 6.85 (m, 3H), 
6.82 (d, J = 8.2 Hz, 1H), 6.00 (dd, J = 7.3, 1.1 Hz, 2H), 4.82 (s, 2H), 3.66 (s, 3H).
13
C NMR (150 MHz, 
CDCl3):  172.1, 171.5, 150.0, 149.5, 148.3, 148.2, 140.5, 135.2, 127.2, 126.4, 122.2, 121.3, 116.1, 
114.2, 109.6, 108.1, 102.4, 81.8, 56.2, 48.8; IR (thin film, cm
-1
): 3502, 2917, 2360, 1749, 1716, 1636, 
1518, 1254, 1163, 1036, 817; TLC (94.5:5:0.1 CH2Cl2:MeOH:AcOH) Rf : 0.27; HRMS (ESI): Calculated 
for [M+H]+ C20H17O8: 385.0923, Found: 385.0919; []D
25
 +222.6 (c = 0.17, MeOH). 
Preparation of Shimobashiric Acid A 1b 
 
To a solution of acid 59b (9.6 mg, 0.025 mmol) in toluene (2.0 mL) at room temperature was added 
trifluoromethanesulfonic acid (excess, ~20 drops). After 2 min, the reaction was diluted with water (5 mL) 
and extracted with ethyl acetate (2 x 5 mL). The combined organic extracts were washed with brine, dried 
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(Na2SO4) and concentrated. A portion of the crude product (5/6) was purified by semi-preparative HPLC 
(A: 10 mM NH4OAc in water, B: 90:10 acetonitrile:10 mM NH4OAc in water; A:B 90:10 to 50:50 over 41 
min). The fractions collected were concentrated on rotatory evaporator to remove acetonitrile and 
extracted with ethyl acetate (10 mL). The aqueous layer was brought to pH=0 with concentrated sulfuric 
acid and extracted with ethyl acetate (2 x 10 mL). The combined organic extracts (excluding the first) 
were washed with brine, dried (Na2SO4) and concentrated to yield shimobashiric acid A 1b (4.5 mg, 0.012 
mmol, 48%) as a colorless oil. Analytical data for 1b: 
1
H NMR (600 MHz, MeOD):  7.68 (d, J = 2.0 Hz, 
1H), 6.98 (dd, J = 8.3, 2.0 Hz, 1H), 6.88 (d, J = 2.0 Hz, 1H), 6.77 – 6.75 (m, 2H), 6.75 (d, J = 6.6 Hz, 1H), 
6.66 (dd, J = 8.2, 2.2 Hz, 1H), 4.78 (d, J = 2.3 Hz, 1H), 4.54 (d, J = 2.3 Hz, 1H), 3.55 (s, 3H); 
13
C NMR 
(150 MHz, MeOD)  174.4, 173.2, 150.7, 149.0, 147.3, 146.3, 141.8, 132.9, 128.0, 126.7, 122.0, 119.2, 
117.1, 116.4, 114.9, 114.1, 83.1, 56.3, 49.7; IR (thin film, cm
-1
): 3392, 2919, 2849, 1734, 1635, 1597, 
1518, 1289, 1204, 1179, 1059, 820; HRMS (ESI): Calculated for [M+Na]+ C19H16NaO8: 395.0743, Found: 
395.0740; []D
26
 +295.6 (c = 0.20, MeOH). 
Table 3-9. Comparison of Physiochemical Properties for Shimobashiric Acid A 
Data 
Type 
Data Reported in 
Isolation Paper 
Our Synthetic Sample Obtained Natural Sample 
1
H
 
NMR 
(MeOD) 
1
H NMR (400 MHz, MeOD) 
3.56 (s, 3H) 
4.55 (bs, 1H) 
4.78 (overlapped, 1H) 
6.67 (dd, J = 8.0, 2.0 Hz, 
1H) 
6.75 (d, J = 8.5 Hz, 1H) 
6.77 (d, J = 2.0 Hz, 1H) 
6.77 (d, J = 8.0 Hz, 1H) 
6.89 (d, J = 2.0 Hz, 1H) 
6.99 (dd, J = 8.5, 2.0 Hz, 
1H) 
7.68 (d, J = 2.0 Hz, 1H) 
1
H NMR (600 MHz, MeOD) 
3.55 (s, 3H) 
4.54 (d, J = 2.3 Hz, 1H) 
4.78 (d, J = 2.3 Hz, 1H) 
6.66 (dd, J = 8.2, 2.2 Hz, 1H) 
6.75 (d, J = 6.6 Hz, 1H) 
6.77 – 6.75 (m, 2H) 
 
6.88 (d, J = 2.0 Hz, 1H) 
6.98 (dd, J = 8.3, 2.0 Hz, 1H) 
7.68 (d, J = 2.0 Hz, 1H) 
1
H NMR (600 MHz, MeOD) 
3.55 (s, 3H) 
4.52 (s, 1H) 
4.59 (d, J = 2.2 Hz, 1H) 
6.68 (dd, J = 8.1, 2.2 Hz, 
1H) 
6.73 (s, 1H) 
6.74 (s, 1H) 
6.81 (d, J = 2.2 Hz, 1H) 
6.90 (d, J = 2.0 Hz, 1H) 
6.96 (dd, J = 8.1, 2.0 Hz, 
1H) 
7.61 (d, J =2.1 Hz, 1H) 
13
C 
NMR 
(MeOD)
 
13
C NMR (100 MHz, MeOD) 
174.5, 173.7, 150.7, 149.1, 
147.4, 146.3, 141.7, 133.7, 
128.0, 126.9, 122.5,  119.4, 
117.2, 116.4, 115.1, 114.3, 
83.6,  56.4, 49.5 
 
13
C NMR (150 MHz, MeOD) 
174.4, 173.2, 150.7, 149.0, 
147.3, 146.3, 141.8, 132.9, 
128.0, 126.7, 122.0, 119.2, 
117.1, 116.4, 114.9, 114.1, 
83.1, 56.3, 49.7 
NA 
Rotation 
(MeOH) 
+205.0 (c 0.16) +295.6 (c 0.20) NA 
IR 
Not Reported 3392, 2919, 2849, 1734, 
1635, 1597, 1518, 1289, 
1204, 1179, 1059, 820 
NA 
MS 373.0928 373.0921 (M+H = 373.0923) NA 
152 
The data reported by Murata and coworkers for natural shimobashiric acid A agrees well with data 
obtained with our synthetic sample. We obtained a natural sample of shimobashiric acid A (~0.16 mg) 
from Murata and the 
1
H NMR spectrum of this sample varied significantly for several resonances relative 
to those reported in its isolation (e.g. 4.58 ppm vs 4.78 ppm). Postulating the presence of concentration 
dependent shifts, we analyzed an equal mixture of natural (0.08 mg) and synthetic shimobashiric acid A 
(0.08 mg) by 
1
H NMR spectroscopy. This analysis clearly showed coalescence of the resonances in 
question, indicating concentration dependent changes in NMR resonances.  This feature may be relevant 
in the analysis of megacerotonic acid (vide supra). 
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